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G protein-coupled receptors (GPCRs) constitute a large family of transmembrane
receptors that transduce extracellular signals into intracellular biochemical responses.
Understanding with chemical precision how GPCRs function in cellular membranes is an
active area of biological research, but despite recent reports of X-ray crystal structures of
several GPCRs, some important questions remain unresolved. For example, the kinetics
and thermodynamics of ligand-receptor interactions that lead to receptor activation and
how allosteric modulators affect receptor signaling need to be addressed. In addition to
basic understanding of transmembrane signaling, studies of GPCRs can provide insights
that might advance drug discovery since a large proportion of existing therapeutic agents
target GPCRs. The first aim of my thesis project was to develop a strategy for the
bioorthogonal labeling of GPCRs with useful chemical probes or chemically reactive
handles at specific defined sites. Several strategies were explored to label unnatural
amino acid residues genetically encoded into GPCRs expressed in mammalian culture.
Using the visual pigment rhodopsin (Rho) as a model GPCR, the strain-promoted [3+2]
azide-alkyne cycloaddition reaction (SpAAC) between dibenzocyclooctyne (DIBO) and

p-azido-L-phenylalanine (azF) was shown to be a suitable strategy for attaching labels to
GPCRs. While characterizing the specificity, kinetics, topology-dependent reactivity of
the labeling chemistry, the reaction rate of SpAAC with azF situated in the
transmembrane region of the receptor was enhanced by up to 1000-fold, which was
attributed to DIBO partitioning into the hydrophobic core of micelles. Then a
fluorescence resonance energy transfer (FRET) assay was developed for the labeled Rho
to demonstrate its functionality with respect to ligand binding. Rho consists of a
chromophore ligand, 11-cis-retinal, bound to the opsin via a Schiff base bond. The
photoisomerization of 11-cis-retinal to all-trans-retinal activates the receptor to trigger
the downstream signaling cascade in photoreceptor cells. The Schiff base bond in the
active conformation is prone to hydrolysis, allowing all-trans-retinal to dissociate from
the ligand-binding pocket. The ligand-free opsin then recombines with 11-cis-retinal to
complete the visual cycle. The FRET assay used to measure the reaction rates of
bioorthogonal labeling chemistries also enabled measurement of retinal entry kinetics and
was utilized first to address the energetics of the recombination reaction between opsin
and 11-cis-retinal. The activation energy for retinal binding was obtained from the
temperature-dependent retinal entry kinetics. The reaction enthalpy was measured by
isothermal titration calorimetry (ITC). The activation energy for the reverse reaction was
measured by chromophore exchange of the bound 11-cis-retinal with exogenous 9-cisretinal. Based on these results, the complete energy diagram was derived for the binding
between 11-cis-retinal and opsin. Additional studies were carried out to determine how
retinal entry and release kinetics were affected by site-directed mutagenesis of set of
highly conserved amino acid residues postulated to be in the pathway for retinal entry

and/or release. A set of mutations located at the fifth and sixth transmembrane (TM)
helices was found to exert a much greater influence on the retinal entry kinetics than on
the retinal release kinetics. Three criteria were used to evaluate the influence of these
mutations: 1) the correlation between side-chain size and entry kinetics; 2) the change in
the activation energy for retinal entry; 3) the effect of increasing polarity at these sites.
Based on these findings, a model was proposed to describe the retinal entry pathway
leading from the membrane-embedded receptor surface to the ligand-binding site in the
transmembrane core. In summary, the methods described in this thesis add to the
chemical biology tool kit for probing the structure-function relationship in GPCRs. As a
specific application of the methodology a detailed analysis is presented that describes the
kinetics and thermodynamics of ligand binding and release in the prototypical GPCR
rhodopsin. Additional applications of the current methodology include, for example,
single-molecule studies of the GPCR signaling complex.
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Chapter One: Introduction

1.1.

G protein-coupled receptors as important drug targets
The G protein-coupled receptor (GPCR) superfamily constitutes the largest group

of transmembrane receptors. All GPCRs share seven transmembrane helices as a
common structural framework and several highly conserved amino acid residues reside
within the transmembrane domain and define receptor sub-classes. As discussed below,
the ligand-binding pocket for class A GPCRs is generally situated within the
transmembrane core region. The extracellular N-terminus, intracellular C-terminus and
the loops between transmembrane helices are much less well conserved but nevertheless
play critical roles in defining receptor trafficking and receptor-G protein interaction,
among other functions.
Despite the common structural features, GPCRs respond to a wide array of stimuli
that are chemically (photon, ions, small molecules, lipids, peptides, proteins) and
functionally (hormones, neurotransmitters, cytokines, ordorants, etc.) divergent. Not
surprisingly, GPCRs mediate a myriad of physiological processes and are widely
implicated in diseases, making them the most important category of all the known drug
targets (Overington et al., 2006). Notable examples include β blockers targeting β
adrenergic receptor for treating hypertension, and HIV entry blockers targeting the
chemokine CCR5 receptor for treating AIDS.
The GPCR superfamily is further divided into five classes named after their
representative member: rhodopsin (class A), Secretin (class B), Adhesion (originally class
B), Glutamate (class C), and Frizzled/Taste2 (Bockaert and Pin, 1999). The rhodopsin
1	
  

receptor family is the largest category, covering a number of nearly 700 receptors
(Lagerstrom and Schioth, 2008).

Figure 1-1. The GPCR signaling pathway. A wide range of ligands can activate
GPCRs. The activated receptor activates the heterotrimeric G protein. The downstream
signaling pathway is determined by the type of Gα being activated by the receptor. The
four classes of Gα are specialized to activate adenylyl cyclase (Gs), inhibit adenylyl
cyclase (Gi), activate phospholipase C (Gq), and regulate guanine nucleotide exchange
(G12/13). The biological response may range from transient events (e.g., opening of ion
channel) to long-term change (e.g., gene expression). Figure taken from (Dorsam and
Gutkind, 2007).
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1.2

Intracellular signaling through GPCRs
GPCRs are exquisitely regulated signaling machines. As the name suggests, the

canonical signaling pathway involves the coupling between the receptor and G protein.
Unlike many other important transmembrane receptors, such as ligand-gated ion channel
receptors and enzyme-coupled receptors, GPCRs lack catalytic activity and requires the
heterotrimeric G protein (Gαβγ) to serve as an intermediate between receptor and effector.
Specifically, GPCR activation by agonist binding leads to GDP-GTP exchange in the Gα
subunit and subsequent decoupling of Gα with Gβγ and receptor. In this regard, GPCRs
functions as a guanine nucleotide exchange factor (GEF). Gα is a weak GTPase whose
activity is regulated by GTPase activating proteins (GAPs). The hydrolysis of GTP to
GDP deactivates Gα and eventually results in the re-association of Gα with Gβγ (Oldham
and Hamm, 2008).
Besides the G protein cycle, the duration of signaling is also regulated through a
process termed desensitization. The receptor can be phosphorylated by GPCR kinases
(GRKs) to induce arrestin binding, which prevents further interaction between receptor
and G protein, and induces endocytosis of the receptor to reduce the density of receptors
on the cell surface.
The picture described here, however, is quite primitive, with many key questions
to be tackled. One important question open to debate concerns the allosteric regulation of
GPCRs. In the classic scenario, ligand-receptor binding precedes receptor-G protein
binding (the “free collision” model). Meanwhile, there is increasing evidence suggesting
that G protein may engage receptor prior to agonist binding (the “pre-coupling” model),
which in turn increases receptor’s affinity to the ligand (Oldham and Hamm, 2008;
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Nobles et al., 2005). Whether the pre-assembled receptor-G protein complex exists in the
cellular context, and if so, what is their physiological significance, is being actively
investigated. Another pharmacologically significant question is the biased signaling of
GPCRs. A particular ligand may not elicit the full repertoire of downstream signaling, but
selectively activate some of the pathways (Violin and Lefkowitz, 2007). Because many
GPCRs mediate more than one downstream signaling pathway with important
physiological consequence, these biased ligands may be exploited to precisely target the
most relevant pathway while leave the rest undisrupted. Addressing these questions often
require a detailed understanding on the conformational dynamics and heterogeneity of
GPCRs.
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1.3

Rhodopsin as a Model System for Studying GPCR: a Historical Perspective
This thesis presents novel chemical approaches for studying GPCR signaling

complex, using the visual photoreceptor rhodopsin as the model system, an excellent
prototypical receptor for class A GPCRs. Here I would like to briefly review the history
of research on rhodopsin to illustrate how knowledge accumulated for a particular
receptor contributed to the grand picture of GPCRs.
1.3.1 The early years of research on rhodopsin
The scientific quest on the biochemistry of visual process has a long-standing
history dating back to the 1830s, when microscopic anatomists began to investigate the
fine structure of the eye and its associated parts. These efforts led to the identification of
the layer structure of retina, including the outer layer consisting of cones and rods, and
the connectivity between retina and nerve fiber. Although the overall importance of retina
in visual function was evident, it remained controversial on which element of retina
mediates the light-sensing function. Heinrich Müller, an anatomist working in Würzburg,
showed that the nerve fibers terminates at the rods and cones, supporting the view that
rods and cones are responsible for light-sensing (Schickore, 2000). Moreover, Müller was
the first to describe the reddish color of vertebrate rod cells.
The significance of Müller’s seminal finding was made clearer by the work of
Franz Boll, who described in 1876 that the red-purple color of rod changed to yellow
upon photobleaching in a wavelength-dependent manner, and that the red color could be
regenerated in the live animal in the dark (Boll, 1876). The reversible change of color
strongly suggested a direct connection between rod cells and the visual action, and
immediately inspired Willy Kühne, a physiologist well acquainted with chemical
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approaches, to pursue this question. Kühne decided that purple was more suitable than
red for describing the color of rod, and coined the neologism “visual purple (sehpurpur)”,
and later “ rhodopsin” to refer to this colored substance. Kühne, together with his
assistants, produced a strikingly large body of knowledge into the chemistry of visual
system that remained unsurpassed for the next fifty years. They found that in contrary to
Boll’s claim, visual purple was not degraded upon death of animal. The photobleaching
of this purple substance involved an intermediate yellow species and the rate of
photobleaching was dependent on the wavelength and intensity of incident light. The
regeneration of visual purple required direct contact between retina and fresh pigment
epithelium. They extracted visual purple with bile salt, and performed the recombination
reaction in vitro by combining the retina and pigment epithelium extraction. Because
visual purple could be salted out, but did not penetrate semi-permeable membrane, Kühne
inferred it to be a protein (Gamgee, 1877; Kühne, 1878; Wolf, 2001).
The pioneering works by the physiologists in the 19th century established the idea
that visual function involved a chemical process in the rod cells of retina. The subsequent
development of spectrophotometry enabled quantitative verification of Kühne’s
qualitative description. Selig Hecht, a biophysicist at Columbia University, proposed a
conceptual scheme for this reversible chemical process. Visual excitation is initiated by
the dissociation of the photosensitive pigment (S) into two molecules (S→P+A), and one
of the resulting products mediates the photo excitation. In turn, the pigment was
regenerated by the recombination of P and A, or a variant P +B (Wald, 1968). A major
contribution by Hecht was the recognition of the quantal nature of visual photochemistry.
He showed that visual excitation only required 5 to 8 photons, an incredibly small
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number, thus the visual system must possess an exceptional efficient signal amplification
mechanism (Hecht et al., 1942).
In 1930s, various lines of evidence suggested visual purple was a protein with a
colored prosthetic group (Hecht, 1942). George Wald, Hecht’s pupil, made a crucial step
towards uncovering the chemical nature of rhodopsin. Inspired by the observation that
dietary night blindness resulted from vitamin A deficiency, Wald showed by UV-Vis
spectroscopy that the chloroform extraction from retina contained a considerable
concentration of vitamin A (Wald, 1933), and proposed that rhodopsin was a carotenoidbound protein (Wald, 1934). In the ensuing years, Wald studied every species he could
possibly obtain, and concluded all the visual pigments, including the cone receptors for
photopic color vision and rod receptor for scotopic vision, shared a similar architecture: a
molecule of retinal bound to a colorless protein opsin, and it was the difference in opsins
that produced the characteristic absorption spectrum for each pigment (Wald, 1953,
1964). The abundance of rhodopsin in bovine retina made it possible for enough material
to be obtained in large quantity, which was non-trivial in an era prior to the advent of
recombinant protein technology. Using bovine rhodopsin as the model system, Wald and
his co-workers delineated the serial conversion of retinoids in the visual cycle (Wald et
al., 1950; Wald and Brown, 1950; Hubbard and Wald, 1952), and elucidated how retinal
was attached to the apoprotein opsin (Bownds and Wald, 1965; Bownds, 1967). These
findings were summarized in Figure 1-2.
1.3.2 Rhodopsin found to be a GPCR
By the year of 1967 when Wald was awarded the Nobel Prize in Physiology or
Medicine, his relentless investigation had pushed the research on rhodopsin to the

7	
  

boundary of the contemporaneous chemical and spectroscopic methodologies.
Nonetheless, how rhodopsin could convert photo-signal into neuroelectric signal could
not be answered without explicit knowledge on the action of opsin. In the late 1970s
sequencing of soluble globular protein was routine. However, sequencing a highly
hydrophobic molecule like rhodopsin remained a formidable challenge. Paul Hargrave, a
leading peptide biochemist, overcame a series of technical difficulties to determine the Nand C-terminal sequence of rhodopsin (Hargrave and Fong, 1977; Hargrave et al.,
1982a), locate the lysine that formed a Schiff base bond with retinal (Wang et al., 1980;
Hargrave et al., 1982b), and characterize the oligosaccharides attached to the N-terminus
(Fukuda et al., 1979, 1982).
From 1982 to 1983, the Ovchinnikov group based in Moscow (Ovchinnikov,
1982) and the Hargrave group (Hargrave et al., 1983) independently published their
magnum opus: the complete amino acid sequence of rhodopsin. The primary structure
yielded the critical insight that the polypeptide of rhodopsin folded into seven
transmembrane helices (Figure 1-3) (Ovchinnikov, 1982; Hargrave et al., 1983). It also
suggested a structural and functional homology between rhodopsin and another known
retinal-bound protein bacteriorhodopsin (Ovchinnikov, 1982).
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Figure 1-2. Summary of the knowledge on the visual cycle by 1968. A) The structures
of 11-cis-retinal (1), 11-cis-retinol (2), all-trans-retinal (3), all-trans-retinol (4) and alltrans-retinyl ester (5). B) The proposed diagram of rod visual cycle. The enzymes in the
visual cycle identified after 1968 are colored in red. The question mark represents the
enzymes Ward hypothesized to exist. The photobleaching of rhodopsin by light causes
11-cis-retinal to isomerize to all-trans retinal that subsequently dissociates from opsin.
All-trans-retinal is then reduced to its alcohol form by all-trans retinol dehydrogenase
(all-trans RDE) (Rattner et al., 2000), the only enzymatic activity identified in the visual
cycle by 1968(Koen and Shaw, 1966). All-trans-retinol then forms all-trans retinyl ester
with fatty acid by the activity of lecithin retinol acyltransferases (LRAT) (Saari and
Bredberg, 1989; Ruiz et al., 1999). All-trans-retinyl ester is isomerized and de-esterified
to yield 11-cis-retinol by the activity of RPE65 isomerohydrolase, without producing 11cis-retinyl ester. The long-awaited retinoid isomerase was first identified through mouse
genetics (Redmond et al., 1998), then characterized by biochemical approach (Jin et al.,
2005; Moiseyev et al., 2005; Moiseyev et al., 2006). 11-cis-retinol was oxidized to 11cis-retinal by 11-cis-retinol dehydrogenase (Simon et al., 1995; Simon et al., 1996).
Rhodopsin is synthesized by the recombination of opsin and 11-cis-retinal, thus
completing the visual cycle. C) The photoactivation of rhodopsin. Light causes the bound
11-cis-retinal to isomerize to all-trans retinal. The all-trans-retinal bound opsin
undergoes through a series of short-lived photo-intermediates (λmax indicated in the
bracket): the 543-nm species (pre-lumi, now commonly referred to as “batho”), the 497nm species (lumi), 478-nm species (Meta-I), 380-nm species (Meta-II), ending in the
dissociation of retinal. These were characterized at low temperatures. The photobleaching
of opsin results in the exposure of new chemical groups, including two thiols groups
(Wald and Brown, 1953) and one proton-binding group. However, Wald incorrectly
positioned retinal on the surface of opsin. The first clue indicating retinal is located in the
hydrophobic core of the disc membrane came the FRET study by the Stryer group
(Thomas and Stryer, 1982). Figure adapted from (Wald, 1968; Nobel Prize lecture)
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Figure 1-3. The topological model of rhodopsin, with functionally important sites
highlighted. Compared with the model proposed in 1983, this model differs slightly in
the assignment of the boundary between the helices and loops. It also incorporated the
information on the site of glycosylation (Fukuda et al., 1979), palmitoylation(Moiseyev et
al., 2006), a critical disulfide bond (Karnik et al., 1988), and molecular determinants for
transducin binding and activation (Franke et al., 1988; Franke et al., 1990). Figure taken
from (Hargrave and Mcdowell, 1992).
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The disclosure of the peptide sequence of rhodopsin quickly led to the advent of
molecular biology of vision: the cloning of the gene encoding bovine rhodopsin (Nathans
and Hogness, 1983), human rhodopsin (Nathans and Hogness, 1984), fruit fly rhodopsin
(Zuker et al., 1985), and human cone receptors for color vision (Nathans et al., 1986).
In the mid-1980s, a groundbreaking advance closely related to rhodopsin was
made at a different frontier. The cloning of β-adrenergic receptor (Dixon et al., 1986;
Frielle et al., 1987)and α-adrenergic receptor (Kobilka et al., 1987) shed light on the
similarity between rhodopsin and adrenergic receptors, which was naturally predicted to
possess seven transmembrane helices. It was quickly appreciated that the similarities
between the visual photoreceptors and endocrine receptors was beyond simple sequence
and structural homology; they resembled each other in the pattern of signaling.
Since late 1950s, the idea of intracellular signal transduction through secondary
messenger has seized intense attention. In fact, the canonical stimulatory G protein (Gs)adenylyl cyclase pathway was first elucidated for the epinephrine system. It embarked
with the discovery of the first secondary messenger, cyclic adenosine monophosphate
(cAMP) (Rall et al., 1957; Rall and Sutherland, 1958). Four years later, the synthetic
enzyme adenylyl cyclase (Sutherland et al., 1962) and degrading enzyme
phosphodiesterase (Butcher and Sutherland, 1962) of cAMP were purified. It was not
long before another cyclic nucleotide, cyclic guanosine monophosphate (cGMP), joined
the class of secondary messenger molecules (Ashman et al., 1963). In the 1970s, it was
found that the production of cAMP requires guanosine triphosphate (GTP) (Rodbell et
al., 1971a; Rodbell et al., 1971b) and a protein component with GTPase activity, later
known as the G protein (Ross and Gilman, 1977a, b).
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In the beginning of 1980s, the cyclic GMP cascade in rod cells had come into
prominence. The observed dramatic hydrolysis of cGMP in rod cells upon illumination
(Woodruff and Bownds, 1979; Yee and Liebman, 1978) and depolarization of ROS
plasma membrane caused by exogenously injected cGMP (Miller and Nicol, 1979) were
consistent with the key features of the visual system: 1) exceptional capability of signal
amplification and 2) coupling between chemical reaction and neuroelectric signal. The
major enzymatic components, cyclic GMP phosphodiesterase (Bitensky et al., 1975; Miki
et al., 1975; Keirns et al., 1975) and GTPase transducin (Wheeler and Bitensky, 1977;
Fung et al., 1981), as well as their interdependence (Kühn, 1980) had been characterized
by the collective efforts of several groups, notably the Bitensky group at Yale University,
the Stryer group at Stanford University and the Kühn group in the Federal Republic of
Germany. In fact, years before the cloning of β2-adrenergic receptor, the analogy between
the light-activated signaling pathway in rod outer segment and epinephrine-stimulated
signaling pathway in hormone-sensitive cells had been articulated first by Bitensky
(Shinozawa et al., 1979; Bitensky et al., 1981; Stein et al., 1982; Bitensky et al., 1982),
then by Stryer (Stryer, 1983, 1986). The flow of information involved the common steps:
1) the extracellular signal activates the receptor; 2) the receptor then stimulates the GDPGTP exchange in a G protein; 3) the GTP-bound G protein acts on a enzyme that
catalyzes the degradation (phosphodiesterase for light-activated pathway) or synthesis
(adenylyl cyclase for the epinephrine-stimulated pathway) of a cyclic nucleotide (Figure
1-4). The sequence and structural homology between photoreceptors and adrenergic
receptors cemented the parallelism, which is now known as the classic G protein-coupled
receptor signaling pathway (Dohlman et al., 1987). The new realization rectified the old
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thought that seven transmembrane helices was the structural hallmark of light-sensing
protein.
The conservation of GPCR pathway implied that the findings about rhodopsin
might also hold true for other receptors. One excellent example was the cloning of
arrestin, the protein regulating the desensitization of GPCRs. In 1983, it was recognized
that agonist-induced desensitization of β2-adrenergic receptor was dependent on
phosphorylation (Stadel et al., 1983; Lefkowitz et al., 1983). However, purified β2adrenergic receptor (GRK2) lost its ability to desensitize the β2-adrenergic receptor,
suggesting an essential component was missing (Benovic et al., 1987a). Around the same
time, the Kühn group identified and purified a 48-kDa protein in rod outer segment that
binds with photoactivated rhodopsin and quenches the cGMP cascade (Pfister et al.,
1985; Wilden et al., 1986). It was quickly shown this 48-kDa protein, later renamed
arrestin, restored the ability of β2-adrenergic receptor kinase to desensitize β2-adrenergic
receptor (Benovic et al., 1987b). The cloning of rhodopsin arrestin (Shinohara et al.,
1987) enabled design of a appropriate hybridization probe leading to the cloning of βarrestin (Lohse et al., 1990). The role of GRK and arrestin in GPCR desensitization
turned out to be a general mechanism for regulating GPCR signaling (Premont and
Gainetdinov, 2007).
If we consider Boll’s work in 1876 marked the beginning of visual chemistry
(Boll, 1876), and the research on adrenergic receptor commenced with the isolation of
epinephrine by Takamine in 1900 (Bennett, 1999; Rubin, 2007), the two fields have
evolved independently for multiple decades before they intersected in the mid 1980s. It
is worth noting that this discovery also inspired the cloning of a large family of olfactory
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receptors (Buck and Axel, 1991), which earned Linda Buck and Richard Axel the 2004
Nobel Prize in Physiology or Medicine.

Figure 1-4. Comparison of the signaling pathway in rod outer segment (A) and
hormone-sensitive cells (B). R: rhodopsin or the adrenergic receptor at the basal state;
hν: photon; H: hormone (e.g. epinephrine); R*: photoactivated rhodopsin; RH: hormonereceptor complex; T: transducin; G: stimulatory G protein (Gs); ACi and AC*: inhibited
and activated form of adenylyl cyclase; PDEi and PDE*: inhibited and activated forms
cGMP phosphodiesterase. Both pathways terminate with the hydrolysis of bound GTP
through the GTPase activity of T or G. Another parallel is that cholera toxin catalyzes the
ADP-ribosylation of both T and G, and blocks their GTPase activity. Figure adapted from
(Stryer, 1983)
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1.3.3 Rhodopsin as a model system for understanding the structure-function
relationship of GPCRs
The discovery of the seven transmembrane helices of GPCRs was both
illuminating and tantalizing. One way to decode the seven helices was to see how small
perturbation to the integral structure would alter the function. The Khorana group
designed the first synthetic gene for bovine rhodopsin (Ferretti et al., 1986), and
demonstrated the heterologous expression of rhodopsin in mammalian cell culture
(Oprian et al., 1987), which paved the way for site-directed mutagenesis study of
rhodopsin. From the late 1980s to 1990s, this approach proved extremely prolific in
understanding the precise structure–function relationship of rhodopsin, yielding
information on the molecular determinants for maintaining the correct folding of the
receptor (Karnik et al., 1988), modulating the stability prorogated Schiff base (Sakmar et
al., 1989, 1991; Nakayama and Khorana, 1991); defining rhodopsin-transducin
interaction (Franke et al., 1990); leading to retinal diseases (Liu et al., 1996; Garriga et
al., 1996; Mollaaghababa et al., 1997), and conferring constitutive activity in the absence
of photoactivation (Kim et al., 1997; Han et al., 1998).
A crucial insight from the mutagenesis study was that rhodopsin activation
involved the rigid-body movement of TM3 and TM6. Spin labels attached to the
cytoplasmic end of TM3 and TM6 indicated a change in their distance in response to
photoactivation (Farrens et al., 1996). When its cytoplasmic end of TM3 and TM6 were
held together by metal ion binding (Sheikh et al., 1996) or by disulfide crosslinking
(Farrens et al., 1996) illuminated rhodopsin failed to activate transducin. These findings
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demonstrated that the relative movement between TM3 and TM6 was essential for
rhodopsin activation.
Another strategy for understanding the seven transmembrane helices was to
examine the structure at higher resolution. In 1993, Schertler and his co-workers obtained
projection structure of rhodopsin at 7-9 Å resolution, providing the first clue for the
arrangement of the seven helices (Schertler et al., 1993). The first high-resolution X-ray
crystal structure of rhodopsin was published in 2000 by Palczewski and his co-workers
(Palczewski et al., 2000). More refined structures that revealed the conformation of 11cis-retinal bound in the binding pocket and internal water network ensued within a few
years (Teller et al., 2001; Li et al., 2004; Okada et al., 2004). These structures of
rhodopsin served as a framework for interpreting the previous biochemical data
accumulated through the mutagenesis studies (Sakmar et al., 2002). It also enabled the
identification of “switches” motifs responsible for maintaining rhodopsin at its basal
state. In 2007, the Kabila group and the Stevens group reported the high-resolution
structures of engineered β2-adrenergic receptor at its inactive state (Rosenbaum et al.,
2007; Rasmussen et al., 2007; Cherezov et al., 2007). A comparison on the structures of
rhodopsin and β2-adrenergic receptor again revealed a high degree of similarity (Figure 5A), proving the utility of rhodopsin as a mode system for studying GPCRs.
The follow-up efforts were devoted to capture functionally relevant
conformations of rhodopsin. The structures of bathorhodopsin(Murakami and Kouyama,
2011; Nakamichi and Okada, 2006a), lumirhodopsin(Nakamichi and Okada, 2006b), a
photoactivated deprotonated intermediate (Salom et al., 2006), and electron
crystallography map of Meta I (Ruprecht et al., 2004)were obtained between 2004 and

17	
  

2006. Two year later, the crystal structures of ligand-free opsin(Park et al., 2008) and
opsin in its G protein-interacting form (Scheerer et al., 2008) were acquired, followed by
the structure of Meta-II rhodopsin (Choe et al., 2011), constitutively active mutant
(Standfuss et al., 2011; Deupi et al., 2012a), and disease mutant (Singhal et al., 2013).
Thus rhodopsin became the first GPCR whose inactive, active and discrete intermediate
states have been crystallized. Comparison of the inactive and the active conformation
confirmed the helix movement model for receptor activation proposed based on the
biochemical studies of rhodopsin in 1990s (Figure 5-C) (Farrens et al., 1996; Sheikh et
al., 1996), and shed light on how photoisomerization transforms retinal from an inverse
agonist to an agonist (Choe et al., 2011; Standfuss et al., 2011). These structures together
provided a framework for understanding the molecular basis of GPCR activation (Deupi
and Kobilka, 2010; Deupi et al., 2012b; Deupi, 2014). Dark-state rhodopsin is thought to
represent the most energetically stable conformation of GPCRs, and activation involves
the accumulative local structural changes that culminate in pronounced helix movement,
particularly the outward tilt of TM6 (Deupi et al., 2012b). It also renovated the simplistic
two-state model for GPCR activation: between the two extremes of the fully inactive and
the fully active conformation there are a series of intermediates; the role of ligand is to
shift the equilibrium of population by altering the energy landscape (Deupi and Kobilka,
2010).
The crystal structures of rhodopsin facilitated rational design of biophysical
experiment to track the sequence and dynamics of conformational changes in receptor
activation (Altenbach et al., 2008a; Ye et al., 2010). Moreover, they served as templates
for homology modeling of GPCRs for virtual drug screening (Archer et al., 2003; Evers
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and Klabunde, 2005), and enabled molecular dynamic simulations to receptor selfassembly in the context of lipid bilayer (Periole et al., 2007; Periole et al., 2012).
In 2011, two structures of β2-adrenergic receptor at its active state, one stabilized
by a nanobody (Rasmussen et al., 2011a), the other stabilized by irreversible agonist
binding (Rosenbaum et al., 2011), were resolved by the Kobilka group. The active-state
structures of β2-adrenergic receptor are remarkably similar to that of rhodopsin (Figure 5C), thus completely validating the helix movement model of GPCR activation. At the
same time, the GPCR field witnessed another important breakthrough: for the first time
an active GPCR in complex with its G-protein partner was crystallized (Rasmussen et al.,
2011b). This structure revealed important contacts on the receptor-G protein interface and
conformational changes that lead to the opening of nucleotide binding pocket.
Currently the number of GPCR crystal structures are still rapidly increasing
(Stevens et al., 2013). In addition to class A GPCRs, class B (Siu et al., 2013) and the
transmembrane domain of class C receptors (Wu et al., 2014; Dore et al., 2014) have also
been successfully obtained. Despite the wealth of knowledge produced from the
structural studies, crystallography has its inherent limitations. First of all, obtaining a
structure for any GPCR remains an expensive and time-consuming task. The reasons
underlying this difficulty include low expression level of receptors in most expression
systems, hydrophobicity of membrane proteins, and the intrinsic structural instability
associated with the basal activity exhibited by most GPCRs. Consequently, except for
rhodopsin, extensive engineering is often required for increasing the thermal stability of
receptors, such as point mutagenesis, T4 lysozyme fusion in the intracellular loop, and
antibody stabilization. However, these altered regions are implicated in receptor-G
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protein or receptor-arrestin interaction. This has complicated the interpretation of the
structures. Second, GPCR activation involves more than two “on” and “off” states, while
a structure only gives the “snapshot” of one conformation. It is particularly challenging to
capture the active state that naturally tends to relax to the energetically favored inactive
state. Not surprisingly, so far active-state structures have been obtained only for a few
extensively characterized GPCRs. For most other GPCRs it will be a formidable task to
obtain enough structures to cover all the relevant conformations. Third, the static nature
of crystal structures provides little insights into the dynamics of receptor activation. All
these considerations raise a need for developing new methodologies.
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Figure 1-5. Comparison of the structures of rhodopsin and β2-adrenergic receptor.
A) The structures of inactive rhodopsin (cyan, PDB 1U19) (Okada et al., 2004) and
inactive β2-adrenergic receptor (mauve, 2RH1) (Rasmussen et al., 2007). B) The
structures of active metarhodopsin (grey, 3PQR) (Choe et al., 2011) and active-state β2adrenergic receptor (orange, 3CAP) (Rasmussen et al., 2011a). Comparison of the
intracellular side of C) inactive rhodopsin and inactive β2-adrenergic receptor and D)
active metarhodopsin and active β2-adrenergic receptor. In the active conformation, the
outward tilt of the cytoplasmic end of TM6 is 6-7 Å and 11 Å in rhodopsin and β2adrenergic receptor, respectively.
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1.4

Chemical approaches for studying GPCRs
A unique craft of chemists is to tailor the property of molecules for tackling

biological problems, which has contributed tremendously to the GPCR field on various
topics, for example, mapping the ligand-receptor binding mode. Before it became
possible to crystallize GPCRs, crosslinking ligand to the receptor was one of the few
ways to interrogating ligand-receptor binding. Even with the great advance in structural
biology of GPCR, the resources needed to acquire the crystal structure for a ligandreceptor complex make it beyond a routine process. More importantly, many ligandreceptor complex are simply too unstable to be crystallized. Therefore, crosslinking often
represents a more practical option (Grunbeck and Sakmar, 2013). This approach, despite
the trials and errors involved to validate the function of the derivatized ligand, has
produced valuable insights. The Khorana designed a photocrosslinking 11-cis-retinal
analog by modifying the β-ionone ring with a diazirine group (Nakayama and Khorana,
1990a). Subsequent photocrosslinking experiment with opsin unambiguously assigned
the β-ionone between TM3 and TM6 (Nakayama and Khorana, 1990b), and mapped the
residues in proximity with retinal (Nakayama and Khorana, 1991). Based on this
photocrosslinking analog, the Nakanishi group further locked the cis-double bond by
adding a six-membered ring. This analog could not undergo the cis-trans
photoisomerization, so it was possible to selectively crosslink retinal with the inactive
receptor. They found that the relative position of β-ionone ring was closer to TM6 in the
dark-state, but shifted to TM3 in the Meta-II state (Zhang et al., 1994). These findings
from photocrosslinking experiments were one decade ahead of the crystal structures
(Palczewski et al., 2000; Choe et al., 2011).
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Nonetheless, understanding the ligand binding mode should not be narrowly
interpreted as knowing the contacts between the ligand and the binding pocket, but how
these contacts are correlated to the function of the receptor. For example, adrenergic
receptor has never been crystallized in complex with important native ligands like
epinephrine or norepinephrine. Yet as early as 1910 the functional groups important for
stimulating the sympathetic response were defined through systematic variation of the
chemical structure of epinephrine (Barger and Dale, 1910). The knowledge on the
structure-activity relationship of adrenergic ligands played an indispensible role in drug
development and fundamental scientific inquiry, including developing the high-affinity
ligands for treating asthma, hypertension, depression, etc. These ligands also proved
powerful tools for investigating fundamental biological questions. For example, the
existence of adrenergic receptors on cell membrane as distinct molecular entities was
open to debate even at the beginning of 1970s. To prove the receptor theory, one needs to
show that ligands specifically bind to surfaces of the cells expected to express the
receptors. This was a challenging experiment, because the adrenergic receptor only
constitutes a small population among the cell-surface proteins. The well-characterized
native ligands were generally not ideal reagents for such purpose, primarily due to their
low affinities and lack of selectivity between α- and β-subtypes. Therefore, when
Lefkowitz and his co-workers set out to search for adrenergic receptors, they chose [3H]
alprenolol for β-adrenergic receptor (Lefkowitz et al., 1974) and [3H]dihydroergocryptine
for α-adrenergic receptor (Williams and Lefkowitz, 1976), both were synthetic highaffinity antagonists with an unsaturated double bond. The tritium labeling was done
through the textbook palladium-catalyzed hydrogenation reaction of alkenes. They were
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able to show that these ligands could bind with the cell membrane in a manner fulfilling
all the properties predicted by the physiological studies: competitive, subtype-selective,
and stereospecific, thereby fully establishing the receptor theory.
For a long period of time, the focus of the chemical toolkit for studying GPCRs
has been on the ligands. In the recent years, our laboratory has expanded the horizon by
developing a general platform for modifying the chemical properties of receptors, which
shall be discussed in greater details in Chapter Two.
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Chapter Two: Bioorthogonal Labeling of Functional GPCRs

2.1

Summary
We have developed a general approach for site-specific bioorthogonal labeling of

G protein-coupled receptors (GPCR). We utilized rhodopsin (Rho), a prototypical class A
GPCR as the model system to study the labeling chemistry. We incorporated ketone and
azide functionality into the receptor by uaa mutagenesis. We performed a comparative
study for two labeling strategies, one targeting the keto group and the other targeting the
azido group. We carried out kinetic analysis of the model reactions, and quantified the
extent of non-specific labeling. We demonstrated the superior bioorthogonality of the
azido group, and concluded that strain-promoted [3+2] azide–alkyne cycloaddition
(SpAAC) reaction of dibenzocyclooctyne (DIBO) with azF is a suitable choice for
labeling discrete sites located in the EC, IC and TM region of Rho with fluorophores. We
found that azF residues situated on the transmembrane surface of detergent-solubilized
receptors exhibit up to 1000-fold rate enhancement compared with azF residues on waterexposed surfaces. We showed that the amphipathic moment of the labeling reagent,
consisting of hydrophobic DIBO coupled to hydrophilic Alexa dye, results in strong
partitioning of the DIBO group into the hydrocarbon core of the detergent micelle and
consequently high local reactant concentrations. The observed rate constant for the
micelle-enhanced SpAAC was comparable with the fastest bioorthogonal labeling
reactions known. Finally, we utilized the azF-Rho labeled with Alexa488 to measure the
kinetics of ligand uptake in a membrane-mimetic bicelle system. We found that the
modification barely perturb the behavior of the receptor with respect to ligand binding.
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2.2

Introduction

2.2.1 Approaches for labeling GPCRs with chemical probes
Biophysical and biochemical studies of GPCRs often rely on the attachment of
appropriate probes to receptors. When designing such experiments, three interrelated
issues need to be taken into consideration: what kind of probes should be introduced,
which region of receptor should be modified with the probe, and how to anchor the probe
to the site of interest. The ideal methodology should be general, i.e., not dependent on the
specific property of the receptor, minimally perturbs its intrinsic functionality, and allow
for flexibility in choosing where to attach the label.
The choice of probe is dictated by the particular question being asked. The
possible probes vary greatly in term of chemical property and span a wide range of
molecular size, from fusion proteins, to small molecules, and to isotopic labels. Among
various types of probes that have been successfully applied to GPCRs, fluorescence is a
particularly powerful and versatile tool. Its high sensitivity allows experiments to be
performed with limited amount of material. The temporal resolution of fluorescence
measurement, combined with the spatial resolution of FRET, is ideally suited for probing
the conformational changes and sequence of events in GPCR signaling.
Fluorescent proteins (Shaner et al., 2005) and organic dyes (Goncalves, 2009) have
been the most popular choice for fluorescent probes. In the recent years, novel
fluorescent reporters like quantum dots (Alivisatos et al., 2005) and rare earth ions
(Selvin, 2002) have received increasing attention. Attaching different types of fluorescent
probes to GPCRs require specialized methodologies. One possibility to visualize GPCR
by fluorescence is to harness the specific interaction between receptor and ligand, or
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between receptor and antibody. In these cases, the fluorescent labels are conjugated to the
ligand or the antibody, and brought into proximity of the receptor by molecular
recognition. However, this thesis is primarily concerned with the strategies for directly
attaching a fluorescent probe to the receptor.
The structural hallmark of GPCRs is the seven transmembrane (TM) helices that
are connected together with extracellular (EC) or intracellular (IC) loops. Prior to the
disclosure of high-resolution structures, it has been learned that the N-terminus, Cterminus, and the loops of the heptahelical receptors may have the structural flexibility to
accommodate major modifications, such as fusion with fluorescent proteins or luciferase
(Kobilka et al., 1988; Barak et al., 1997; Tarasova et al., 1997; Angers et al., 2000; Gales
et al., 2005; Bohme and Beck-Sickinger, 2009; Lohse et al., 2012). With the development
of molecular cloning and recombinant protein technology, fluorescent protein fusion has
evolved to a powerful tool for studying the behavior of GPCRs in vivo. Receptors tagged
with a fusion protein were characterized for ligand binding, downstream signaling, and
trafficking, and often found to maintain the wild-type behaviors (Gales et al., 2005).
These constructs were widely used to assess the dimerization between receptors and the
interaction between receptor and downstream signaling protein. However, alteration of
the native behavior of receptors remains a concern, which requires careful case-by-case
evaluation. Moreover, fluorescent proteins often suffer from a high probability of
photobleaching and low quantum yield. By comparison, small-molecule fluorophores
offers greater brightness and photostability, and cover a wider range of spectrum.
Further improvement has been pursued in two directions. The first strategy is
aimed at reducing the length of polypeptide that needs to be inserted into the receptor.
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For example, fluorescein arsenical hairpin binder (FlAsH/ReAsH) technology utilizes the
coordination between sulfur and arsenic to chelate a biarsenical derivative of fluorescein
to a tetracysteine peptide motif. FlAsH was paired with cyan fluorescent protein to
monitor the conformational change in receptor activation. The reduced size of FlAsH
greatly enhanced the FRET signal and sensitivity (Hoffmann et al., 2005; Hoffmann et
al., 2010). Unlike FlAsH/ReAsH, chemoenzymatic labeling methods create covalent
linkage, instead of coordination interaction, between short peptide/probe pair (Rashidian
et al., 2013). Typically, enzymes catalyzing post-translational modification are repurposed to add a probe or a reactive handle to a peptide sequence genetically encoded
into the target protein. In the case of formylglycine generating enzyme (FGE) (Rush and
Bertozzi, 2008) and sortase (Popp et al., 2007) the acceptor sequence can be as short as
five residues. An important direction of chemoenzymatic labeling research is to alter the
substrate specificity of these post-translational modification enzymes to incorporate
unique functional groups that are bioorthogonal, i.e., not naturally present in
biomolecules, into the target protein. The Ting group has created biotin ligases that are
capable of ketone, alkyne or azide analogues of biotin to a 15-mer acceptor peptide (Chen
et al., 2005; Slavoff et al., 2008). The earliest report on chemoenzymatic labeling of a
GPCR dates back to 1978, when the Stryer group used transglutaminase to inserted
small-molecule fluorophores into the third intracellular loop of Rho (Pober et al., 1978).
So far the applications of chemoenzymatic labeling to GPCRs have remained relatively
rare. Nonetheless, the rapid expansion of chemoenzymatic labeling toolkit makes it a
promising tool to the GPCR community.
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The second strategy substituted the fluorescent or luminescent protein for selflabeling proteins, which, unlike the post-translational modification enzymes described
above, catalyze the covalent modification of themselves rather than a different target
protein. For instance, mammalian O-6-methylguanine-DNA methyltransferase has been
engineered to accept benzylguanine derivatives as substrate (Keppler et al., 2003;
Keppler et al., 2004). This approach, known as SNAP/CLIP-tag, has expanded the
repertoire of fluorescent reporters to include organic dyes (Maurel et al., 2008) and rare
earth metal ions (Emami-Nemini et al., 2013). The second member in the category of
self-labeling proteins is Halo-tag, a modified haloalkane dehalogenase (Los et al., 2008).
In a recent report, cAMP receptor carrying Halo-tag was labeled with
tetramethylrhodamine and imaged for single-particle tracking in live cells (SnaarJagalska et al., 2013). Compared with fluorescent proteins, self-labeling proteins combine
the advantage of fusion protein tag and covalent labeling and promise a greater freedom
in choosing fluorescent reporters with desired photophysical properties (Gronemeyer et
al., 2005).
The approach of fusion protein, despite numerous successful demonstrations, is
inherently limited by the shear size of protein tag. Bulky fusion proteins often prove
inadequate when subtle conformational changes, particularly those in the transmembrane
region of GPCRs, are being studied. In addition, the EC surfaces of GPCRs can be
critical for receptor-ligand binding, and the IC surface for receptor-G protein interaction.
Hence for certain applications it is desirable to leave the EC and IC surface intact.
Therefore, approaches that enable attachment of a probe to a single residue has a decisive
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advantage over the methodologies described above for investigating the structurefunction relationship of GPCRs.
Covalent labeling of protein residues has been extensively studied (Glazer, 1970;
Sletten and Bertozzi, 2009). Classic methods rely on bioconjugation chemistries targeting
the reactive groups of the amino acid residues, such as the primarily amine of lysine, the
thiol group of cysteine, the side chain of tyrosine and tryptophan, and the N-terminal
amino group (Glazer, 1970). Apparently, except for the N-terminal amino group, none of
these reactive residues is likely to occur for once in the protein. While the reactivities of
the same residue in one protein can be differently modulated by sterical factors or pH,
and some selectivity can be achieved by judicious choice of reaction conditions, the
optimization process can be laborious. Unlike globular proteins, GPCRs are hydrophobic
membrane proteins, expressed at low level, and often unstable without bound ligands.
Therefore, the reactions for labeling GPCRs are expected to proceed under mild
conditions, exhibit good kinetics, yield stochiometrically-labeled product without
chromatographic purification, and minimally depend on solvent accessibility. Meanwhile,
removal of the naturally occurring reactive residues by site-directed mutagenesis may
result in functional alteration.
Among these classic protein labeling chemistries, maleimide and methane
thiosulfonate chemistries targeting cysteine thiol groups have been a popular choice,
because cysteines is one of the rarest amino acids in the composition of proteins, and the
number of reactive cysteines can be further reduced by the formation of disulfide bond.
Not surprisingly, tremendous efforts have been made to understand the cysteine
chemistry for prototypical GPCRs like Rho (Rousselet and Devaux, 1978; Chen and

30	
  

Hubbell, 1978; Resek et al., 1993; Yang et al., 1996) and β2-adrenergic receptor (Gether
et al., 1997) to achieve site-specific labeling of the receptors. These studies yielded
important insights into the structure-function relationship of GPCRs. The FRET
experiment in the Stryer group in 1972 with Rho (Wu and Stryer, 1972) provided early
insights into the physical dimension of this molecule. It is worth noting that this study
was among the first demonstrations how FRET could be applied as a molecular ruler for
macromolecules (Stryer, 1978). Site-directed spin labeling of the cytoplasmic end of Rho
in 1990s revealed the rigid-body helix movement in receptor activation, a feature
subsequently confirmed by crystal structures (Farrens et al., 1996; Altenbach et al., 1996).
Later, spin labeling of the TM helices of Rho enabled high-resolution distance mapping
of the helix movement of Rho (Hubbell et al., 2003; Altenbach et al., 2008b).
Fluorescence spectroscopy involving conformational-sensitive probes have been
exploited to probe the activation of Rho (Farrens and Khorana, 1995; Dunham and
Farrens, 1999), as well as the ligand-specific conformation (Ghanouni et al., 2001; Yao et
al., 2006) and oligomerization (Mathiasen et al., 2014) of β2-adrenergic receptor.
However, as all GPCRs possess multiple cysteines, generating the cysteine-free
background and validating the functional integrity of the mutant receptor remain a
cumbersome process (Resek et al., 1993; Yang et al., 1996; Gether et al., 1997). The long
histories of the research on Rho and β2-adrenergic receptor have produced sufficient
experience for manipulating these two prototypical GPCRs and characterizing the
functionality of their cysteine-free mutants, a legacy not necessarily available to
researchers working on an expanding list of therapeutically interesting receptors.
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Moreover, reactive cysteines exist in abundance in cells, thereby limiting the applicability
of sulfhydryl chemistries practically to purified receptors.
2.2.2 Unnatural amino acid (uaa) mutagenesis of GPCR
To develop a general approach for site-specific labeling of GPCRs, we have opted
for an alternate strategy to introduce bioorthogonal functionalities into receptors using
unnatural amino acid (uaa) mutagenesis (Davis and Chin, 2012; Huber and Sakmar,
2014).
Incorporating uaas into protein was realized in 1989, by combining non-sense
suppression and chemically acylated suppressor tRNA in an in vitro translation system
(Noren et al., 1989). This method was used to generate uaa-containing soluble globular
proteins, such as β-lactamase (Noren et al., 1989), T4 lysozyme (Mendel et al., 1991),
staphylococcal nuclease (Judice et al., 1993), and Cytochrome P450 (Kimata et al.,
1995). Owing to the difficulty in delivering chemically acylated suppressor tRNA into
cells, in vivo suppression was possible only for giant cells (e.g. Xenopus oocytes)
(Nowak et al., 1995). However, synthesis of functional membrane proteins requires the
coordinated actions of multiple organelles to fold the polypeptide, add post-translational
modifications, and transport them to the correct membranes. Such conditions can be very
difficult to reconstitute in vitro.
An ingenious solution to this problem was reported in 2001, when Wang et al
presented a general methodology for in vivo non-sense suppression by engineering an
archaebacterial tyrosyl tRNA/synthetase pair that is orthogonal to the endogenous
tRNA/synthetase pairs of E. coli and yet effectively utilized by the ribosome (Wang et
al., 2001). In 2002, a new pair of mutant E. coli Tyr-tRNA synthetase and B.
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stearothermophilus suppressor tRNATyr was generated to enable non-sense suppression
in mammalian cells (Sakamoto et al., 2002). Further genetic screening for E. coli Tyr-RS
variants in the yeast system expanded the range of uaas that can be incorporated into
protein with high specificity (Deiters et al., 2003; Chin et al., 2003a; Chin et al., 2003b).
Based on these discoveries, our laboratory pioneered in incorporating uaas into
mammalian GPCRs. The first successful example of incorporating a uaa into GPCR was
done in the yeast system (Huang et al., 2008), which is of limited use to the majority of
GPCRs. We has greatly improved the suppression efficiency of amber codon suppression
in mammalian cell culture by creating a novel chimera of H. sapiens and B.
stearothermophilus tRNATyr that forms an orthogonal pair with the existing E. coli TyrRS in the human HEK293T cell line. As most GPCRs cannot be expressed in bacterial
culture, and even in mammalian cell cultures their expression levels are generally low,
uaa mutagenesis would not have become a practical approach for studying GPCRs
without achieving reasonable suppression efficiency.
We have adapted this orthogonal pair of suppressor tRNA and tRNA synthetase to
incorporate analogues of phenylalanine, namely p-acetyl-L-Phe (AcF), p-azido-L-Phe
(azF), and p-benzoyl-L-Phe (BzF), into GPCRs heterologously expressed in transiently
transfected cells (Ye et al., 2008; Ye et al., 2009). In this way we are able to incorporate
several bioorthogonal functionalities, namely the keto group in AcF, the azido group in
azF, and the benzophenone group in BzF, into various GPCRs (Figure 2-1). We found
that these uaas can be specifically inserted into the intracellular, extracellular, and
transmembrane region of GPCRs, as long as the original residues are not structurally or
functionally critical.
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Figure 2-1. Incorporation of unnatural amino acids (uaas) into GPCRs by amber
codon suppression. HEK293T or HEK293F cells are co-transfected with three different
plasmids encoding the evolved aminoacyl synthetase gene, the chimeric suppressor tRNA
gene, and the GPCR gene with an in-frame amber (TAG) mutation at a specific position.
The transfected cells are cultured in the presence of the uaa corresponding to the tRNA
synthetase. The bacterial orthogonal tRNA/synthetase pair is orthogonal to the
endogenous mammalian tRNAs and synthetases, thereby preventing incorrect translation
of the codons for natural amino acids. The ribosome is capable of utilizing the suppressor
tRNA charged with the uaas to suppress the normal function of amber stop codon,
resulting in a full-length receptor tagged with a uaa at the desired position (figure adapted
from Daggett and Sakmar, 2011).
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We further developed several applications based on the individual spectroscopical
or chemical reactivity of these uaas. The azido group in azF exhibits a vibrational
signature distinct from that of the native residues in the infrared spectrum and thus serves
as a probe for the local electrostatic environment. The engineered azF-Rho enabled us to
track the conformational changes involved in Rho activation (Ye et al., 2010; Ye et al.,
2009). BzF and azF are also photoactivatable crosslinkers, and were used to map the
ligand binding modes for the chemokine receptors CCR5 and CXCR4 (Grunbeck et al.,
2011; Grunbeck et al., 2012), the substance P receptor NK1 in native cell membrane
(Valentin-Hansen et al., 2014), as well as the binding sites of the chemokine receptors
with conformation-sensitive monoclonal antibody (Ray-Saha et al., 2014). This targeted
photocrosslinking approach using genetically encoded uaas bypassed the need of adding
photoactivatable groups to ligands, which may alter the binding mode, particularly in the
case of small-molecule ligands (Grunbeck and Sakmar, 2013). Unnatural amino acid
mutagenesis has also been successfully applied to ligand-gated channels (Zhong et al.,
1998), voltage-gated ion channels (Dougherty, 2000; Pless et al., 2011), and ionotropic
glutamate receptors (Klippenstein et al., 2014) to probe ligand-receptor interaction and
protein conformational changes (Pless and Ahern, 2013).
2.2.3 Site-specific fluorescent labeling of GPCRs
Here we present a detailed study on site-specific fluorescent labeling of functional
GPCRs by combining uaa mutagenesis and bioorthogonal labeling chemistry (Figure 2-2).
Previous applications of similar approaches for protein labeling mostly involved highly
expressing, soluble proteins, such as superoxide dismutase (Deiters et al., 2004), T4
lysozyme (Brustad et al., 2008), myoglobin (Nguyen et al., 2011), maltose-binding
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protein (Seo et al., 2011; Seo et al., 2014), GFP (Plass et al., 2011; Reddington et al.,
2012; Borrmann et al., 2012), calmodulin (Wang et al., 2014), etc. By comparison,
GPCRs are low-expressing, hydrophobic membrane proteins that are easily denatured
under the conventional protein labeling conditions. Hence, bioorthogonal labeling of
GPCRs requires careful optimization based on their specific properties.
We chose Rho, a prototypical class A GPCR, as the model system to study the
labeling chemistry. We have previously demonstrated incorporation of AcF and azF into
various sites of Rho (Ye et al., 2010; Ye et al., 2008; Ye et al., 2009). Ketones and azides
are both bioorthogonal reactive handles, for which a wealth of bioconjugation chemistries
has been accumulated. However, we have observed non-specific labeling of wt rhodopsin
by chemistries targeting ketone. Therefore, the first issue addressed in this chapter is the
bioorthogonality of the two labeling strategies, one targeting the keto group in AcF and
the other targeting the azido group in azF. We showed that azF is a superior
bioorthogonal reactive handle compared with AcF. We also found that chemistries with
azF generally exhibit greater kinetics. Based on these findings, we concluded that strainpromoted [3+2] azide–alkyne cycloaddition (SpAAC) reaction of dibenzocyclooctyne
(DIBO) with azF is a suitable choice for labeling GPCRs.
The second question is whether this labeling strategy is general. We tested multiple
sites located in the EC, IC and TM region of Rho with different DIBO derivatives, and
found the reaction to be robust and modular. While characterizing the kinetics of SpAAC
between DIBO and azF-rhodopsin, we found the reaction to be much faster than the
SpAAC involving two small molecules. Hence the third task we have accomplished here
is to explain the observed rate enhancement by a model based on the partitioning of

36	
  

DIBO derivatives into micelles. This finding added new insights into the practical
application of bioorthogonal labeling to GPCRs. Finally, we evaluated the functional
integrity of labeled Rho with a steady-state fluorescence-quenching assay. We showed
that attaching to a fluorophore to the fourth helix of Rho does not significantly perturb
the behavior of receptor with respect to ligand binding.
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2.3

Results

2.3.1 The bioorthogonality of keto group and azido group as labeling handles
We conducted a comparative study for the labeling chemistries utilizing the two
reactive handles incorporated into GPCRs through amber codon suppression. We chose
oxime ligation to biotinylate AcF-tagged Rho (Figure 2-3A), and the strain-promoted
[3+2] azide–alkyne cycloaddition (SpAAC) for azF-tagged Rho (Figure 2-3B),
respectively.

Figure 2-2. Bioorthogonal labeling of uaa-tagged GPCRs. The uaa-tagged mutant
GPCR was heterologously expressed in mammalian cell culture. A fluorescent tag is
conjugated to the uaa through a bioorthogonal labeling chemistry.

We chose S144 located at the second IC loop of Rho as the target site for studying
the reaction kinetics. This site has good uaa incorporation efficiency and reactivity
towards labeling reagents. S144azF Rho was solubilized in n-dodecyl-β-D-maltoside
(DM) micelles, captured to an immunoaffinity matrix (1D4 mAb-sepharose 2B) via its Cterminal epitope, and reacted with labeling reagents reagent. The 1D4 mAb is specific to
the C-terminal epitope of Rho (Molday and Mackenzie, 1983). The excess unbound
reagents were washed away before the labeled receptor was specifically eluted. (Figure 23C) The reaction of azF with DIBO-biotin was performed at pH 7.2. The reaction of AcF
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Figure 2-3. Bioorthogonal reaction for labeling the azido group and the keto group
in GPCRs. A) The strain-promoted [3+2] azide-alkyne cycloaddition (SpAAC) between
p-azido-L-phenylalanine (azF) and dibenzocyclooctyne-biotin (DIBO-biotin). B) The
oxime ligation between p-acetyl-L-phenylalanine (AcF) and alkoxyamine-PEG12-biotin.
C) The experimental scheme for labeling uaa-tagged rhodopsin (Rho). The
heterologously expressed Rho was solubilized in n-dodecyl-β-D-maltoside (DM) and
immunopurified with the C-terminal specific 1D4 antibody. The receptor bound to the
resin was subjected to the labeling reaction. After the excess labeling reagent was washed
away, the labeled Rho was specifically eluted from the resin.
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Figure 2-4. Kinetic study of labeling chemistries for azF-tagged Rho and AcF-tagged
Rho. Upper panel: Rho S144azF and Rho wt reacted with 50 µM DIBO-biotin. Lower
panel: Rho S144AcF and wt Rho reacted with 10 mM alkoxyamine-PEG12-biotin. Red:
700-nm channel for streptavidin IRDye 680RD (biotinylation signal). Green: 800-nm
channel for IRDye800CW goat anti-mouse secondary antibody (1D4 signal). Yellow:
700-nm and 800-nm channel merged together. In order to clearly visualize any possible
background labeling for Rho wt, higher detector sensitivity for the 700-nm channel was
chosen during image acquisition.
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with alkoxyamine-PEG12-biotin was performed under a more acidic condition of pH 6.0,
as a balance between reaction rate and maintenance of the protein integrity. We
performed kinetic studies for the two model reactions. The time-series samples were
analyzed by dual-color IR-based quantitative Western blot. The possibility of twochannel detection eliminates the need of performing extra loading controls (Figure 2-4)
We found that the combination of SpAAC and azF exhibited reaction kinetics that
was faster by two orders of magnitude (Table 2-1), and also displayed higher specificity
(Figure 2-5). The combination of oxime ligation and AcF resulted in substantial
background labeling for wt Rho (~0.1, Figure 2-5B). Interestingly, the rate of the nonspecific reaction was faster than that of the specific reaction and complete within half an
hour. The receptor was photobleached prior to SDS-PAGE separation and did not contain
a covalently-bound retinal. Thus the aldehyde group of retinal can be ruled out as the
cause of background labeling.
Table 2-1. The reaction kinetics of the bioorthogonal chemistries

Second-order rate constant (M–1 s–1)
Labeling reagent

Biotin-DIBO

Biotin-alkoxyamine

Rho substrate

S144azF

S144AcF (specific) WT (non-specific)

Measurement 1

9.6 ± 1.5

0.026 ± 0. 005

0.044 ± 0. 009

Measurement 2

7.6 ± 1.1

0.028 ± 0.007

0.22 ± 0.05

Average

8.6 ± 1.3

0.027 ± 0.006

0.13 ± 0.04
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Figure 2-5. Comparison of labeling chemistries for azF- and AcF-Rho. The timeseries samples were analyzed using dual-color quantitative Western blot. As the labeling
reagents have different linker lengths and detectabilities, the Western blot signals from
two chemistries cannot be directly compared. Therefore, to simplify the interpretation of
data, the extent of labeling (ξ) was normalized under the assumption that ξ for the
specific component for each labeling chemistry, upon the completion of reaction, is
assigned to 1.0. A) The kinetic study for the azF-Rho and wt Rho reacted with 50 µM
DIBO-biotin. The background labeling for wt Rho was negligible. The second-order
reaction rate (k2) for Rho S144azF with DIBO-biotin is 8.6 ± 1.3 M−1 s−1. B) Kinetic
study for the AcF-Rho and wt Rho reacted with 10 mM alkoxyamine-PEG12-biotin. The
specific k2 for Rho S144AcF with alkoxyamine-PEG12-biotin is 0.027 ± 0.006 M−1 s−1,
two orders of magnitude lower than that of azF with DIBO-biotin. There was a
substantial non-specific component for this reaction, based on the background labeling of
wt Rho. The non-specific k2 for wt Rho with alkoxyamine-PEG12-biotin is 0.13 ± 0.04
M

−1 −1

s .

After testing different choices of uaas and bioorthogonal chemistries, we
concluded that the combination of azF and DIBO is a suitable strategy to label GPCRs, as
it exhibits higher specificity and faster kinetics.
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2.3.2 Choice of site for fluorescent labeling
The structural hallmark of GPCRs is their seven TM helix bundle connected with
three EC loops and three intracellular IC loops. We chose an EC site Y102 that has been
shown to be amenable for covalent modification (Ye et al., 2008). On the cytoplasmic
surface, we chose C140 located at the end of TM3, S144 in the second IC loop, and A234
in the third IC loop, and A246 at the end of TM6. For the transmembrane region, we
selected TM4, which is positioned distal to the main helix bundle and it is generally not
involved in the helix rotation required for GPCR activation (Farrens et al., 1996; Park et
al., 2008; Scheerer et al., 2008; Rasmussen et al., 2011b). Compared with all other TMs,
the residues of TM4 are least likely to contribute to the ligand binding pocket
(Venkatakrishnan et al., 2013). Thus, we reasoned that modification of residues in TM4
would have minimal effects on the intrinsic functionality of the receptor (Figure 2-6). We
generated amber stop codon at every turn of TM4 (N151, M155, A158, V162, L165,
A169, V173). These residues were chosen because their side chains point outward from
the helix bundle (Figure 2-7). We avoided mutating the residues involved in the
conserved non-covalent contact between TM3 and TM4 (in the case of Rho they
correspond to W161, A164, A168) (Venkatakrishnan et al., 2013). Except for L165amb
(not shown), all the constructs yielded expression of full-length receptor containing azF
(Figure 2-8). While the TM region of Rho in DM micelles is expected to be shielded by
the alkyl chain of DM. The variation of the local environment on protein surface allows
us to systematically assess the behavior of SpAAC for labeling a transmembrane protein.
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Figure 2-6. Comparison of the crystal structures of different Class A GPCRs with
bound ligands: 1) Rho and 11-cis-retinal (protein data base access code 1GZM) (Li et al.,
2004); 2) β2 adrenergic receptor and carazolol (2RH1) (Cherezov et al., 2007); 3)A2A
adenosine receptor and ZM241385 (3EML) (Jaakola et al., 2008); 4) CCR5 chemokine
receptor and maraviroc (4MBS) (Tan et al., 2013); 5) CXCR4 chemokine receptor and
IT1t (3ODU) (Wu et al., 2010); 6) D3 dopamine receptor and eticlopride (3PBL) (Chien
et al., 2010). Viewed from the EC side, with the ligands shown in red. The TM4 of these
receptors (indicated by an arrow) are positioned outside the helix bundle and not in
contact with the ligands.
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Figure 2-7. Structure of bovine Rho with 11-cis-retinal and the tested amino acid
residues (PDB: 1U19. red: 11-cis-retinal; blue: TM4 sites). A) Cytoplasmic view. B)
Side view. For the TM sites, the Ballesteros-Weinstein notation is shown in parentheses
(Ballesteros and Weinstein, 1995). The hydrophobicity of the local environment at these
sites is estimated by the percent of lipid contacts versus water contacts. The values give
the fraction of the surface exposure of these residues to lipids as observed in molecular
dynamics simulations of Rho in a phospholipid bilayer membrane (Huber et al., 2004).
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Figure 2-8. The heterologous expression of Rho with single azF substitution at the
indicated positions. HEK293F cells were transfected with three plasmids encoding the
suppressor tRNA, the aminoacyl tRNA synthetase, and Rho with an amber mutation. The
cell lysates were analyzed by Western blot (100 µg total protein per lane). The receptor
was probed with 1D4 mAb specific to the C-terminus of Rho, followed by goat-antimouse 800 CW (LI-COR). The full-length receptor was detected only when the
expression medium was supplemented with azF, indicating specific incorporation of azF
into Rho.
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2.3.3 Fluorescent labeling of Rho with Alexa488-DIBO at different sites
We utilize DIBO derivatives of Alexa fluors to generate fluorescently labeled Rho
by SpAAC (Figure 2-9).

Figure 2-9. The SpAAC reaction Alexa488-DIBOs and azF. Alexa555-DIBO was also
used in the present study. However, its chemical structure has not been disclosed by the
manufacturer.
Figure 2-10 shows the results obtained for a typical reaction of azF-Rho samples
treated for 18 h with 50 µM Alexa488-DIBO at 25ºC. The in-gel fluorescence shows a
prominent fluorescent band for all the azF-Rho variants, whereas the wt sample does not
show a fluorescent band above background level. Among all the azF-Rho variants, the
signal from Y102-Alexa488 Rho was weaker compared with all other variants. Due to
glycosylation and oligomerization, Rho appeared as a smear in the SDS-PAGE gel. To
confirm the purity of the sample, we treated the purified S144-Alexa488 Rho with
PNGaseF to remove the glycans. We found no other fluorescently labeled protein was
47	
  

present in the sample, except for Rho visualized as monomer, dimer and trimer in the gel.
The robust labeling of the TM region is particularly interesting, because the hydrophobic
alkyl chain of DM might be expected to shield the TM region of Rho in DM micelles.

Figure 2-10. Fluorescent labeling of azF-Rho with Alexa488-DIBO. After labeling
reactions, samples were separated by 4–12% SDS-PAGE and the gel image was taken
with a confocal 488-nm laser fluorescence scanner using an emission filter set optimized
for Alexa488 detection. Strong fluorescent bands were observed for the all the mutants,
whereas that for Y102azF was significantly weaker. No band was observed for wt Rho
treated under the same condition.
Rho utilizes a chromophore 11-cis-retinal as its native ligand (Figure 2-11). Darkstate Rho exhibits a characteristic absorption band centered at 500 nm. After
photobleaching in the presence of NH2OH, 11-cis-retinal isomerizes to all-trans-retinal
and dissociates from the binding pocket. In the resulting spectrum, the 500-nm band of
Rho shifts to 370 nm, revealing the absorption peak of the fluorophore. Thus the
concentrations of 11-cis-retinal-bound Rho and fluorophore can be quantified from their
respective absorption peaks. In the representative spectra, the labeling ratio for S144azF-
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Rho was 1.13, while that of wt Rho is only 0.04 (Figure 2-11), demonstrating that this
reaction was specific with azF-Rho.

Figure 2-11. UV-Vis spectra of wt and S144azF Rho treated with Alexa488-DIBO.
The dark state (dark) and illuminated (light) spectra are normalized to the amount of Rho
using the 380-nm absorbance of the illuminated sample (light). Comparison of the
absorbance at 495 nm illustrates the small amount of Alexa488 present in the purified wt
sample mainly due to co-purification and to a lesser extent due to background labeling.
We quantified the labeling stoichiometries for Alexa488-labeled azF-Rho variants
by UV-Vis spectroscopy (Figure 2-12). Except for Y102azF Rho, which was clearly
under labeled with a labeling stoichiometry of 0.56, all the azF-Rho variants exhibited a
dye/protein ratio above 1.0, ranging from 1.05 for A234azF Rho to 1.68 for V173azFRho (Figure 2-12). The super-stoichiometry possibly resulted from a fraction of receptors
that did not regenerate with 11-cis-retinal.
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Figure 2-12. The UV-Vis spectra of azF-Rho variants with Alexa488 attached to
different sites. Red: dark-state Rho; green: photobleached Rho; blue: the difference
spectrum (dark–light). The dark−light difference spectrum at 500 nm was used to
calculate the concentration of Rho (cRho) using an extinction coefficient of 40,600 M−1
cm−1. The Alexa488 concentration (cAlexa488) was calculated from 495-nm absorbance in
the light spectrum using the extinction coefficient 73,000 M−1 cm−1. The label-to-protein
ratio was calculated as cAlexa488/cRho and indicated in the upper right corner.
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To enhance the yield of functional receptors, we followed a purification procedure
shown to reduce impurities from partially folded receptors (Ridge et al., 1995; Reeves et
al., 1999). Alternatively, it is possible that the extinction coefficient of Alexa488 varies
with the chemical environment of a particular labeling position. A detailed analysis of
this issue is beyond the scope of this paper, but we are confident that this observation is
not the result of background reactivity of DIBO with sites other than azF, since the
labeling ratio for wt Rho is only 0.04 (cf. Figure 2-10).
2.3.4

Optimizing the concentration of Alexa488-DIBO for labeling Rho
We performed the labeling reaction with S144azF-Rho under different

concentrations of Alexa488-DIBO and analyzed the labeled products by in-gel
fluorescence and UV-Vis spectroscopy. Figure 2-13A shows the in-gel fluorescence of
Rho reacted with 50, 20, 10 and 5 µM of Alexa488-DIBO (approximately 100 to10-fold
molar excess of the receptor. Panel B shows the dark state (Dark), photobleached (Light),
and the difference (Dark–Light) spectra of these samples. The corresponding apparent
labeling stoichiometries are 1.84, 1.15, 1.14, and 1.13, respectively. We speculated two
possible reasons for the unexpectedly high stoichiometry of S144azF Rho labeled with 50
µM Alexa488-DIBO in this particular reaction. First, a higher concentration of
Alexa488-DIBO might be more difficult to wash away, resulting in an increase of copurified free dyes in the elution. Second, the estimate for the amount of Rho used in this
particular reaction might be low. Consequently, the relative percentage of unbound dyes
would be higher compared to other samples. The control experiment with wt Rho also
disfavors the possibility of a high degree of non-specificity. In the reactions where the
concentrations of Alexa488-DIBO were reduced to 20, 10 and 5 µM and there was more
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Rho to start with, the resulting stoichiometries are consistent and close to the expected
value 1.0. The in-gel fluorescence data also support our hypothesis: the receptor bands
exhibit similar intensities, while the 50-µM reaction gives a much more pronounced band
for the unbound dye (in order to normalize the amount of receptor, a larger volume of 50µM sample was loaded to the SDS-PAGE gel.) Taken together, the data suggest that the
super-stoichiometry observed from the spectra is likely to represent the presence of
unbound Alexa488, rather than promiscuous labeling. We recommend keeping the DIBO
reagent at 10-fold molar excess.

Figure 2-13. Labeling of Rho at position S144 with various concentration of
Alexa488-DIBO. A) The in-gel fluorescence and B) UV–Vis spectra of Rho reacted
with 50, 20, 10 and 5 µM of Alexa488-DIBO. For the in-gel fluorescence assay, 50 ng of
sample was loaded into each lane. The apparent labeling stoichiometries determined
from the spectra are 1.84, 1.15, 1.14, and 1.13 correspondingly. In addition to the
receptor, the in-gel fluorescence also reveals unbound Alexa488-DIBO, which decreases
with the concentration of the labeling reagent. For the 50-µM reaction, the band of free
dye is particularly pronounced (marked by the white star).
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2.3.5

Labeling azF-Rho using DIBO derivatized with different Alexa fluorophores
To evaluate whether the labeling reaction for azF-Rho is dependent the

fluorophores conjugated to DIBO, we also tested Alexa555-DIBO, Alexa594-DIBO, and
Alexa647-DIBO. Figure 2-14 shows the fluorescent labeling of azF-Rho at site 144 with
different Alexa fluor-DIBO. The apparent dye-to-protein ratio for S144-Alexa555-,
S144-Alexa594-, and S144-Alexa647-Rho are 1.11, 1.20, and 1.03, respectively. By
comparison, for wt Rho treated under the same condition, the resulting labeling
stoichiometries were below 0.04. These results demonstrated that the labeling strategy is
specific and modular.

Figure 2-14. Fluorescent labeling of azF-containing Rho at site S144 with different
Alexa-DIBOs. Upper panel: the normalized spectra for Rho S144-Alexa fluor and Rho
wt treated under the same conditions. Lower panel: the dark-state, light-state, and
difference UV-Vis spectra of Rho labeled at S144. The initial concentration of Alexa488DIBO is 5 µM; for Alexa555-DIBO 50 µM; for Alexa594-DIBO 5 µM; for Alexa647DIBO 20 µM. The extinction coefficients for Alexa488-DIBO, Alexa555-DIBO,
Alexa594-DIBO, and Alexa647-DIBO are assumed to be 71, 000 M−1 cm−1, 155, 000 M−1
cm−1, 92, 000 M−1 cm−1, and 239, 000 M−1 cm−1. The apparent dye-to-protein ratio for azFRho and wt Rho are indicated in the figure.
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2.3.6

Kinetic study of SpAAC between azF-Rho and Alexa-DIBO
The knowledge on the kinetics of the SpAAC reaction for azF-Rho would guide

the rational optimization of the reaction conditions. In principle, the reaction kinetics can
be determined more accurately using UV-Vis spectroscopy. However, it requires large
amount of samples (each measurement requires approximately 1 µg of purified azF-Rho).
Therefore, we chose in-gel fluorescence and silver staining for quantifying the relative
extent of reaction (Figure 2-15A). As predicted, the conjugation reaction between
S144azF Rho and Alexa488-DIBO was pseudo-first order (Figure 2-15B), giving a
second-order rate constant for the coupling reactions (k2) of 62 M −1 s−1.

Figure 2-15. The kinetic study of SpAAC between S144azF-Rho and different Alexa
488-DIBO. A) The time course of the reaction shown by in-gel fluorescence. For each
time point, 10 µL of sample was loaded to the SDS-PAGE gel. The fluorescence signal
was quantified using ImageJ. The amount of protein loading was obtained from silver
staining of the same gel, and quantified using ImageJ. The fluorescence intensity
corrected for protein loading was calculated as I =F/S. B) The normalized extent of
reaction versus the reaction time. The extent of reaction upon completion is assigned to
1.0. The data was fitted using pseudo first-order kinetic model. The k2 for Rho S144azF
with Alexa488-DIBO is 62 ± 12 M−1 s−1 based on two independent sets of experiments.
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We also determined the reaction rates between S144azF-Rho and other Alexa
fluor-DIBO reagents (Figure 2-16). The k2 of Alexa555-DIBO and Alexa594-DIBO were
close to that of Alexa488-DIBO. Alexa647-DIBO reacted slower with S144azF-Rho.
Overall, all the Alexa fluor-DIBO reagents exhibited significantly enhanced kinetics that
was 2~3 orders of magnitude higher than the reaction rate (0.17 M−1 s−1) reported for the
SpAAC between benzyl azide and DIBO in methanol (Ning et al., 2008; Debets et al.,
2011).

Figure 2-16. The kinetic study of strain-promoted azide-alkyne cycloaddition
between S144azF-Rho and different Alexa-DIBOs. A) Alexa555-DIBO, B) Alexa594DIBO, and C) Alexa647-DIBO. The resulting k2 are 36 ± 9 M−1 s−1 , 60 ± 8 M−1 s−1, and
11 ± 2 M−1 s−1, respectively.
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To quantitatively assess how the local environment on the TM surface contributes
to the reactivity of SpAAC. We measured the reaction rates of SpAAC at two sites,
M155azF and V162azF, both of which are located in the middle of TM4 (Figure 2-17).

Figure 2-17. The location of azF modulates the kinetics of the SpAAC reaction
between azF-Rho and Alexa488-DIBO. Reaction time course of three azF-Rho variants,
S144 (IC2), M155 (TM4), and V162 (TM4) were measured based on the method
described earlier (cf. Figure 2-15). The data points were fitted using pseudo first-order
kinetic model. The calculated k2 is 62 ± 12 M−1 s−1 for S144azF-Rho, (3.2 ± 0.4)×102 M−1
s−1 for M155azF-Rho, and (1.9 ± 0.5) ×102 M−1 s−1 for V162azF-Rho. The curve for
Y102azF-Rho was simulated based on the k2 (0.27 M−1 s−1) estimated from single time
point labeling stoichiometry data (dye/protein ratio = 0.56 after 18 h).
The k2 for M155azF-Rho and V162azF-Rho were (3.2 ± 0.4)×102 M−1 s−1 and
(1.9 ± 0.5) ×102 M−1 s−1, respectively (Figure 2-17). The labeling reaction of Y102azFRho with 50 µM Alexa488-DIBO for 18 h yielded a stoichiometry of 0.56, which
corresponded to a second order rate constant of 0.27 M−1 s−1. This value is similar to the
rate observed for the SpAAC reactions between two small molecules (Ning et al., 2008;
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Debets et al., 2011). The crystal structure of Rho shows that Y102 is a solvent-accessible
site with the side chain pointing towards the EC space. Molecular dynamics simulations
of Rho in a phospholipid bilayer membrane show that Y102 is water exposed with only
minimal (5%) contacts to lipids (cf. Figure 2-7) (Huber et al., 2004). Thus, a 103-fold
enhancement of SpAAC kinetics was observed for azF residues located in the TM region
as compared with the polar region, demonstrating that the local environment near the TM
surface greatly accelerates the cycloaddition reaction.
2.3.7

The accelerated SpAAC in the TM region can be explained by the

partitioning of Alexa488-DIBO between DM micelles and water

Figure 2-18. The scheme of filtration experiment to determine the partition
coefficient of Alexa488-DIBO between micelles and water. A) The partition
equilibrium of Alexa488-DIBO between DM micelle and water. B) The filtration
experiment with spin filter. Alexa488-DIBO solution with DM was added into the spin
filter. The experiment is based on the different molecular weight of Alexa488-DIBO
(MW = 1039.23) and DM micelles (~50 kDa). The molecular weight cut-off of the
microporous membrane is 10 kDa. Therefore, the heavier DM micelles, together with the
Alexa488-DIBO partitioning into them, are expected to remain in the retentate fraction,
while the free Alexa488-DIBO will flow through the membrane.
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The micelles formed by amphiphilic detergents consist of a non-polar core
covering the hydrophobic protein surface and a polar envelope surrounding the
hydrophobic core. A straightforward explanation for the observed rate enhancement
would be that Alexa488-DIBO molecules partition into the DM micelles, resulting in an
increased local concentration of the reactive moiety around azF. To test this hypothesis,
we designed a filtration experiment, where Alexa488-DIBO was mixed with various
concentrations of DM micelles and centrifuged in spin filter units with regenerated
cellulose membrane with a molecular weight cut-off of 10 kDa. The larger DM micelles,
together with the Alexa488-DIBO partitioning into them, are expected to remain in the
retentate fraction, while the free Alexa488-DIBO will flow through the membrane
(Figure 2-18) (Strop and Brunger, 2005).

Figure 2-19. Representative spectra for the filtration experiment. A) Alexa488-DIBO
solution (~5 µM) prepared in DPBS with 0.1% DM. Solid: the Alexa488-DIBO solution
before filtration; dash: the filtrate; dot: the retentate. In the presence of DM, the recovery
of Alexa488-DIBO was approximately 100%. B) Alexa488-DIBO solutions in DPBS.
solid: before filtration; dash: the filtrate; dot: the retentate. In the absence of DM, the
recovery of Alexa488-DIBO was lowered to approximately 67%. The concentration of
Alexa488-DIBO was calculated from the 492-nm absorbance (ε495nm = 73, 000 M−1 cm−1).
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The concentration of Alexa488-DIBO the filtrate and retentate were quantified by
UV–Vis spectroscopy (Figure 2-19 and Table 2-2). We showed that the total
concentration of Alexa488-DIBO in the retentate increased with the weight/volume
percent of DM (Table 2-2).
Table 2-2. The concentrations of Alexa488-DIBO and
the volumes of filtrate and retentate
f0 of DM
(%)

c1
(µM)

V1
(µL)

c2
(µM)

V2
(µL)

c0
(µM)

Recovery*
(%)

0

2.86

190

3.28

210

4.69

66

0

3.05

170

4.13

220

5.40

68

0.05

2.12

185

9.05

210

5.76

101

0.10

1.33

200

10.5

210

5.74

105

0.10

1.37

180

9.29

210

5.74

98

0.25

0.562

180

10.2

205

5.64

101

0.25

0.557

180

9.58

220

5.64

98

0.50

0.519

185

10.6

210

5.70

103

0.50

0.423

195

11.8

200

5.81

106

1.00

0.325

175

10.8

220

5.92

104

*Note: The recovery of Alexa488-DIBO was calculated as

c1V1 + c2V2
.
c0 (V1 + V2 )

We calculated the partition coefficient of Alexa488-DIBO between DM micelles
and buffer at different DM concentrations. (Table 2-3; and Figure 2-20; the detailed
procedures are explained in Appendix I). We found that when the concentration of DM is
0.1% (w/v), the effective local concentration of Alexa488-DIBO in DM micelles was
increased by a factor of 7.8 ×102, a value in good agreement with the observed rate
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enhancement (1.2×103-fold for M155azF and 7.0 ×102-fold for V162azF as compared to
Y102azF). Therefore, the effect of partition suffices to explain the rate enhancement
(Table 2-3 and Figure 2-20).
Table 2-3. Calculation of the partition coefficient at different DM concentrations

f0 of DM
(%)

( c2 − c1 )V2
c1 (V1 + V2 )

P (×103)

Rate enhancement

0

0.08

N.A.

N.A.

0

0.20

N.A.

N.A.

0.05

1.74

4.21

1.35 ×103

0.10

3.53

3.81

795

0.10

3.11

3.41

773

0.25

9.13

3.78

362

0.25

8.91

3.69

361

0.50

10.3

2.10

183

0.50

13.6

2.77

187

1.00

18.0

1.82

95

2.3.8 Evaluation of the functionality of the labeled Rho
We then addressed whether the engineered Rho variants carrying the fluorescent
label remained functional. We utilized a fluorescence-quenching assay to assess their
photoactivation and ligand binding (Figure 2-21). This assay is based on the energy
transfer between Alexa488 (the donor), and the bound 11-cis-retinal (the acceptor). The
emission spectrum of Alexa488 overlaps with the absorption band of dark-state Rho
centered at 500 nm, causing significant quenching of Alexa488 fluorescence by 11-cisretinal. Upon photoactivation, 11-cis-retinal isomerizes to all-trans-retinal to generate the
active-state metaRho II (Meta-II), and the retinal absorption peak shifts to 380 nm. This
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Figure 2-20. Alexa488 DIBO partitions into the micelle. A) Partition coefficient (water
to micelle) from ultrafiltration experiment with various concentrations of DM. The
observed partition coefficients (P) were plotted as against the weight/volume percent of
DM (f0). We found empirically a linear correlation between P and f0 (R2 = 0.81). B)
Atomic model of Rho (PDB:1GZM) embedded in a micelle (150 DM molecules). The
SpAAC conjugated V162azF-DIBO-Alexa488 is shown as sticks including hydrogens.
For size comparison, one of the 150 DM molecules is shown in sticks but without
hydrogens. The protein backbone is shown as a cartoon (ice blue). 11-cis-retinal is shown
in spheres (red). The hydrophobic core of the micelle is rendered as a green surface sliced
by the image plane just behind the dye. The white surface shows the extension of the
head groups of the micelle sliced in the same plane. The model of Alexa488-DIBO was
generated with Schrödinger’s small-molecule drug discovery suite, and the model of DM
micelle was constructed by charmm-gui micelle builder (Cheng et al., 2013). A short
molecular dynamics simulation (1.3 ns) was performed with namd2.10 (Phillips et al.,
2005) to relax the DM micelle around the receptor.
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spectral shift results in loss of quenching and an increase in the Alexa488 signal. Then
11-cis-retinal dissociates from the binding pocket, giving opsin with the empty binding
pocket (Menon et al., 2001). Therefore the Alexa488 signal can serve as a reporter for the
recombination reaction between 11-cis-retinal and the apoprotein opsin. Upon addition of
exogenous 11-cis-retinal, the Alexa488 signal decrease as retinal enters the binding
pocket of opsin and forms the protonated Schiff base linkage. It is worth noting that the
excitation light for Alexa488 may also cause photoisomerization of 11-cis-retinal, which
can be further enhanced by the energy transfer between Alexa488 and 11-cis-retinal. This
energy transfer may result in a lower apparent recombination rate. Therefore it is
important to minimize the excitation intensity by using very narrow band-pass filter to
reduce such a systematic error.
A typical fluorescent quenching experiment with S144-Alexa488 Rho is shown in
Figure 2-21, Panel A. After 5 min (arrow a’) we added 30 mL of Rho sample (typically
0.3–1.0 mg) into lipid/detergent micelles to a final concentration of 15–50 nM. Upon
illumination (arrow b′), we observed a fast increase of fluorescence signal. This is
because photoisomerization of 11-cis to all-trans-retinal, accompanied by a change from
a protonated Schiff base (Rho state) to a deprotonated Schiff base (Meta-II state), causes
disappearance of spectral overlap between Rho and Alexa488, and consequent loss of
quenching. While the system was allowed to equilibrate for 45 min, all-trans-retinal was
released as the Meta-II state decayed, and the apoprotein opsin became the dominant
species. Upon addition of 1.5 mM (1.48–1.59 mM) 11-cis-retinal (30–100-fold excess)
(arrow c′), we observed a gradual decrease of the fluorescence signal for the Rho S144Alexa488 sample, corresponding to the kinetics of 11-cis-retinal binding and formation of
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the dark state Rho. The regenerated species was further illuminated twice (arrow d′ and
e′) to demonstrate the formation of photoactivable pigment. After the addition of NH2OH
(arrow f′), the photobleached Rho (arrow g′) could not be regenerated by 11-cis-retinal.
The first regeneration process was fit to a monoexponential model yielding a time
constant (Figure 2-21B). This time constant corresponds to the pseudo-first-order
process of Rho formation from opsin under excess 11-cis-retinal. The second order rate
constant was calculated for each experiment using the exact retinal concentration
(Henselman and Cusanovich, 1976). The quenching efficiency between Alexa488 and
retinal and the degree of regeneration were calculated as explained in Figure 2-22, Panel
A. Based on more than three measurements, the regeneration of S144-Alexa488 Rho was
96 ± 4%. Therefore, S144-Alexa488 Rho retained its wt behavior with respect to ligand
binding.
The wt Rho sample treated under the identical reaction conditions with Alexa488DIBO was tested using the same fluorescent quenching assay (Figure 2-22, turquoise).
In contrast to the results from S144-Alexa488 Rho, almost no visible change in the
fluorescence signal was observed throughout the assay for wt Rho, confirming that little
or no Alexa488-DIBO was covalently attached to the wt receptor without an azido handle.
This is consistent with the absence of a fluorescent band in the SDS-PAGE gel (cf. Figure
2-10 and 2-11). To assure there is no significant change in fluorescence for the wt
sample, we modified the experiment by increasing the excitation intensity by
approximately 4-fold, and found that after correction for the larger excitation intensity,
the increase in signal due to photoactivation is approximately 1% relative to the S144azF
mutant.
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Figur 2-21. The fluorescence-quenching experiment to assess the functionality of
Alexa488 labeled Rho. A) The full fluorescence time course of the Alexa488-Rho
variants in steady-state fluorescence quenching assay. Fluorescence spectroscopy was
performed at 28°C on a SPEX Fluorolog spectrofluorometer in photon counting mode.
During time scan experiments the excitation wavelength was 488 nm with 0.2-nm bandpass to minimize photobleaching, and the emission was measured at a wavelength of 525
nm with 15-nm band-pass. The Alexa488-labeled Rho elutions (30 µL) were added into
the cuvette (indicated by a′) at a final concentration of 15–50 nM to the assay buffer under
constant stirring. Rho was photoactivated with green light (b′). The decay of the
photoproducts to the apoprotein opsin was monitored for 45 min before 11-cis-retinal
(final concentration ~1.5 µM) was added (c′). The exponential decay of the fluorescence
back to the pre-illuminated levels indicated a pseudo first-order reaction regenerating
Rho from opsin. Repeated illumination (d′) resulted in a fluorescence change of similar
magnitude but opposite sign as the regeneration reaction. Repeated bleaching (e′)
resulted in a similar change of signal. The two additional illuminations at d′ and e′
illustrated the reversibility of the process. However, in this case opsin that forms by
decay of the Meta-II state immediately regenerated to the dark state due to the presence
of excess 11-cis-retinal. We added 50 mM hydroxylamine (NH2OH) at pH 6 (f′) to
inactivate retinal by oxime formation. Bleaching in presence of hydroxylamine
(indicated by g′) resulted in fast decay of the photoproducts to yield opsin. The shutter
was closed at the end of the experiment (h′). B) The kinetics of the regeneration of S144Alexa488-Rho. Inset: the absorption spectrum of 11-cis-retinal working solution.
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Figure 2-22. Comparison of Alexa488-Rho and wt Rho in the steady-state
fluorescence-quenching assay. A) The S144Alexa488-Rho shows increase in
fluorescence upon photoactivation and subsequent quenching with 11-cis-retinal. The
small increase in fluorescence signal at a′ for the wt Rho is due to free label (~3% as
compared to S144-Alexa488 Rho), since subsequent illumination or 11-cis-retinal
addition did not show significant fluorescence changes (less than 1% of the amplitude
compared to S144-Alexa488 Rho). Together these results confirm that little or no
Alexa488 was covalently attached unless the azF was present and that the sitespecifically labeled Rho was fully functional in terms of photoactivation and regeneration.
The quenching efficiency is calculated from

E = 1 − FDA / FD = 1 − ( F1 − F0 ) / ( F2 − F0 ) ).

The degree

of regeneration is calculated as ( F2 − F3 ) / ( F2 − F1 ) . B) Background labeling is estimated
from the retinal uptake amplitude for the wt and S144azF samples (

[( F − F ) I
4

5

c

Alexa488 Alexa488

] / [( F − F ) I
2

3

c ] ) , accounting for the relative intensity of the excitation

wt wt

light (I) and the concentration of the sample (c). The background labeling in the wt
sample appears to be less than 1% of all Rho molecules.
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Figure 2-23. The full fluorescence time course of the azF-Rho variants labeled at
TM4 in the steady-state fluorescence-quenching assay.
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Rho (90%). All the regenerated Rho variants can be repeatedly photoactivated,
demonstrating the formation of a functional pigment (Figure 2-23). The rates of
recombination reactions between 11-cis-retinal and N151-, M155-, A158-, and V162Alexa488 Rho are consistent with the value obtained for S144-Alexa488 Rho (Figure 224). The regeneration kinetics of A169- and V173-Alexa488 Rho are slightly faster (3040%) compared with S144-Alexa488 Rho (Figure 2-24A). While the difference was not
significant, we would like to discuss some possible effects. Differences in energy
transfer efficiency between Alexa488 and retinal in Rho could change the sensitivity of
the experiment bleaching artifacts due to the probe light. Sites 169 and 173 are closer to
the binding pocket and Alexa488 attached to these two sites exhibits higher energy
transfer efficiency than when the fluorophore was conjugated to site 144. Higher transfer
efficiency between Alexa488 and retinal in Rho would lead to higher bleaching rates and
consequently reduced observed regeneration kinetics. Thus, we ruled out the possibility
that the faster recombination kinetics for A169-Alexa488 and V173-Alexa488 Rho was
an artifact embedded in the energy transfer scheme, as greater energy transfer between
Alexa488 and retinal should cause the measured kinetics to be even slower. An alternate
explanation would be that modification of the sites in proximity to, although not a part of,
the binding pocket caused slightly altered ligand binding kinetics.
The energy transfer efficiencies of these Alexa488-labeled variants are dependent
on the distance between the site of labeling and the binding pocket (Figure 2-24B).
Among all the Alexa488-labeled azF-Rho variants, S144-Alexa488 Rho showed the
lowest quenching efficiency (0.55 ± 0.04), while A169-Alexa488 Rho showed the highest
quenching efficiency (0.76 ± 0.04). This result is consistent with distance measurements
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based on with the crystal structure of Rho and the site-dependent quenching efficiency
thus provides an additional line of evidence for the site-specificity of the labeling strategy.
It should be pointed out that here we used the z-axis coordinates of the alpha carbon of
the labeled sites and the center of 11-cis-retinal to estimate the distance between
Alexa488 and retinal. A rigorous treatment should take into account the dipole
orientations of Alexa488 and 11-cis-retinal, the length and conformation of the linker
between the alpha carbon and the fluorophore, and the angular distribution of the linker
relative to TM4, which is beyond the scope of this study.

Figure 2-24. The binding kinetics and energy transfer efficiency between Alexa488Rho variants and 11-cis-retinal. A) The second-order rate constants (k2) of 11-cisretinal uptake by different Alexa488-Rho variants. S144-Alexa488 Rho was used as a
reference to normalize the reaction rates of other variants. B) The energy transfer
efficiencies between 11-cis-retinal (acceptor) and Alexa488 (donor) attached to different
sites of Rho plotted versus the Z-axis distance between the alpha carbon of the labeled
site (blue dot), and the center of mass of the retinal molecule (red dot), as determined
from the crystal structure (inset, PDB 1U19) (Okada et al., 2004).
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2.4

Discussion

2.4.1 The non-specific reactivity of chemistries selective for the keto group
Our aim in this present study was to identify highly selective and robust labeling
chemistries that could exploit site-directed uaa mutagenesis of GPCRs. Initially we
focused on the keto group in AcF (Ye et al., 2008). Because keto groups have been
studied for site-specific fluorescent labeling in several model systems (Cornish et al.,
1996; Hang and Bertozzi, 2001). Under roughly physiological conditions, ketones and
aldehydes react specifically with hydrazide (or aminooxy) reagents through hydrazone
(or oxime) ligation (Bayer et al., 1988; Wang et al., 2003). These reactions have been
used to label proteins at genetically encoded N-terminal aldehyde tags (Shi et al., 2012),
and with more flexibility at site-specifically incorporated uaas (Cornish et al., 1996;
Fleissner et al., 2009). However, in our initial attempts to label AcF tagged Rho with a
fluorescein-hydrazide, we observed substantial covalent modification of wt Rho in the
absence of AcF (Ye et al., 2008). In order to determine if such background reactivity was
specific to a membrane glycoprotein, like Rho, we studied a soluble, non-glycosylated
protein, recombinant firefly luciferase. While we were able to label AcF-tagged
luciferase, we also found similar background reactivity in wt luciferase with different
reagents selective for ketone and aldehyde (Huber et al., 2013).
Previous studies have reported that cellular oxidation processes often convert some
amino acid residues to carbonyl derivatives (i.e., ketone and aldehyde) that can react with
hydrazide reagents (Ahn et al., 1987; Stadtman and Levine, 2003). These reactive
carbonyl groups normally present in proteins are known to originate from unusual posttranslational oxidation processes to the side-chains of lysine, histidine and cysteine
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residues under oxidative stress (Stadtman, 1993). More recently, a role of reactive lipid
hydroperoxides has been described in a phenomenon known as “protein carbonylation”
(Grimsrud et al., 2008). In our study, we obtained the rate constants of the reaction
specific for the AcF handle, and the non-specific reaction for the wild-type receptor, and
found the latter to be significantly faster than the former. This finding is consistent with
the hypothesis that protein oxidation may involve the generation of aldehyde group,
which has a more reactive carbonyl group than the ketone group in AcF. We suggested
earlier (Huber et al., 2013) that these reactive carbonyl groups have been previously
overlooked as the origin of background labeling in protein tagging experiments, possibly
because low molecular weight proteins (Wang et al., 2003; Zhang et al., 2003) or highly
modified components were employed as the model systems (Zeng et al., 2009). Therefore,
the chemistries for aldehyde and ketone should be chosen with caution to achieve the
desired protein modification.
2.4.2 A comparative study of labeling chemistries for the azido group
After carefully evaluating the non-specific reaction with labeling ketone, we
explored the alternative of using azido groups as reactive handles to label proteins.
Azides react specifically with phosphines through the Staudinger-Bertozzi ligation (Kiick
et al., 2002; Saxon and Bertozzi, 2000), with alkyne reagents through copper (I)catalyzed [3+2] azide–alkyne cycloaddition (CuAAC), with oxanorbornadienes through
tandem [3+2] cycloaddition–retro-Diels–Alder (tandem crDA) (van Berkel et al., 2007),
or with cyclooctynes through SpAAC (Debets et al., 2011; Agard et al., 2004; Sletten and
Bertozzi, 2011).
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Encouraged by the previous reports of Staudinger ligation to label azidocontaining proteins (van Berkel et al., 2007; Tsao et al., 2005; Debets et al., 2010;
Schilling et al., 2011), we investigated the possibility of using fluorescein-phosphine to
label azF-tagged luciferase and Rho. We found the Staudinger ligation reaction of azFluciferase with the phosphine reagents gave essentially no background as compared with
the hydrazone and oxime ligations, indicating the true bioorthogonality of azido group
over the keto group (Huber et al., 2013). However, when we applied the Staudinger
ligation to label the membrane protein Rho, we experienced difficulties with the
hydrophobicity of the fluorescein-phosphine label. Moreover, we found that the overall
utility of the Staudinger ligation was limited by its relatively slow reaction kinetics and
sub-stoichiometric ratio of labeling. The Staudinger ligation only achieved 30% labeling
of Rho after reacting for 12 h at room temperature (Huber et al., 2013), in spite of the
nearly stoichiometric conjugation of azF in other recombinant proteins with fluoresceinphosphine as reported previously (Tsao et al., 2005). In agreement with our findings, a
recent report of Staudinger ligations targeting two different azido amino acids showed
that azF was only incompletely modified by phosphines, which was attributed to the
shorter linker length between the backbone and the azide (Yanagisawa et al., 2008).
We also considered the CuAAC reaction, commonly referred to as the coppercatalyzed click chemistry. However, we were concerned about the potential damage from
Cu to the purified protein and live cells, as Cu can switch its oxidative states easily,
thereby inducing undesirable chemical modifications to proteins and cells. This
drawback of CuAAC prompted a hunt for reagents that react with azide in the absence of
metal catalysts.
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A report in 1953 mentions an explosive reaction of cyclooctyne with phenyl azide
forming a viscous liquid product (Blomquist and Liu, 1953), later identified as 1-phenyl4.5-cycloocteno-1.2.3-triazol (Wittig and Krebs, 1961). In 2004, the Bertozzi group
capitalized on these pioneering studies on the chemistry of many-membered rings in
1950s and 1960s and introduced SpAAC of cyclooctynes and azides as efficient
bioconjugation reagents (Agard et al., 2004). In order to overcome problems such as low
reactivity, poor reagent stability, and difficult synthetic pathways of the earlier
cyclooctynes for bioconjugation, Boons and colleagues introduced dibenzocyclooctyne
derivatives for bioconjugation by SpAAC (Brustad et al., 2008) based on a 1969 report
on the spontaneous reaction of dibenzocyclooctyne with phenyl azide (Seitz et al., 1969).
Despite the reports of degradation of the cyclooctyne BARAC in presence of glutathione
(Jewett et al., 2010), it was generally believed that SpAAC involving the cyclooctynes
results in low background labeling (Sletten and Bertozzi, 2011). In a recent study, three
cyclooctynes, DIBO, BCN, and DIBAC were used to evaluate azide-independent labeling
of proteins, demonstrating that all of these reagents exhibited undesirable reactivities to
varying extents, by a radical-based thiol-yne addition mechanism that modifies cysteine
residues in proteins (van Geel et al., 2012). Interestingly, DIBO appeared to have
drastically reduced background labeling as compared with BCN and DIBAC (van Geel et
al., 2012).
2.4.3 The non-specific reactivity of DIBO for protein labeling
We present three independent lines of evidence that can be used to estimate the
background labeling by DIBO in wt Rho: 1) the absence of Alexa488 absorbance (<5%)
in UV-Vis spectrum; 2) the absence of Alexa488 fluorescence emission in the in-gel
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fluorescence image (~5%); and 3) negligible change in fluorescence signal upon
photoactivation in the fluorescence-quenching assay (<1%). We contend the steady-state
fluorescence-quenching assay provided the most accurate information for non-specific
covalent labeling, because the energy transfer is critically dependent on the distance
between the donor and the receptor.
Another concern is the potential reduction of azide to amine in the cellular context,
which would decrease the number of reactive handles present in Rho. The in vitro
reduction of aryl azide by thiols to aryl amines has been reported (Staros et al., 1978),
and the reduction product of azF might be utilized by the aminoacyl synthetase (Nehring
et al., 2012). Reduction of genetically encoded azido group to amino group has also been
observed by mass spectroscopy (Kiick et al., 2002; Liu et al., 2007). However, in the case
of unnatural amino mutagenesis, it is not clear whether the degradation of azF occurred
before or after incorporation into protein. Reduction of azF would lead to a decrease of
the labeling stoichiometry and might contribute to the apparent sub-stoichiometry for
Y102azF Rho. Y102azF is exposed to the oxidizing extracellular environment rather than
the reducing environment of the cytosol. Theoretically, compared with Y102azF,
S144azF is more likely to be degraded in the cellular environment. Due to the difficulty
of mass spectroscopy experiment with GPCRs, we do not have direct experimental
evidence to test this possibility. Overall, we believe that the slow reaction kinetics, rather
than the reduction of azF, is the major cause for the sub-stoichiometrical labeling for
residues like Y102azF.
As mentioned earlier, it has been reported that such azide-independent background
labeling of proteins with cyclooctyne reagents was primarily due to reactive cysteine
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thiols (van Geel et al., 2012) in analogy to radical, photoinitiated thiol-yne additions
(Fairbanks et al., 2010; Hoogenboom, 2010). In Rho there are four membrane-embedded
cysteines, three cytoplasmic cysteines, and three extracellular or intradiscal cysteines
(Karnik et al., 1988). Among them, two cytoplasmic cysteines (C140 and C316) have
been shown to be highly reactive towards traditional thiol-specific reagents (Mielke et al.,
2002). The normally S-palmitoylated cysteines (C322 and C323) may be incompletely
palmitoylated and available for derivatization (Resek et al., 1993; Blaskovic et al., 2013),
since S-palmitoylation is a reversible post-translational modification (Blaskovic et al.,
2013). Consequently, except for the two cysteines that form a disulfide bond (C110 and
C187), from two to eight remaining cysteines are potentially reactive towards DIBO. We
estimate based on 1% background labeling of wild-type Rho that the selectivity factor of
DIBO for azF over cysteine is between 200:1 and 800:1, which is sufficient to achieve
good bioorthogonality in a chemically defined system.
The present study was primarily focused on labeling purified protein for in vitro
experiments, but it also gave some insight into application of cyclooctyne reagents in live
cell labeling. Considering the selectivity of DIBO reagents, the applicability of this
approach depends on the relative abundance of the targeted azido groups over thiol
groups from cysteine-containing proteins. The GPCRs are difficult targets that are
generally expressed at low levels on the cell surface. Rho is among the best-expressing
GPCRs in mammalian cells (6×106 molecules/cell) and the expression levels of other
GPCRs are likely to be lower than Rho (Oprian et al., 1987; Sarramegna et al., 2003).
Moreover, based on our experience, uaa-tagged Rho has significantly lower expression
levels (10–20% compared to the wild-type receptor). We do not have direct information
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regarding the abundance of cysteines reactive to cyclooctyne, but we can estimate the
number of cysteines in membrane proteins per cell. Membrane proteins constitute
approximately 30% of the human proteome (Almen et al., 2009) and membrane proteins
in the post-nuclear fraction comprise ~9% of total protein mass in human HeLa cells
(Bosmann et al., 1968), which corresponds to ~21 pg per cell or ~3.3×108 membrane
proteins considering each protein molecule has on average 350 amino acids (Milo, 2013).
Cysteine has been shown to vary from 0.2% to 0.5% in the total amino acid composition
of cultured cells (Okayasu et al., 1997). Assuming membrane proteins have a similar
length and composition of amino acids, the total number of cysteines in the membrane
proteins is no less than 2 ×108 copies/cell. Therefore, on cell surface the abundance of
cysteine is likely to be 2×102-fold greater than that of azF in the well-expressing GPCR
Rho. With about 200:1 selectivity of DIBO for azF over cysteine, we would expect an
equal contribution from specific labeling and background reactivity with cysteines. The
situation would be much worse for receptor densities typically employed for singlemolecule fluorescence tracking experiments (~1 µm−2) (Hern et al., 2010; Calebiro et al.,
2013), which corresponds to only 2500 receptors per cell (Sommerhage et al., 2008). The
oxidative state of cysteine thiols should also be taken into account; the exposed cysteines
in the extracellular side are likely to be oxidized to disulfide bonds, while the
transmembrane and intracellular cysteines more likely in the reduced form. However,
considering the hydrophobicity of cyclooctynes, we cannot exclude that possibility that
these reagents would partition into lipid bilayer and react with the transmembrane
cysteines. Also, certain cyclooctyne derivatives are designed to permeate the membrane
(Beatty et al., 2011). Taken together, owing to the cross reactivity with cysteines, it can
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be challenging to achieve an ideal signal-to-noise ratio for labeling and imaging lowabundance molecules on live cells using cyclooctyne reagents, as the chemistry is
selective over the major non-specific reaction by only two orders of magnitude. Not
surprisingly, successful applications of cyclooctyne reagents to live cell labeling
normally necessitate the choice of high-abundance target molecules (e.g., peracetylated
N-azidoacetyl mannosamine) in the cell surface (Jewett et al., 2010), or promiscuous
incorporation of azido uaas into multiple protein molecules (Beatty et al., 2010). Thus,
we contend that the cross-reactivity with thiols should be evaluated in parallel with
hydrophobicity for the development of new cyclooctyne derivatives for live-cell labeling.
2.4.4 Accelerated SpAAC in micellar environment
While the reaction kinetics of SpAAC with azF-Rho varies with the specific
chemical and structural properties of the labeling reagent and the location of the azF
residue, it has proven generally satisfactory for our purpose. Interestingly, we noted in
our system a substantial rate enhancement effect (from 4-fold to 1000-fold) for the
SpAAC reaction (8.6 ± 1.3 M−1 s−1 for DIBO-biotin or 62 ± 12 M−1 s−1 for Alexa488DIBO and Rho-S144azF) as compared with model reactions of DIBO and benzylazide in
methanol (0.17 M−1 s−1 ) or water/acetonitrile (1:4 v/v) (2.3 M−1 s−1) (Ning et al., 2008;
Debets et al., 2011).
The unexpectedly high reaction rates of SpAAC between the ~40-kDa biomolecule
S144azF-Rho and DIBO prompted us to postulate that the reactivity of the DIBO reagent
is modulated by the local environment on the protein surface, and that the hydrophobicity
of the local environment contributes to the observed reactivity enhancement. Therefore,
we determined the kinetics for two TM4 azF-Rho variants, M155azF- and V162azF-Rho,
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and found even greater rate enhancement effect. To explain this observation, we designed
a filtration experiment to determine the partition coefficient of Alexa488-DIBO between
micelle and water. We hypothesized that the partitioning of Alexa488-DIBO resulted in a
higher local concentration of DIBO around azF, and hence the accelerated reaction. We
found such a simple model suffices to explain the order of magnitude of the rate
enhancement effect for SpAAC with azF-Rho in micelles.
A popular method to predict the stickiness of cyclooctynes and fluorescent dyes,
and their applicability for fluorescent labeling, is based on in silico calculation of the noctanol/water partition coefficient (cLogP) (Debets et al., 2011; Hughes et al., 2014). We
used ChemBioDraw 14 to calculate cLogP = –11.8 for Alexa488-DIBO. Thus the high
value of the measured partition coefficient (Log 780 = +2.9) of Alexa488-DIBO between
DM micelles and water seems counterintuitive. However, the cLogP of DIBO was
calculated as +4.4 (Debets et al., 2011), suggesting a strong tendency for DIBO to
partition into the hydrophobic core of DM micelles. The linker length between the
hydrophobic DIBO and the hydrophilic Alexa488 enabled the polar moiety to reside
outside the water/detergent interface (Figure 4D). Overall, the amphiphilicity of
Alexa488-DIBO makes it thermodynamically favorable to partition into the micelle and
adopt the orientation that brings the reactive DIBO moiety into proximity of azF. This
finding also supports an earlier report that the calculated cLogP does not robustly predict
lipid membrane interactions of fluorescent dyes (Hughes et al., 2014).
The partition effect also helps to explain several earlier observations. The k2 for
S144azF-Rho (62 ± 12 M−1 s−1) is two orders of magnitude higher than the reaction rate
for the EC site Y102azF, but one order of magnitude lower than that of TM4 sites
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M155azF and V162azF. Site S144 is located in the IC2 loop that exhibits higher
flexibility than the rigid site Y102 (Huber et al., 2004). Although the residue S144 is
largely exposed to water with only 7% lipid contacts (cf. Figure 2-7), substitution of
serine for azF increases the hydrophobicity of this site, and consequently its probability to
partition into the lipidic environment. Recently, we found that a site located in a
hydrophobic cavity on the EC side of the CCR5 chemokine receptor was much more
efficiently labeled by SpAAC than other EC sites (Naganathan et al., 2015). Interestingly,
recent labeling experiments with azF-tagged GFP showed large variation of SpAAC
reaction rates for different labeling positions. The most highly reactive site (k2 = 17.8 M−1
s−1) had the least surface exposure of all tested sites and was in a non-charged but polar
local environment with an adjacent aromatic phenylalanine residue (Reddington et al.,
2012). Taken together, a strong determinant for the SpAAC reactivity of DIBO is the
hydrophobicity of the local environment in which azF resides.
2.4.5 Alternate uaas for site-specific labeling of proteins
In the recent years, the pyrrolysyl-tRNA synthetase/tRNA pair (Srinivasan et al.,
2002; Polycarpo et al., 2004; Blight et al., 2004) has been developed as an alternative to
evolved tyrosyl-tRNA synthetase/tRNA pairs for amber suppression, first in E.coli
(Neumann et al., 2008), later in yeast (Hancock et al., 2010) and mammalian cells
(Hancock et al., 2010). A major advantage of the pyrrolysyl synthetase is its high
substrate side-chain promiscuity (Wan et al., 2014). In addition to azido and alkynyl
groups for CuAAC or SpAAC (Nguyen et al., 2009), the engineered pyrrolysyl
synthetases have enabled a wider range of bioorthogonal reactive group to be genetically
encoded into protein, including 2-aminothiols for cyanobenzothiazole condensation
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(Nguyen et al., 2011), strained alkynes for SpAAC (Plass et al., 2011) or tetrazine
ligation (Borrmann et al., 2012; Lang et al., 2012), strained alkenes for Diels-Alder
reaction (Plass et al., 2012), norbornene that reacts with nitrile-imines (Kaya et al., 2012)
or tetrazine (Lang et al., 2012), tetrazines with trans-cyclooctyenes (Seitchik et al., 2012),
acrylamide with nitrile imine (Lee et al., 2013), etc. The list will continue to grow in the
foreseeable future.
An appealing feature about some of these newly developed labeling methods is
their ultrafast reaction kinetics, with k2 up to 104 M−1 s−1 (Lang and Chin, 2014a, b).
However, most of the proof-of concept studies were based on globular proteins that are
routine to express and purify, and their applicability to proteins of greater biological
significance is yet to be demonstrated.
To prepare fluorescently labeled proteins for research applications, reaction
kinetics is certainly one of the important concerns, but not the predominant one. Nonspecificity can be an issue as well. The strained alkenes (Hoyle and Bowman, 2010),
strained alkynes (van Geel et al., 2012) and tetrazines (Jewett and Bertozzi, 2010) all
have been suggested or demonstrated to react with thiols, which raises the possibility that
these genetically encoded reactive handle may also suffer from cross-reactivity with
neighboring cysteines, or with intracellular cysteines in the course of protein folding and
trafficking.
Non-specificity can be an issue as well. The strained alkenes (Hoyle and
Bowman, 2010), strained alkynes (van Geel et al., 2012), and tetrazines (Jewett and
Bertozzi, 2010) all have been suggested or demonstrated to react with thiols, which raises
the possibility that these genetically encoded reactive handle may also suffer from cross-
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reactivity with neighboring cysteines, or with intracellular cysteines in the course of
protein folding and trafficking. In our hands, we found the non-specific reaction between
DIBO and free cysteine in Rho to be less than 1%, which would meet our need for
subsequent fluorescence experiment.
Based on our own experience gleaned from labeling GPCRs, we contend that
characterization of reaction specificity, kinetics, and topology-dependent reactivity, and
protein functionality are much needed for successful application of the bioorthogonal
chemistries to protein labeling.
2.4.6 The fluorescent quenching assay based on Alexa488 fluorescence
Earlier kinetics studies of chromophore binding and regeneration in Rho utilized
tryptophan (Trp) fluorescence (Farrens and Khorana, 1995; Schadel et al., 2003;
Sanchez-Martin et al., 2013). However, this approach relies intrinsic Trp residues that are
sensitive to ligand-binding or ligand-induced conformational changes and thus has
significant limitations. First, due to the low quantum yield of Trp, studying intrinsic
fluorescence requires up to 10 times more protein (>10 µg or 0.5 µM) (Schadel et al.,
2003; Sanchez-Martin et al., 2013) than needed when the receptor is labeled with
extrinsic fluorophores with higher quantum yields (<1 µg/50 nM in our study). In addition,
native Trp residues are not necessarily well positioned to serve as active-site probes.
Moreover, so-called inner filter effects limit the useful concentration of UV-absorbing
11-cis-retinal in Trp-fluorescence experiments. Furthermore, in terms of more general
applications, not all GPCR ligands will be able to quench or otherwise alter Trp
fluorescence, which limits its general applicability to other GPCR systems. We thus
developed a fluorescent quenching assay to circumvent these limitations of Trp
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quenching studies and subsequently show that the site-specifically labeled azF-Rho
remain functional photoreceptors with respect to ligand binding and release. Our results
highlight the advantage of utilizing an extrinsic fluorescent reporter, which allows the
flexibility of choosing the optimal photophysical properties to address a specific question,
instead of relying on the intrinsic Trp fluorescence.
We envision this assay to be implemented to study the Rho mutations implicated
found in various retinal diseases, such as congenital stationary night blindness (Rattner et
al., 1999). The applications of this steady-state fluorescence-quenching assay are
described in Chapter Three and Chapter Four. Furthermore, it could potentially provide a
general scheme for studying the ligand-receptor interaction in vitro, especially for the
peptide ligands available as fluorophore conjugates. While many previously-reported
ligand binding assays similarly exploit the energy transfer between ligand and receptor
(Middleton and Kellam, 2005), our methodology is advantageous in two significant
ways: 1) it does not involve a fluorescent fusion protein or fluorescent antibody, and is
less likely to give an artifact due to extensive modification on native state of receptors; 2)
it might provide insights into the mode of binding by comparing receptors specifically
labeled at different positions.
2.4.7 The advantage of targeting the TM region of GPCRs
Attaching probes to the TM region of membrane proteins have been a major
technical challenge in the field (Pless and Ahern, 2013). To our knowledge, the
fluorescent reporters have anchored to the TM region only by incorporation of
fluorescent uaas (Cohen et al., 2002; Pantoja et al., 2009). While the fluorescent uaas
benefit from short linker length between the protein backbone and the fluorophore, the

81	
  

photophysical properties of the fluorophores are often limited by the small size of the
fluorophore. Unlike maleimide/cysteine chemistry, which involves a thiolate anion
intermediate and preferably labels sites exposed to aqueous environment (Li et al., 2002),
the DIBO/azF combination readily modifies sites in the hydrophobic TM region. This
property of SpAAC offers several opportunities for future work. First, the EC surfaces of
GPCRs are often critical for receptor-ligand binding, and the IC surface for receptor-G
protein interaction. Thus for numerous applications it is desirable to leave the EC and IC
surface intact. Second, the sequence of molecular events in GPCR activation has received
increasing interest (Ye et al., 2010; Altenbach et al., 2008b). The capability to anchor a
probe to a particular site in the TM region of GPCRs will be a valuable tool for such
studies. Third, it is expected to facilitate FRET study on the structure-function
relationship of GPCRs. The energy transfer efficiency of FRET is sensitive to the
distance between donor and acceptor, making it a popular tool for probing the small
changes in protein conformation at the ensemble and single molecule level (Wu and
Stryer, 1972; Stryer, 1978; Roy et al., 2008). However, the transfer efficiency also
depends on the dipole orientation of fluorophores as well as refractive index of medium,
making it difficult to obtain the absolute distance between the donor and the acceptor
from FRET alone, and additional structural information is often crucial for correct
interpretation of the results. However, for most GPCRs high-resolution structures are still
not readily available. The conservation of the TM4 in Class A GPCRs makes it an ideal
internal “molecular ruler”, enabling the FRET data to be understood in the context of a
homology model (Costanzi, 2011). The TM4 sites shown to be suitable for SpAAC
reaction can be extrapolated to other GPCRs (Ballesteros and Weinstein, 1995).
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The preference of SpAAC with sites embedded in hydrophobic environment
provides a unique possibility for studying membrane proteins. We anticipate that the
micelle-enhanced bioorthogonal labeling strategy reported here will be useful to
investigate receptor oligomerization, lipid-receptor interactions, and single-molecule
FRET of GPCR-ligand interactions (Huber and Sakmar, 2014; Bockenhauer et al., 2011;
Huber and Sakmar, 2011).
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2.5

Material and Methods

2.5.1

Materials
E. coli TOP10 (Invitrogen) was used for plasmid propagation and isolation.

Oligonucleotides were obtained from eOligo or Fisher Scientific. Plasmid DNA was
purified using standard Maxi Prep Kits from Qiagen. AcF (RSP Amino Acids LLC) and
azF (Chem-Impex International) were used without further purification. The plasmid
pSVB.Yam is a tRNA expression vector carrying a humanized chimeric gene encoding
an amber suppressor tRNA derived from the B. stearothermophilus tRNATyr (Ye et al.,
2008). pcDNA.RS-Tyr is a protein expression vector based pcDNA3.1 (+)/neo
(Invitrogen) with a gene encoding E. coli Tyr-RS with a C-terminal FLAG tag (Ye et al.,
2008), pcDNA.RS-AcF (E. coli Tyr-RS-Y37I/D182G/F183M/L186A) and pcDNA.RSazF (E. coli Tyr-RS-Y37L/D182S/F183M/L186A) are the tRNA synthetase for AcF and
azF, respectively (Ye et al., 2008; Ye et al., 2009), and pMT4 carries the synthetic gene
encoding wt bovine Rho (Franke et al., 1988). We introduced amber mutations into the
Rho gene by QuikChange mutagenesis (Stratagene). The primers are listed in Table 2-4.
All plasmid constructs were confirmed by automated DNA sequencing. The HEK293F
cell lines, the transfection reagents (FreeStyle MAX), and expression media (OptiPRO
SFM reduced serum medium, serum-free FreeStyle 293 expression medium) were
obtained from Invitrogen/Thermo Fisher Scientific. Sepharose 2B was purchased from
Sigma. 1D4-Sepharose 2B was prepared from 1D4 mAb and CNBr-activated Sepharose
2B (2 mg IgG per mL packed beads) as described below. Alexa488-DIBO was obtained
from Molecular Probes/Thermo Fisher Scientific as dry powder, and dissolved in DMSO
at 5 mM and stored at -20°C.
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Table 2-4 The primers for site-directed mutagenesis
Mutation

Forward (5’→3’)

Reverse (5’→3’)

Y102amb

cctctctccatgggtagttcgtcttcggtcc

ggaccgaagacgaactacccatggagagagg

C140amb

cggtacgtggtggtgtagaagcccatgagcaac

gttgctcatgggcttctacaccaccacgtaccg

S144amb

gtgcaagcccatgtagaacttccgcttcggtga

tcaccgaagcggaagttctacatgggcttgcac

N151amb

cttccgcttcggtgagtagcacgccatcatg

catgatggcgtgctactcaccgaagcggaag

M155amb

gaaccacgccatctagggcgtcgccttcacc

ggtgaaggcgacgccctagatggcgtggttc

A158amb

cgccatcatgggcgtctagttcacctgggtc

gacccaggtgaactagacgcccatgatggcg

V162amb

gtcgccttcacctggtagatggctctggcc

ggccagagccatctaccaggtgaaggcgac

L165amb

cacctgggtcatggcttaggcctgtgcggcc

ggccgcacaggcctaagccatgacccaggtg

A169amb

gctctggcctgtgcgtagccgccgctcgtc

gacgagcggcggctacgcacaggccagagc

V173amb

ggccccgccgctctagggctggtctagatac

gtatctagaccagccctagagcggcggggcc

A234amb

gtcaaggaggcttaggcccagcagcaggag

ctcctgctgctgggcctaagcctccttgac

A246amb

gccaccactcagaagtaggagaaggaggtc

gacctccttctcctacttctgagtggtggc

2.5.2 Heterologous expression of wt and mutant Rho in suspension cells
HEK293F suspension cells were cultured in serum-free FreeStyle 293 expression
medium in a 125-mL disposable, sterile, polycarbonate Erlenmeyer flask (Corning) at
37°C in 5% CO2 atmosphere. The cell culture was shaken on an orbital shaker at 125 rpm.
For amber codon suppression, the cell culture was diluted to a density of 106 cells/mL in
a 30-mL culture supplemented with 1 mM uaas (AcF or azF) before transfection. Plasmid
DNA (38.6 µg in total, 18.4 µg of pMT4.Rho containing the amber codon, 18.4 µg of
pSVB.Yam, and 1.84 µg pcDNA.RS) was added into OptiPRO SFM (a total volume of
0.6 mL) reduced serum medium. In another sterile tube, transfection reagent FreeStyle
MAX (38.6 µL) was diluted in into OptiPRO SFM (a total volume of 0.6 mL). The
diluted transfection reagent was gently combined with the DNA. The mixture was let
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stand at room temperature for 10 minutes and then added into the cell culture (total cell
number 3×107). The cells were harvested 96 hours post-transfection. The total cell
number upon harvesting normally ranged from 6×107 to 8×107.
2.5.3

Regeneration of heterologously expressed Rho
The harvested cells were resuspended in DPBS (Gibco, supplemented with

leupeptin and aprotinin, Sigma) at a density of 107 cells/mL in a 15-mL conical,
polypropylene tube (Falcon). In the dark room, 11-cis-retinal (1.4 mM ethanol solution)
was added into the cell suspension to a final concentration of 5 µM (Oprian et al., 1987;
Starace and Knox, 1998). The suspension was nutated at 4°C overnight. Excess 11-cisretinal was removed by spinning down the cells and discarding the supernatant fraction.
The regenerated cells can be immediately used, or may be stored at −20°C for several
months.
2.5.4

Coupling 1D4 mAb with CNBr-activated sepharose 2B resin.
The method was based on earlier literature(Oprian et al., 1987; Knepp et al., 2011).

In a typical preparation, 50 mL of 1D4 antibody stock solution (0.92 mg/mL in PBS) is
coupled to 25 mL of CNBr-activated sepharose 2B. Before the coupling reaction, 1D4
mAb stock solution (50 mL) was concentrated by centrifugation (2,800 × g) at 4 °C using
Amicon centrifugal filter unit (Ultra 15, 10 kDa MWCO) until the volume was reduced to
2 mL. The concentrated 1D4 mAb was diluted in Coupling buffer (10 mM borate, 150
mM NaCl, pH 8.2) with 60 mL coupling buffer and centrifuged again until the remaining
volume was 2∼3 mL. The concentrated mAb solution was transferred into a
polypropylene falcon tube and measured for its concentration and volume to determine
the recovery yield. Meanwhile, the sepharose 2B resin was washed with ultrapure water
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(3 times the volume of resin) for 5 times to remove the ethanol in the storage buffer,
followed by two washes with bicarbonate buffer (1M sodium bicarbonate, pH 11.0). After
the washes, the resin was resuspended in equal volume of bicarbonate buffer to make a
50% slurry and kept on ice before use. The CNBr activation of sepharose was done in ice
bath to maintain the temperature below 5 °C. During the reaction, the pH and temperature
of the reaction mixture was monitored with a pH meter and a thermometer. The CNBr
solution (approx. 2.55 g CNBr in 2-3 mL acetonitrile) was gently added to the sepharose
under mixing by a tissue-culture magnetic stirrer. The reaction was allowed to proceed
from 10 to 30 min. During this time 10 M NaOH was added dropwise to neutralize HBr
and keep the pH approximately constant. When the reaction was close to completion, the
decrease of pH should slow down. The activated sepharose was instantly transfer into a
Büchner funnel connected to a suction flask to remove the unreacted CNBr. The flask
was filled with ~100 mM Fe (II)SO4 (3 g in 100 mL water) to destroy the unreacted
CNBr. The resin was washed 4 times with ice-cold ultrapure water (50 mL each time)
and twice with ice-cold coupling buffer (50 mL each time). Then the activated sepharose
resin was transferred into 50-mL Falcon tube and resuspended in coupling buffer to make
50% slurry. Transfer slurry to tubes for coupling. The concentrated 1D4 resin was
immediately added into the slurry and thoroughly mixed it by ten inversions. The mixture
was kept on nutator at 4 °C overnight to allow the primary amines of the mAb to react
with the CNBr-activated resin. After the reaction was complete, the mixture was
centrifuged to remove the supernatant (check whether supernatant is free of protein;
A280 should be ≤ 0.05). Then resin was washed with 4-5 volumes of 10 mM glycine in
DPBS for 20 min on a nutator at 4 °C to deactivate the excess CNBr. In the end the resin
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was washed twice with 4~5 volumes of DPBS and resuspended in DPBS as 50% slurry.
The 1D4 mAb sepharose 2B resin was stored as 50% slurry in PBS with NaN3 (10 mM)
at 4 °C.
2.5.5

Purification of heterologously expressed Rho
The regenerated cells were lysed with the solubilization buffer (1 mL per 107

cells, 1% (w/v) DM, 50 mM HEPES or Tris-HCl, pH 6.8, 100 mM NaCl, 1 mM CaCl2
with complete EDTA-free protease inhibitor cocktail) for at least 1 h at 4°C. All the
regenerated samples were maintained in the dark and handled in a darkroom using red
safe lights. The cell lysates were centrifuged at 100,000 × g for 30 min at 4°C. The
supernatant fraction was mixed with 1D4-Sepharose-2B resin (50 µL or 100 µL) and
incubated overnight at 4°C. The resin was then transferred into a microporous
centrifugal filtering unit (Microcon-MC pore size 0.48 µm, Millipore), which allows for
efficient removal of washing buffer. The resin was first washed with DPBS containing
0.1% (w/v) DM for three times (30 min incubation each time), and then with a low-salt
buffer (0.1% (w/v) DM in 2 mM phosphate buffer, pH 6.0). Eventually, the receptor was
eluted with the elution buffer (100 µL, no less than the volume of the resin; 0.1% (w/v)
DM and 0.33 mg/mL C9 peptide in 2 mM phosphate buffer, pH 6.0). The resin was
incubated with the elution buffer on ice for at least 1 h. The purified receptor was
collected in a clean 1.5 mL Eppendorf tube. Two elutions should recover 70–80% of the
receptor. The Rho yield from 107 HEK293F cells is typically 5−8 µg for wt and 0.5−1 µg
for azF variants.
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2.5.6

UV–Vis spectroscopy of the purified Rho
The dark-state absorption spectrum of Rho was recorded on a Lambda-800

spectrophotometer (PerkinElmer Life Sciences) in a 50-µL micro-cuvette with a 10-mm
path length. The receptor was then photobleached by irradiating the sample for 30 s with
a 335-mW 505-nm LED light source (Thorlabs) placed on top of the cuvette before
acquiring the light spectrum. The dark−light difference spectrum at 500 nm was used to
calculate the concentration of Rho using an extinction coefficient of 40,600 M−1cm−1. The
Alexa-488 concentration was calculated from 495-nm absorbance in the light spectrum
using the extinction coefficient 73,000 M−1 cm−1. The labeling stoichiometry is the ratio
of the Alexa-488 and Rho concentrations determined this way.
2.5.7 Bioorthogonal labeling of Rho
The 11-cis-retinal regenerated cells were lysed with the solubilization buffer (1 mL
per 107 cells, 1% (w/v) DM, 50 mM HEPES or Tris-HCl, pH 6.8, 100 mM NaCl, 1 mM
CaCl2 with complete EDTA-free Protease Inhibitor Cocktail, Roche) for at least 1 h at
4°C. The lysate was cleared by centrifugation at 100,000 × g for 30 min and incubated
overnight at 4°C with 1D4-mAb-sepharose 2B (100 µL). The resin was transferred into a
1.5-mL Eppendorf tube and washed three times for 30 min each with 0.5 mL reaction
buffer. Then the reaction buffer (200 µL) was mixed with the resin (100 µL) to give 300µL slurry.
The reaction was stopped by centrifugation and removal of the supernatant fraction.
The resin was then transferred into a microporous centrifugal filtering unit (MicroconMC pore size 0.48 µm, Millipore). The resin was first washed with the reaction/wash
buffer for three times (30 min incubation each time) to deplete the unreacted dyes, and
89	
  

then with a low-salt buffer (0.1% (w/v) DM, 2 mM sodium phosphate buffer, pH 6.0).
The receptor was eluted with elution buffer (100 µL, no less than the volume of the resin;
0.33 mg/mL C9 peptide in 0.1% (w/v) DM, 2 mM sodium phosphate buffer, pH 6.0). The
resin was incubated with the elution buffer on ice for at least 1 h. The purified receptor
was collected in a clean 1.5-mL Eppendorf tube. The elution was repeated a second time.
The combined elutions were supplemented with 150 mM NaCl and characterized by UVVis spectroscopy and in-gel fluorescence. Purified samples were stored at −80°C and
thawed on ice before use.
2.5.8

Kinetic study of SpAAC and oxime ligation
The reaction was performed under the same condition as described above. The

starting mixture consists of uaa-tagged Rho or wild-type Rho bound to 1D4-sepharose 2B
resin (100 µL), and reaction buffer (200 µL). At different time points, an aliquot of the
resin/buffer mixture (30 µL) was taken out and added into 0.4 mL of pre-cooled
reaction/wash buffer in a clean 1.5-mL Eppendorf tube to quench the reaction. The resin
was centrifuged and the supernatant containing unreacted labeling reagents was removed.
The resin was washed once with 0.4 mL of wash buffer (30 minutes) to remove the
remaining labeling reagent. The labeled Rho was eluted with the elution buffer
containing the C9 peptide (15 µL elution buffer × 2). The time-series samples were
separated by SDS-PAGE gel (10 µL eluate for each time point) and analyzed with dualcolor quantitative western blot using 1D4 mAb as primary antibody, IRDye800CW goat
anti-mouse secondary antibody (LI-COR), and IRDye680RD Streptavidin (LI-COR) for
biotin detection. The degree of labeling was measured as the ratio of the biotinylation
signal to 1D4 signal (protein loading). The extent of labeling reaction (ξ) was calculated
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as the ratio of biotinylation signal (700-nm channel) to 1D4 signal (800-nm channel) (i.e.,
ξ= I700/I800). Because the blots from two membranes are subject to random variations for
each chemistry, the uaa-tagged Rho and wt Rho time-series samples were further
analyzed on the same SDS-PAGE gel for comparison. The ξ was plotted as a function of
the reaction time, and fitted using the first-order exponential model to obtain the pseudo
first-order rate constant k1. The reaction rate constant k2 was calculated as k1/c (labeling
reagent).
2.5.9

Dual-color quantitative Western blot analysis
Appropriate amount of labeled Rho was separated by SDS-PAGE under reducing

conditions. The sample was transferred to Immobilon-FL Transfer Membrane
(Millipore), blocked with 1% BSA in PBS (20 mM phosphate saline buffer, pH 7.2) at
room temperature for 1 h, and stained with 1D4 monoclonal antibody (5000-fold dilution
from 1 mg/mL 1D4 stock solution in PBST: 20 mM phosphate saline buffer, pH 7.2, with
0.1% Tween20) against the C-terminal epitope of Rho. After washing with 1× PBST (5
min × 4), the membrane was blotted simultaneously with IRDye800CW goat anti-mouse
secondary antibody (20,000-fold dilution, LI-COR) and IRDye680RD Streptavidin
(5,000 × dilution, LI-COR). The unbound secondary antibody and streptavidin were
washed away with 1× PBST (5 min × 4). The membrane was scanned with Odyssey SA
Infrared Imaging System to quantify the biotinylation signal (700-nm channel) and the
amount of loaded protein (800-nm channel). The image was analyzed with Image Studio
(LI-COR software). Rho as a glycosylated membrane protein runs as a smear on the
SDS-PAGE gel. Thus the entire region of the smear was selected to measure the biotin
and 1D4 signal intensity.
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2.5.10 Kinetic study of SpAAC using Alexa488-DIBO
The reaction was performed under the same condition as described above. The
initial concentration of the labeling reagents (10 µM) was approximately 20-fold excess
molarity. At different time points, an aliquot of the resin/buffer mixture (30 µL) was
taken out and added into a clean 1.5-mL Eppendorf tube. The reaction was quenched by
adding the wash buffer (0.4 mL; 0.1% DM (w/v) DPBS, pH 7.2) and centrifugation.
Washing and elution were done as described in the previous section. The labeled Rho
was first separated by SDS-PAGE electrophoresis, and then visualized by in-gel
fluorescence. Silver staining was performed for the same gel in order to normalize the
sample concentration.
2.5.11 In-gel fluorescence to detect covalent Rho labeling
The labeled and purified Rho sample (50−100 ng) was separated by SDS-PAGE
under reducing conditions. In order to minimize protein aggregation, the sample was not
heated prior to loading. Gels were briefly washed in ultrapure water and then visualized
on a confocal Typhoon 9400 fluorescence scanner (GE) with 488-nm laser excitation and
510–520 nm band-pass for the fluorescence emission.
2.5.12 Silver staining to quantify protein concentration.
After electrophoresis, the SDS-PAGE gel was rinsed in the fixative buffer (40%
water, 50% methanol, 10% acetic acid) for at least one hour with two or three changes of
buffer. Then the gel was transferred into ultrapure water to remove the residual acid and
methanol. The staining buffer was prepared fresh by adding solution A (0.4 g silver
nitrate dissolved in 2 mL water) drop wise into solution B (0.7 mL 30% ammonium
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hydroxide added into 10.5 mL 0.36% sodium hydroxide solution) under constant stirring.
Following the clearing of the brown precipitate, the total volume of the staining buffer
was brought to 50 mL with ultrapure water. The gel was stained under gentle agitation for
10 to 15 minutes, and briefly washed with ultrapure water to remove the staining buffer.
Meanwhile, the developing buffer was prepared as follows: mix 30% formaldehyde (50
µL) with 1% citric acid (0.5 mL), and add water to 100 mL. The time needed for
achieving best contrast may vary from one experiment to another. Typically, when the
background began to turn yellow, we stopped development by transferring the gel into
1% acetic acid. After through washing in water, the silver-stained gel was scanned and
analyzed with ImageJ.
2.5.13 Determination of the partition coefficient of Alexa488-DIBO between micelle
and water
Approximately 5 µM Alexa488-DIBO solution was prepared in 1× DPBS buffer
containing various concentrations of DM micelles (up to ~ 1% (w/v)). 400 µL of the
solution was placed in an ultrafiltration spin filter (Amicon Ultra 0.5 mL centrifugal
filters, MWCO 10 kDa) and centrifuged at 14,000 × g for 5~7 min until the volume of the
filtrate was approximately 200 µL. The accurate volumes of the filtrate and the retentate
were determined by pipetting. The concentrations of Alexa488-DIBO in the filtrate and
retentate were quantified by UV-Vis spectroscopy (ε495nm = 73, 000 M−1 cm−1).
2.5.14 Functional characterization of labeled Rho by steady-state fluorescence
Fluorescence spectroscopy was performed at 28 °C on a SPEX Fluorolog
spectrofluorometer in photon counting mode. The time course experiments were done by
adding Alexa488-labeled receptor elutions (30 µL) at a final concentration of 15–50 nM
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to the assay buffer (450 µL; 10 mg/mL POPC, 10 mg/mL CHAPS, 125 mM KCl, 25 mM
MES, 25 mM HEPES, 12.5 mM KOH, pH 6.0) under constant stirring. During time scan
experiments the excitation wavelength was 480 nm with 0.2-nm band-pass to minimize
photobleaching, and the emission was measured at a wavelength of 525 nm with 15-nm
band-pass. The 11-cis-retinal stock solution in ethanol was diluted in the assay buffer,
and 20 mL of this working dilution was added to the cuvette to a final concentration of
1.5 µM (1.48–1.59 µM) retinal. For each measurement, the concentration of freshly
diluted retinal (cretinal) was determined from its 378-nm absorbance (extinction coefficient
24,400 M−1 s−1). The pseudo-first order rate constant (k1) was obtained by fitting the
fluorescence signal with monoexponential decay model. The second-order recombination
reaction rate constant (k2) was calculated as k1/cretinal.
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Chapter Three: Kinetics and Thermodynamics of the Chromophore
Binding Reaction in Rhodopsin

3.1

Summary
The fundamental molecular event underlying dark adaptation is the recombination

reaction between opsin and 11-cis-retinal after photobleaching of rhodopsin. We report
here a detailed analysis of the kinetics and thermodynamics of this “regeneration”
reaction. To enable FRET-based measurement of the recombination between opsin and
11-cis-retinal, we prepared a recombinant rhodopsin with a genetically encoded azidoPhe (azF) that was subsequently modified with Alexa488 fluorophore in a quantitative
bioorthogonal labeling reaction. We also utilized a phospholipid/detergent bicelle system
that provided a thermostabilizing lipid bilayer environment over the long timescales
required for the experiments. The recombination reaction followed a second-order rate
law. The temperate-dependent kinetics of the recombination reaction and the dissociation
reaction were measured to derive the enthalpic and entropic changes required to achieve
the transition state. We were also able to quantify for the first time in vitro, the very slow
dissociation rate of 11-cis-retinal from rhodopsin. Isothermal titration calorimetric was
used to obtain the total change in enthalpy for the 11-cis-retinal binding reaction. We
considered all of the experimental results obtained to derive an energy landscape plot for
the rhodopsin regeneration reaction. These results provide insights relevant to dark noise
and dark adaptation in the visual system as well as to ligand-binding reactions in related
G protein-coupled receptor systems.
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3.2

Introduction

3.2.1 Rhodopsin regeneration and dark adaptation
The rod cell visual photoreceptor rhodopsin (Rho), responsible for scotopic, or
dim-light vision, consists of a heptahelical transmembrane apoprotein opsin and a
chromophore, 11-cis-retinal (Wald, 1968; Schertler et al., 1993; Palczewski et al., 2000).
In the dark state, opsin and 11-cis-retinal are covalently linked together through a
protonated Schiff base (PSB) (Bownds and Wald, 1965; Bownds, 1967). The interactions
between the amino acid side chains in the ligand-binding pocket and 11-cis-retinal give
Rho its characteristic absorption band centered at 500 nm (Shichi, 1970). Upon
photoactivation, the chromophore 11-cis-retinal absorbs a photon to isomerize to alltrans-retinal (Hubbard and Wald, 1952), triggering a series of conformational changes
that eventually results in the Meta-II state to activate heterotrimeric G protein
(transducin) for downstream signaling (Stryer, 1986; Sakmar et al., 2002). The decay of
Meta-II is accompanied by the hydrolysis of the Schiff base bond and subsequent
dissociation of retinal from its binding pocket. To recycle the photoreceptor, the
apoprotein opsin recombines with 11-cis-retinal to from rhodopsin, a process referred to
as regeneration.
Regeneration of Rho in the dark after photobleaching is the fundamental
molecular event underlying visual dark adaptation. The correlation between the fraction
of Rho and visual sensitivity under various lighting conditions is described by the
Dowling-Rushton relation (i.e., the fraction of unregenerated Rho is proportional to the
log threshold elevation) (Rushton, 1961; Lamb and Pugh, 2006). Furthermore, efficient
regeneration of Rho is required for preventing the deterioration of rod outer segment
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(ROS) morphology (Dowling and Wald, 1960). Therefore, it is of great importance to
understand the chemical mechanism of the recombination reaction between opsin and 11cis-retinal. However, compared to the photoisomerization of retinal and the receptor
activation process (Cooper, 1981; Schick et al., 1987), the energetics of the regeneration
reaction remains much less well understood.
3.2. 2 The reconstitution method for studying rhodopsin regeneration
Kühne and his assistant Ewald described the first in vitro regeneration experiment
of Rho in 1878 (Wolf, 2001; Kühne, 1978). After many failed attempts to reproduce this
initial observation, it was confirmed nearly fifty years later by Hecht and his co-workers
(Hecht et al., 1936; Chase and Smith, 1940). It was found that regeneration occurred only
for Rho freshly extracted with bile salt or digitalin crystals at nearly neutral pH. Wald
later demonstrated that the regeneration process was the recombination reaction between
opsin and 11-cis-retinal (Wald and Brown, 1950).
The kinetic characterizations for this recombination reaction were carried out
under a variety of conditions with respect to the method of receptor reconstitution,
concentration of retinal, temperature, pH, ionic strength, etc., and the resulting reaction
rates reported in the literature span three orders of magnitude (102~105 M−1 s−1)
(Henselman and Cusanovich, 1976; Zorn and Futterman, 1973; Matsumoto and
Yoshizawa, 1975; Matsumoto et al., 1978; Mccaslin and Tanford, 1981; Sakamoto and
Khorana, 1995; Gross et al., 2003a; Gross et al., 2003b; Piechnick et al., 2012). It was
often observed that Rho solubilized in detergent micelles could not be fully regenerated
(Sanchez-Martin et al., 2013; Mccaslin and Tanford, 1981; Sakamoto and Khorana,
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1995), with the notable exception of digitonin, a nonionic steroidal glycoside (Wald and
Brown, 1950; Matsumoto and Yoshizawa, 1975; Matsumoto et al., 1978).
We initially hypothesized that the observed poor regeneration efficiency were due
to the low thermostability of opsin in these detergent micelle systems. The regeneration
reaction begins with the apoprotein opsin, which is unstable in most detergent systems,
and irreversibly loses its ability to bind with retinal with a half-life ranging from minutes
to hours, depending on the specific detergent. Among the studied detergents, digitonin
confers highest thermostability for opsin (Degrip, 1982a). However, digitonin has several
practical disadvantages, such as inhomogeneity, variable solubility, a low CMC, a high
micelle molecular weight, difficulty to remove by dialysis (Degrip, 1982a; Hjelmeland
and Chrambach, 1984). These properties make digitonin cumbersome to use. Thus the
mild and highly soluble detergents like n-octyl-β-glucoside (OG) or n-dodecyl-β-Dmaltoside (DM) have gained a greater popularity for studying Rho and other GPCRs.
Some studies utilized Rho with a pair of mutations N2C/D282C (Xie et al., 2003)
that introduced a thermostabilizing disulfide bond to achieve enhanced regeneration in
DM micelles (Gross et al., 2003a; Gross et al., 2003b; Piechnick et al., 2012).
Nonetheless, the possibility of generating an artifact from the additional disulfide bond
close to the retinal binding pocket remains a concern. Phospholipid additives (Sakamoto
and Khorana, 1995) or reconstitution of Rho into liposomes (Sanchez-Martin et al., 2013)
facilitated the regeneration process. However, addition of phospholipids only increases
the yield to approximately 80% regeneration (Sakamoto and Khorana, 1995) and the
preparation of liposome and subsequent insertion of Rho into the liposome is a laborious
process (Sanchez-Martin et al., 2013).

98	
  

Our aim was to study the recombination reaction between opsin and retinal using
a suitable platform that provides a lipid bilayer environment and is easy to manipulate.
Therefore we turned to the bicelles, a model lipid bilayer system comprises of long-chain
phospholipids and either detergents or short-chain phospholipids (Sanders and Prosser,
1998). The long-chain phospholipids form planar lipid bilayer fragments, which are edgestabilized by detergents or short-chain phospholipids that provide enhanced solubility in
the aqueous phase (Whiles et al., 2002). An increasing number of studies involving
membrane proteins reconstituted into bicelles suggest that in the presence of the lipid
environment the membrane proteins are more likely to retain their native activities than
when reconstituted in detergent systems (Durr et al., 2012).
3.2.3

Deriving energy diagram for the chromophore binding reaction in rhodopsin
In order to draw the energy diagram for a ligand-receptor binding reaction with a

single transition state (TS), minimally two out of three of the following measurements
need to be made: 1) the activation energy of the forward reaction Δ≠Gon , 2) the activation
energy of the reverse reaction Δ≠Goff , and 3) the energy difference between the reactants
and the products under a particular state ΔG°’ (Figure 3-1). Based on the transition state
theory:
≠

k T −Δ G k T −Δ
k = B e RT = B e
h
h

≠

H −T Δ ≠ S
RT

Where ΔG≠ is the Gibbs energy of activation, ΔH≠ is the enthalpy of activation,
ΔS≠ is the entropy of activation, kB is Boltzmann's constant, and h is Planck's constant.
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ΔGon≠ and ΔGoff≠ need to be obtained by kinetic measurements, while G°’
requires a method to measure the energy difference between the reactants and the
products.

Figure 3-1. Energy diagram for the recombination reaction between receptor and
ligand based on transition state (TS) theory. The forward reaction refers to the
association between the receptor and the ligand. The reverse reaction refers to the
dissociation of the ligand from the receptor. The free energy of activation for the forward
reaction is defined as Δ≠Gon = GTS − (GR+GL), for the reverse reaction as Δ≠Goff = GTS −
GR L. The overall change of free energy under a particular state is defined as ΔG°’= GR L −
•

•

(GR+GL). The reaction rates of the forward reaction and the reverse reaction are defined
as kon and koff, respectively.
Based on the linear form of the Eyring-Polanyi equation:

k
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h
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By measuring the temperature-dependent reaction kinetics, it is possible to
separate the enthalpic and entropic contribution to free energy required for activation.
We measured the kinetics of the forward reaction (kon) of the recombination
between 11-cis-retinal and opsin using novel FRET-based assays. We utilized expressed
recombinant Rho with a genetically encoded p-azido-Phe (azF) at position 144 that was
labeled with Alexa488 using a robust bioorthogonal labeling reaction. The
S144Alexa488-Rho and unlabeled Rho purified from bovine ROS enabled precise kinetic
measurement of the regeneration reaction. We employed a 1-palmitoyl-2oleoylphosphatidylcholine/3-[(3-Cholamidopropyl) dimethylammonio]-1propanesulfonate (POPC/CHAPS) bicelle system to reconstitute Rho. We then measured
the kinetics of the very slow reverse dissociation reaction of 11-cis-retinal from Rho (koff)
by monitoring the exchange of the 11-cis-retinylidene chromophore with 9-cis-retinal in
vitro. Finally, we measured the enthalpy of the reaction using isothermal titration
calorimetry (ITC). In summary, using FRET, UV-Vis spectroscopy, and ITC assays, we
were able to derive the kinetic and thermodynamic properties of the reversible
regeneration reaction between 11-cis-retinal and rhodopsin and derive an energy
landscape diagram.
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3.3

Results

3.3.1 The thermostability of photobleached Rho
To analyze the recombination reaction between opsin and retinal, we need a
reconstitution method that stabilizes opsin at its functional state. We developed a
POPC/CHAPS bicelle system to mimic the native membrane environment for the
receptor. Previous studies on Rho reconstituted into DMPC/CHAPS bicelles has
demonstrated that bicelles of various composition confers an increased thermostability to
opsin(Reeves et al., 1999; McKibbin et al., 2007, and facilitates the formation of
rhodopsin-Gt high-affinity complex {Kaya, 2011 #1044). Moreover, compared to
liposome vesicles, bicelles are easier to prepare, and produce less background signal in
spectroscopic studies (Durr et al., 2012). We used the ability of binding with 11-cisretinal as a criterion for correctly-folded, functional opsin, which can be quantified based
on the recovery of 500-nm absorbance. Rho purified from ROS was solubilized in ndodecyl-β-D-maltoside (DM) micelles or POPC/CHAPS bicelles, photobleached by 505nm irradiation, and subsequently incubated at 28 °C for various lengths of time. Then the
photobleached samples were supplemented with fresh 11-cis-retinal, and kept in the dark
until the regeneration was complete. The samples were then analyzed using UV-Vis
spectroscopy (Figure 3-2). The extent of regeneration was assessed based on the recovery
of 500-nm absorbance. We found that the DM-solubilized samples lost the potential to
recombine with 11-cis-retinal with a half-life of 2.1 h (Figure 3-2F). By comparison,
more than 98% of the POPC/CHAPS-solubilized pigment retained the potential for
regeneration over 18 hours (Figure 3-2F), demonstrating the thermostabilizing property
of POPC/CHAPS bicelles.
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Figure 3-2. Photobleached Rho is more stable in POPC/CHAPS bicelle than in DM
micelle. A) The structure of DM and the cartoon of Rho reconstituted in DM micelles.
B) The structure of 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and 3-[(3Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) and the cartoon of
Rho reconstituted in POPC/CHAPS bicelles. C) The experimental procedures for
assaying the thermal stability of photobleached Rho in either DM micelles or
POPC/CHAPS bicelles. Rho purified from bovine ROS was reconstituted into DM
micelles or POPC/CHAPS bicelles, photobleached by 505 nm-LED irradiation, and
incubated in the dark at 28 °C for the indicated lengths of time. Then the samples were
supplied with fresh 11-cis-retinal diluted in the POPC/CHAPS bicelle buffer (the molar
ratio of 11-cis-retinal to opsin was 1.5:1). After complete regeneration (reaction time >15
h), the extent of regeneration was evaluated based on the 500-nm absorbance of the
difference spectrum (the spectrum of the dark-state sample subtracted by the spectrum of
the photobleached sample in the presence of NH2OH). D) The end-point difference
spectra of Rho in DM micelles showed a gradual loss of the 500-nm absorbance,
indicating the formation of thermal denatured opsin that could not be regenerated with
11-cis-retinal. E) The end-point difference spectra of Rho in POPC/CHAPS bicelles
showed that all the samples could be effectively regenerated. F) The time course of the
thermal denaturation of Rho in DM micelles and in POPC/CHAPS bicelles at 28 °C. The
500-nm absorbance of the regenerated samples were normalized using the initial
concentration of Rho measured before photobleaching. In DM, the time course was fitted
into a mono-exponential model, with a half-life of 2.1 h. In POPC/CHAPS bicelle,
photobleached Rho was essentially stable over 18 h.
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3.3.2

FRET-based assays to measure the kinetics of 11-cis-retinal binding to opsin
We established two FRET-based assays to measure regeneration kinetics, both of

which involve a fluorescent reporter as the energy donor and retinal as the acceptor
(Figure 3-3). The first assay utilizes intrinsic Trp fluorescence. Energy transfer between
Trp residues and 11-cis-retinal results in approximately 80% quenching of the Trp
fluorescence in the dark-state Rho. Upon photoactivation, 11-cis-retinal isomerizes to
give all-trans-retinal, followed by the formation of the active Meta-II state characterized
by a deprotonated Schiff base (SB). At Meta-II state, the retinal absorption peak shifts
from 500 nm to 380 nm and the increased energy transfer further reduces the Trp
fluorescence. The Meta-II species decays over time, and all-trans-retinal is released from
its binding pocket, causing Trp fluorescence to increase (Farrens and Khorana, 1995).
Therefore Trp fluorescence can be used in principle to measure the kinetics of retinal
release through Meta-II decay and retinal entry.
The second assay utilizes an extrinsic fluorophore reporter Alexa488, which can
be site-specifically attached to a receptor containing azF using a labeling protocol
described in Chapter II. Approximately 50% of the Alexa488 fluorescence in S144Alexa488 Rho is quenched by the bound 11-cis-retinal, due to the spectral overlap
between the 500-nm absorption peak and Alexa488 emission. Once the Meta-II species is
formed, the spectral shift results in the loss of this spectral overlap, and consequently a
decrease in energy transfer between the donor and the acceptor. Thus Alexa488
fluorescence serves as an unambiguous indicator for the formation of the PSB, as it can
be effectively quenched by the dark-state Rho alone. Previously, fluorescein has been
attached to Rho as a reporter for retinal entry (Wu and Stryer, 1972).
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Figure 3-3. The energy transfer scheme for the Trp and Alexa488-based FRET
assays. The assays employ an engineered Rho that harbors an Alexa488 fluorescent
reporter covalently attached to the second intracellular loop of Rho (S144-Alexa488
Rho). The absorption spectra of Rho (A), Meta-II state Rho (B), and opsin (C) are
overlaid with the fluorescence emission peak of Trp (blue, maximum at 330 nm) and
Alexa488 (green, maximum at 520 nm). The scales of the peaks do not correspond to
their actual intensities. A) At the dark-state, about 50% of Alexa488 fluorescence is
quenched by the 500-nm absorption peak of Rho (1),(Tian et al., 2014) and about 80% of
the fluorescence of Trp is quenched by the lower 380-nm peak (2) of Rho (Farrens and
Khorana, 1995). B) Upon photoactivation, 11-cis-retinal isomerizes to form all-transretinal, followed by the formation of the active Meta-II state with a deprotonated Schiff
base (SB). As a result, the retinal absorption peak shifts from 500 nm to 380 nm, and
fluorescence emission of Alexa488 no longer overlaps with the 500-nm absorption peak
(1), resulting in an increase of Alexa488 signal. Meanwhile, the energy transfer
efficiency between Trp and the Meta-II Rho increases due to absorption peak of Meta-II
Rho at 380 nm (3). Since the energy transfer efficiency is already high in Rho, this
increased spectral overlap only slightly further reduces the Trp fluorescence. C) The
deprotonated SB between opsin and all-trans-retinal hydrolyzes, causing retinal to
dissociate from the binding pocket of opsin. This process is referred to as Meta-II decay.
Neither Alexa488 nor Trp fluorescence is quenched in the apoprotein opsin, as the energy
acceptor retinal is not within the physical proximity of the energy donor.

106	
  

However, fluorescein exhibits dramatically reduced fluorescence at pH 6.0, as
compared to neutral or basic pH. Compared to fluorescein, Alexa488, a fluorescein
derivative, shows greater photostability and much less pH sensitivity. Moreover,
Alexa488 fluorescence falls into a clean window of retinal absorbance so that the inner
filter effect is negligible even for experiments involving a high retinal concentration.
We reconstituted Rho into POPC/CHAPS bicelle by simply adding Rho purified
in DM micelles into the bicelle-containing assay buffer. We then photobleached the Rho
and allowed the Meta-II decay to reach completion. Upon the addition of exogenous 11cis-retinal, we observed a robust mono-exponential decrease in the Trp or Alexa488
fluorescence signal (Figure 3-4A, C). By contrast, we were not able to observe a similar
extent of regeneration over a comparable time scale for Rho reconstituted in DM micelles
(Figure 3-4B, D), suggesting that the presence of lipid bilayer environment was critical
for regeneration.
We observed a small drop of fluorescence signal upon the addition of 11-cisretinal for ROS Rho and S144-Alexa488 Rho in 1% POPC/CHAPS bicelle, and S144Alexa488 Rho in 0.1% DM (Figure 3-4A, C, D). However, for ROS Rho reconstituted in
0.1% DM (Figure 3-4B), this initial drop was much larger. Moreover, in the experiments
with Rho in POPC/CHAPS bicelle, where we observed effective regeneration, the
fluorescence signal at the end of the reaction was also slightly smaller than the signal
before photobleaching (Figure 3-4A, C).
In addition to the energy transfer, there are three plausible factors that may cause
a reduction in the fluorescence signal. First, the dilution effect from adding 20 µL of
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Figure 3-4. Comparison of Rho regeneration in bicelles and micelles. A) Purified
ROS Rho reconstituted in 1% POPC/CHAPS bicelles; B) ROS Rho in 0.1% DM micelles
(inset: ROS Rho in 2% DM micelles); C) Purified S144azF mutant Rho labeled with a
Alexa488 fluorophore (S144-Alexa488 Rho) in 1% POPC/CHAPS bicelles; D) S144Alexa488 Rho in 0.1% DM micelles. In all cases, dark-state ROS Rho or S144-Alexa488
Rho in 0.1% DM (30 µL) was added into the assay buffer (450 µL) containing either
CHAPS/POPC bicelles or DM micelles (arrow a′). The sample was then photobleached
by 505-nm LED light to form the active Meta-II state (arrow b′). After Meta-II decay was
close to completion, ligand 11-cis-retinal diluted in the assay buffer (20 µL) was added to
initiate pigment regeneration (arrow c′). In Panel A) and B), the Trp fluorescence of ROS
Rho was excited at 295 nm (bandpass 0.6 nm) and collected at 330 nm (bandpass 15 nm).
In Panel C) and D), the Alexa488 fluorescence of the mutant S144-Alexa488 Rho was
excited at 488 nm (bandpass 0.2 nm) and collected at 520 nm (bandpass 15 nm). In the
POPC/CHAPS bicelle system, both the Trp-based and Alexa488-based FRET assay
showed a mono-exponential decrease of fluorescence signal upon the addition of
exogenous 11-cis-retinal, indicating the formation of Rho. By contrast, such regeneration
behavior was not observed for Rho in DM micelles.
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retinal solution into the 480 µL-assay buffer can account for approximately 4% of the
decrease in fluorescence signal. Second, the photons used to excite Trp residues as well
as the photons emitted from them can be re-absorbed by the retinal molecules with a nonnegligible extinction coefficient between 295 nm and 330 nm, which is referred to as the
inner filter effect. Third, retinal tends to partition into the hydrophobic compartment of
micelles or bicelles, and any retinal molecule surrounding the receptor can quench Trp
fluorescence. The first is applicable for both the Trp-based and Alexa488-based assay,
while the second and the third factors are more important only in the Trp-based assay.
Thus, Alexa488-based assay has the advantage of circumventing the interference of
retinal. At 28 °C, Alexa488-labeled Rho can be regenerated to 96 ± 4%, demonstrating
that POPC/CHAPS bicelle enables essentially complete regeneration of Rho (Figure 34C).
For ROS Rho reconstituted in 0.1% DM (Figure 3-4B), the initial drop of signal
upon addition of 11-cis-retinal was too pronounced be regarded as merely dilution and
inner filter effect, but probably reflects some real energy transfer process. We propose
that the initial fast quenching might indicate the partition of retinal into the hydrophobic
compartment of DM micelles (Mccaslin and Tanford, 1981), which brings retinal and the
receptor into physical proximity for energy transfer, but not necessarily requires retinal to
enter the binding pocket for regeneration. The experiment with S144-Alexa488 Rho in
DM provided a clear piece of evidence that no PSB was formed in the DM micelle
system. We further reasoned that increasing the concentration of DM would reduce such
non-specific quenching. In the experiment for ROS Rho in 2% DM (Figure 3-4B: inset),
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the initial drop was only 1/3 of what was observed in 0.1% DM, thus qualitatively
supporting our hypothesis.
Having established a robust assay for measuring the regeneration kinetics, we
asked whether the DM-solubilized photobleached Rho, after transfer into POPC/CHAPS
bicelle, has the same kinetics. We performed the fluorescence-quenching experiment for
photobleached ROS Rho and incubated at 28 °C for 40 min, 60 min, and 13 h (Figure 35). No regeneration was observed for the sample that had been kept at 28 °C for 13 h,
indicating complete loss of activity. For the 40-min and 60-min samples, the secondorder rate constant (k2) at 28 °C was 1.0 ± 0.2 ×103 M−1 s−1. This value is in good
agreement with the regeneration kinetics obtained for Rho reconstituted in bicelle prior to
photobleaching.

Figure 3-5. The regeneration of micelle-solubilized Rho after transfer into bicelles.
Dark-state Rho solubilized in 0.1% DM (30 µL) was photobleached by 505-nm LED
light (18 s, 495-nm cut-off filter) to form the active Meta-II state. The sample was
incubated at 28 °C for A) 60 min and B) 13 hours. Then the sample was added into 450
µL of the assay buffer containing either CHAPS/POPC bicelles (arrow a′). Exogenous
11-cis-retinal solution (20 µL) was added more than 45 min later (arrow b′). No
regeneration can be observed for the 13-hour sample, consistent with the results shown in
Figure 3-2. For the 60-min sample and another 40-min sample (not shown), the secondorder rate constant at 28 °C was 1.0 ± 0.2 ×103 M−1 s−1.
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Figure 3-6. The regeneration of Rho in micelles at 4 °C. The Trp fluorescence was
recorded as described in Figure 3-4. The sample compartment was cooled to 4 °C by
water bath. Dry air was blown through the sample compartment to prevent condensation
on the cuvette. Dark-state ROS Rho purified in 0.1% DM (30 µL) was added into the
assay buffer (450 µL) containing 1% DM micelles (arrow a′). The sample was then
photobleached by 505-nm LED light to form the active Meta-II state (arrow b′). After
Meta-II decay was close to completion, 11-cis-retinal diluted in the assay buffer (20 µL)
was added to initiate pigment regeneration (arrow c′). After overnight regeneration,
NH2OH was added to the sample (arrow d’). In the end, the regenerated pigment was
photobleached again in the presence of NH2OH (arrow e’), and the shutter was closed to
record the dark count. Inset: the kinetics of regeneration was fitted with a monoexponential model. The k2 for Rho regeneration in 1% DM at 4 °C was 1.4 ×103 M−1 s−1.
In 0.1% DM, the initial quenching of Trp fluorescence masked real regeneration kinetics.
We also tested the regeneration of ROS Rho at 4 °C in DM micelles (Figure 3-6).
We found that at a low temperature, it was possible to obtain fully regenerated pigment in
both 0.1% DM and 1% DM. In 1% DM the k2 is 1.4 ×103 M−1 s−1.

112	
  

3.3.3 The kinetics of the recombination reaction between opsin and 11-cis-retinal
To obtain the activation enthalpy and entropy of retinal binding to opsin, we first
tested whether the recombination reaction between bicelle-solubilized Rho and 11-cisretinal in POPC/CHAPS bicelles is bimolecular. We conducted the Trp-based
fluorescence quenching assay for Rho purified from ROS using various retinal
concentrations (molar ratio of retinal to receptor: 8.4 to 67), and derived the rate constant
by assuming the regeneration kinetics was pseudo first-order. The linear relation between
the pseudo first-order reaction rate and retinal concentration demonstrates that this
reaction follows simple second-order rate law within the tested range of retinal
concentrations (Figure 3-7A). Hence the second-order rate constant can be calculated by
dividing the pseudo-first order rate constant with the concentration of retinal.
We further measured the temperature-dependence of Rho regeneration kinetics
(Figure 3-7B and Table 3-1), and derived the activation enthalpy (Δ≠Hon) and the
activation entropy (-TΔ≠Son) from an Eyring plot (Figure 3-7B). For comparison with the
existing literature, we also analyzed the data by Arrhenius plot to derive the activation
energy (Ea,on) and the pre-exponential factor (A). These thermodynamic parameters are
summarized in Table 3-2. These results showed that wild-type Rho purified from the
natural source and the heterologously expressed Rho behaves the same with respect to
regeneration. We also showed that the modification of Rho at position 144 in the second
intracellular loop does not alter regeneration kinetics. This is expected from the Rho
structure since the position 144 is located outside of and distant from the retinal-binding
pocket.
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Figure 3-7. The kinetics of the recombination reaction between 11-cis-retinal and
opsin. A) The regeneration kinetics of ROS Rho at 28 °C was measured at various
concentrations of 11-cis-retinal (molar ratio of Rho to receptor: 8.4 to 67). The observed
pseudo first-order rate constant (kobs) was plotted against the retinal concentration, and
shown to linearly correlate with the concentration of 11-cis-retinal (R2 > 0.98). The slope
of the plot corresponds to the second-order rate constant (kon =1.20 ± 0.05 ×103 M−1 s−1).
B) Eyring plot for the second-order rate constants of three Rho samples (Table 3-1): 1)
purified wt Rho from bovine ROS Rho; 2) purified wt Rho heterologously expressed in
HEK293T cells (PMT4 Rho); 3) purified S144azF mutant Rho labeled with a Alexa488
fluorophore (S144-Alexa488 Rho). The thermodynamic parameters derived from the
Eyring plot (Δ≠Gon, Δ≠Hon, -TΔ≠Son ) and the Arrhenius plot (Ea,on) are consistent for
different Rho samples (Table 3-2).
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Table 3-1 Second-order rate constants (k2 , 103 M−1 s−1) for retinal entry
ROS Rho

PMT4 Rho

Rho S144-Alexa488

36 °C

2.1 ± 0.2

2.2 ± 0.5

2.7 ± 0.4

28 °C

1.03 ± 0.04

0.87 ± 0.30

1.1 ± 0.2

20 °C

0.36 ± 0.03

0.27 ± 0.06

0.54 ± 0.12

12 °C

0.13 ± 0.3

0.12 ± 0.2

0.18 ± 0.4

Table 3-2. The thermodynamic parameters for Rho regeneration at 28 °C
ROS Rho

PMT4 Rho

S144-Alexa488 Rho

kon (103 M−1 s−1)

1.03 ± 0.04

0.9 ± 0.3

1.1 ± 0.2

Δ≠Hon (kcal mol−1)

20.3 ± 0.9

21.3 ± 1.3

18.8 ± 1.0

−TΔ≠Son (kcal mol−1)

6.6 ± 0.9

7.8 ± 1.2

5.4 ± 0.9

Δ≠Gon (kcal mol−1)

13.7 ± 0.5

13.6 ± 4.5

13.4 ± 2.4

Ea,on (kcal mol−1)

20.8 ± 0.9

21.9 ± 1.3

19.4 ± 1.0

lnA

35.0 ± 1.6

36.6 ± 2.2

32.7 ± 1.7
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We then considered the question of whether the observed kinetics reflects retinal
entry into the receptor binding pocket, or retinal diffusion among bicelles. Based on the
high partition coefficient of 11-cis-retinal between lipids and water, we reasoned that the
k2 for the recombination reaction should be inversely correlated to the concentration of
bicelle. We measured the recombination reaction kinetics in 2% POPC/CHAPS bicelles,
and found the k2 was 45 ± 13% of that 1% POPC/CHAPS bicelles.

Figure 3-8. The stop-flow experiment for measuring the retinal diffusion kinetics
among bicelles. A)The fluorescence emission spectrum of pyrene, obtained by principle
component analysis. B)The kinetics of pyrene fluorescence quenching by retinal. The
pyrene fluorescence signal was fitted with monoexponential decay model. The first-order
time constant was 36 ± 3 s−1.

We also designed a stop-flow experiment in which pyrene-lipid doped
POPC/CHAPS bicelle was mixed with bicelles containing 11-cis-retinal (Figure 3-8).
The proximity of retinal with pyrene would result in the partial quenching of pyrene
fluorescence (Farrens and Khorana, 1995). The temporal resolution of stop-flow
experiment enabled us to track the rapid diffusion of retinal among bicelles. We found
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that the time constant for the diffusion of retinal among bicelles is three orders of
magnitude higher than the observed retinal binding rate (the calculation is explained in
Appendix II). Based on the pyrene-quenching experiment, we concluded that the
diffusion of retinal among bicelles could be ruled out as a rate-limiting factor for the
overall kinetics measured in the regeneration experiment.
3.3.4 The kinetics of the dissociation reaction between opsin and 11-cis-retinal
The SB linkage between 11-cis-retinal and K296 of opsin is known to extremely
stable. Here we quantitatively assessed the stability of the SB bond by measuring the
chromophore exchange rate of the bound 11-cis-retinal with exogenous 9-cis-retinal. The
9-cis-retinal can be admitted into the ligand-binding pocket only following the
dissociation of 11-cis-retinal. The recombination product of opsin with 9-cis-retinal,
isorhodopsin (isoRho), has its absorbance maximum shifted from 500 nm to 487 nm
(Hubbard and Wald, 1952). Therefore, in a mixture of 11-cis-retinal bound Rho and 9cis-retinal bound isoRho, the fraction of newly formed isoRho can be quantified by
monitoring the decrease in 500-nm absorbance and the increase in the associated 487-nm.
Because in this experiment the concentration of added 9-cis-retinal is much higher than
that of 11-cis-retinal, we assume the fraction of newly formed Rho is negligible, and thus
the fraction of newly formed isoRho can serve as a good approximation for 11-cis-retinal
dissociation.
We first asked whether opsin in POPC/CHAPS bicelles effectively recombines
with 9-cis-retinal (Figure 3-9). The addition of exogenous 9-cis-retinal resulted in robust
regeneration of isoRho. The second-order rate constant for the recombination reaction
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between opsin and 9-cis-retinal at 28 °C ((6.7 ± 0.3) ×102 M−1 s−1) was slightly slower
than that between opsin and 11-cis-retinal ((1.03 ± 0.04) ×103 M−1 s−1).

Figure 3-9. The regeneration of ROS Rho with 9-cis-retinal monitored by Trp
fluorescence. Dark-state Rho solubilized in 0.1% DM (30 µL) was added to 450 µL of
the assay buffer containing either CHAPS/POPC bicelles or DM (arrow a′). The sample
was then photobleached by 505-nm LED light (18 s, 495-nm cut-off filter) to form the
active Meta-II state (arrow b′). After Meta-II decay was close to completion, ligand 9-cisretinal was added to initiate pigment regeneration (arrow c′). The Trp fluorescence was
excited at 295 nm (bandpass 0.6 nm) and collected at 330 nm (bandpass 15 nm). The
concentration of 9-cis-retinal working solution was determined from its 374-nm
absorbance (extinction coefficient 36,000 M−1 cm−1). The second-order rate constant (6.7
± 0.3 ×102 M−1 s−1) was calculated by dividing the pseudo first-order rate constant with
the 9-cis-retinal concentration.
We next tested whether 11-cis-retinal bound to Rho can be exchanged with 9-cisretinal. ROS Rho was purified by lectin affinity chromatography and obtained in
POPC/CHAPS bicelles. The thermostabilizing effect of POPC/CHAPS allowed us to
choose prolonged reaction time (1×, 2× and 3×11.6 days; Figure 3-10). We conducted the
chromophore-exchange experiment of Rho at 28 °C, 36 °C, and 44 °C, with a 9-fold
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Figure 3-10. Measurement of slow chromophore exchange rate in ROS Rho
reconstituted in bicelles. A) The scheme of chromophore exchange in Rho. After the
spontaneous dissociation of 11-cis-retinal, opsin either recombines with 9-cis-retinal, or
proceed through the thermal denaturation pathway. B) Rho was slowly converted to
isorhodopsin (isoRho) in the presence of 9-cis-retinal. The formation of isoRho was
measured at different temperatures (28 °C, 36 °C, and 44 °C) as a function of time. UVVis spectra were recorded at 106 s (11.6 days), 2×106 s (23.2 days), and 3×106 s (34.8
days). The spectra were normalized based on the λmax. C) The difference spectra of the
Rho-isoRho mixtures were subtracted from the spectrum of pure Rho to reveal the
decrease in the 500-nm absorbance of Rho and increase in the 487-nm absorbance of
isoRho. D) The fraction of isoRho formed by chromophore exchange was plotted versus
the incubation time at 28 °C (square), 36 °C (circle), and 44 °C (diamond). The data after
correcting for the effect of opsin thermal denaturation were fitted using a monoexponential model to derive the first-order rate constant. Inset: the Eyring plot for the rate
constants at different temperatures (R2 = 0.99). The calculated Δ≠ Hoff is 38.4 ± 4.4 kcal
mol−1. At 28 °C we also obtained from the Arrhenius plot (not shown) an Ea,off of 38.9 ±
4.4 kcal mol−1and a pre-exponential factor A of 5.7×1020.
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excess of 9-cis-retinal. Then the samples were immunopurified to remove the excess
retinal and analyzed by UV-Vis spectroscopy. We observed a gradual increase in the 487nm absorbance and a decrease in the 500-nm absorbance, indicating the conversion of the
11-cis-retinal-bound Rho to 9-cis-retinal-bound isoRho (Figure 3-10 B,C ).
During the unusually long reaction time of the chromophore exchange
experiment, opsin denaturation could compete with 9-cis-retinal, causing a greater
underestimation for the exchange kinetics, particularly at high temperatures. Therefore,
we performed a correction for the effect of opsin thermal denaturation. We assume that
retinal dissociation was the rate-limiting step, and the resulting opsin either followed the
thermal denaturation pathway, or recombined with 9-cis-retinal. The amount of the
denatured opsin could be quantified by UV-Vis spectroscopy. Based on the absorption
spectra, significant opsin denaturation was found only for the samples incubated at 44 °C
(Figure 3-11 and Table 3-3). The correction procedure is described in the experimental
section.
We plotted the fraction of isoRho against time and analyzed the kinetics based on
the assumption that this reaction follows first-order kinetics (Figure 3-10D and Figure 311). We derived the Eyring plot (Figure 3-10D, inset) and Arrhenius plot (not shown) for
the dissociation reaction, as well as ΔGoff≠, Δ≠Hoff, and -TΔ≠Soff and Ea,off. We found that
Without the correction, dissociation kinetics at high temperatures and consequently the
activation enthalpy for the reverse reaction (shown by the slope of the Eyring plot) would
be underestimated (uncorrected: 33.5 ± 1.4 kcal mol−1; corrected: 38.4 ± 4.4 kcal mol−1)
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Table 3-3. The fraction of retinal dissociation and the rate constant

Temperature (°C)

28

44

44

(uncorrected)

(corrected)

36

t = 1×106 s

0.0345

0.125

0.475

0.578

t = 2×106 s

0.0708

0.225

0.658

0.844

t = 3×106 s

0.0880

NA

NA

NA

5.82 ± 0.38

8.89 ± 0.22

koff (10−7 s−1)

0.328 ± 0.016 1.29 ± 0.02

Figure 3-11. The retinal dissociation rates in Rho. The solid line represents the Eyring
plot for rates corrected for opsin denaturation, the dash line for rates uncorrected for
opsin denaturation.
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3.3.5

The reaction enthalpy of the recombination reaction between opsin and 11-

cis-retinal
Having characterized the transition state energy change of the forward and the
reverse reaction, we further conducted an ITC experiment to measure the overall enthalpy
change. Opsin was purified and reconstituted in POPC/CHAPS bicelles to provide a
thermostabilizing lipid bilayer environment. The opsin samples in the titration chamber
were mixed with 11-cis-retinal solutions prepared in the same POPC/CHAPS bicelle
buffer. Three independent experiments were performed (Figure 3-12). In the raw data
plots, the differential powers first decreased, then increased after the titration point
(Figure 3-12A-C). The two types of peaks showed different kinetics (Figure 3-12E).
Thpeaks occurring before the titration points have significantly longer decay time, and
consequently correspond to larger integrated reaction heat. We speculate the peaks after
the titration point reflected the mixing heat. We observed the reaction enthalpy in the
range of −20 to −25 kcal mol−1, giving an average ΔH°’ of – 21.6 ± 1.6 kcal mol−1.
Nonetheless, the stoichiometry of retinal binding to opsin was 1.15 ± 0.14, slightly
greater than the expected value 1.0. We performed careful titrations to determine the
extinction coefficient of opsin and retinal in the POPC/CHAPS bicelle buffer (Figure 313 and Table 3-4). Due to the limitations of the sensitivity of the ITC instrument and
corresponding high concentrations necessary to give a measurable signal, we could not
determine Kd from the shape of the titration curve (Pierce et al., 1999).
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Figure 3-12. Reaction enthalpy for the binding of 11-cis-retinal to opsin determined
by ITC experiments. A-C) Raw ITC data plots from three independent experiments. In
each panel, the differential power was plotted versus time. The baseline curve was
generated by sampling the intermediate time points between each injection. In these plots,
the signals were corrected by subtracting the baseline. D) The integrated reaction heat per
mole of injectant versus the stoichiometry for three independent experiments (dots,
squares, and triangles). Note that due to the very slow binding kinetics the experiments
are about 10 times longer and the corresponding differential power signals are severalfold smaller than in typical ITC studies of a ligand binding to a protein. The calculated
ΔH°’ were −24.2 ± 1.5 kcal mol−1, −19.4 ± 0.5 kcal mol−1, and −21.2 ± 1.6 kcal mol−1,
respectively, giving an average ΔH°’ of – 21.6 ± 1.3 kcal mol−1. E) 3-dimensional
projection of a representative ITC experiment (Panel C). Time-X represents the entire
time course of the experiment; Time-Y represents the time course of each injectant.
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Figure 3-13. Determination of molar extinction coefficients of 11-cis-retinal, opsin,
and Rho. A) The UV-Vis spectra of Dilution series of 11-cis-retinal in the
POPC/CHAPS bicelle buffer. B) An aliquots of 11-cis-retinal (120 µL; linear dilution
series with 16 concentrations in the range from 0 to 31.5 µM) was mixed with aliquots of
purified opsin (120 µL, 10.2 µM). After complete regeneration, the UV-Vis spectrum of
each sample was recorded. C) The correlation of the absorption of 11-cis-retinal in
POPC/CHAPS bicelle buffer at 378 nm (corrected for a dilution factor of 0.375) was
plotted against the 499-nm absorbance of Rho in the opsin samples. The perfect linear
correlation before the saturation of the retinal binding site yielded a molar extinction
coefficient of Rho ε499 nm = 42,742 M−1 cm−1. D) The absorption spectra of opsin (black)
and Rho (red) are compared. The corresponding extinction coefficients are shown in
Table 3-4. The resulting A279/A499 ratio of Rho at the equivalence point is 1.58 ± 0.01,
indicating a slightly higher purity than previously best results obtained by column
chromatography 1.65–1.75 (Litman, 1982) and 1.60 –1.70(Degrip, 1982b), suggesting
that the opsin sample is fully regenerable.
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Table 3-4. Molar extinction coefficient of opsin and Rho in POPC/CHAPS bicelles
ε 279 nm / M−1 cm−1

ε499 nm / M−1 cm−1

Opsin

56,057 ± 184

−

Rho

67,532 ± 221

42,742

3.3.6 The energy landscape of Rho regeneration
We sought to integrate the information gleaned from the above experiments into a
single energy diagram, based on the assumption that the partial reactions for ligand
binding and unbinding proceed over the same transition state, i.e., the dissociation of 11cis-retinal represents the reverse reaction for the recombination reaction on the
microscopic level. We assumed a modified biochemical standard state, with Rho
reconstituted into POPC/CHAPS bicelles in aqueous solution, at 28 °C, pH 6.0, under
ambient atmospheric pressure, and all other conditions at 1 M.
The values in the energy diagram were derived as follows:
The free energy (ΔG)
1. The activation energy of the forward reaction (Δ≠Gon = 13.7 ± 0.5 kcal mol−1)
was obtained from the retinal binding kinetics (kon = (1.03 ± 0.04)×103 M−1 s−1)

Δ ≠ Gon = −RT ln

kon h
k BT

The error was given by:

σ ( Δ ≠ Gon ) ≈ RT

σ ( kon )
kon
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2. The activation energy of the reverse reaction (Δ≠Goff = 27.9 ± 1.4 kcal mol−1 )
was obtained from the chromophore exchange kinetics (koff = (0.328 ± 0.016)×10−7 s−1)

Δ ≠ Goff = −RT ln

koff h
k BT

The error was given by:

σ ( Δ ≠ Goff ) ≈ RT

σ ( koff )
koff

3. The energy difference between the reactants and the products under a particular
state (ΔG°’ = 14.5 ± 0.9 kcal mol−1) was obtained by dissociation constant:

ΔG°’ = −RT ln K d
With both the binding and unbinding rates known, the equilibrium dissociation
constant (Kd = 40 ± 2 pM) between retinal and opsin can be derived by:

K d = koff / kon
The error is given by:
1/2

(* " σ ( k ) % 2 " σ ( k ) % 2 ,*
off
on
σ ( Kd ) = Kd ) $
' +$
' *+ # koff & # kon & *.

σ ( ΔG°’) ≈ RT

σ ( Kd )
Kd

In the energy diagram (cf. Figure 7) we only indicated Δ≠Gon and ΔG°’.
The enthalpic term (ΔH)
4. The activation enthalpy of the forward reaction (Δ≠Hon = 20.3 ± 0.9 kcal mol−1)
was obtained from the Eyring plot of the retinal binding kinetics (cf. Table 1). The error
was derived from the fitting error.
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kon
Δ ≠ H on 1
kB Δ ≠ Son
=−
⋅ + ln +
T
T
R
h
R
5. The activation enthalpy of the reverse reaction (Δ≠Hoff = 38.4 ± 4.4 kcal mol−1)
was obtained from the Eyring plot of the chromophore exchange kinetics (cf. Figure 5B,
inset). The error was derived from the fitting error.

koff
Δ ≠ H off 1
k
Δ ≠ Soff
=−
⋅ + ln B +
T
T
R
h
R
6. The reaction enthalpy (ΔH°’= –21.6 ± 1.3 kcal mol−1) was directly measured by
the ITC experiment (cf. Figure 6). The error for the reaction enthalpy was obtained based
on three independent measurements.
Ideally the difference between the activation enthalpy of the forward and reverse
reactions should have the same value as the enthalpy of formation:

Δ ≠ H on − Δ ≠ H off − ΔH o’ = 0
Insert the values above, we have:

Δ ≠ H on − Δ ≠ H off − ΔH o’ = 3.5 ± 4.7 kcal mol−1
Therefore, the apparent discrepancy of 3.5 kcal mol−1 can be explained by the
experimental errors.
The entropic term (−TΔS)
7. The activation entropy of the forward reaction (Δ≠Son = 22 ± 3 cal mol−1) was
obtained from the Eyring plot of the retinal binding kinetics. The entropic term was
calculated for 28 °C (−TΔ≠Son = 6.7 ± 0.94 kcal mol−1). The error was derived from the
fitting error.

kon
Δ ≠ H on 1
kB Δ ≠ Son
=−
⋅ + ln +
T
T
R
h
R
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8. The activation entropy of the reverse reaction (Δ≠Soff = 34 ± 14 cal mol−1) was
obtained from the Eyring plot of the chromophore exchange kinetics. The entropic term
was calculated for 28 °C (−TΔ≠Soff = 10.4 ± 4.3 kcal mol−1). The error was derived from
the fitting error.

koff
Δ ≠ H off 1
k
Δ ≠ Soff
=−
⋅ + ln B +
T
T
R
h
R
9. The reaction entropy was calculated by (−TΔS°’=ΔG°’−ΔH°’= −7.1 ± 1.6 kcal
mol−1). The error was derived by:
1/2

2
2
σ (T ΔS°’) = #$σ ( ΔG°’) + σ ( ΔH °’) %&

Based on these results, we present here the energy diagram for the regeneration
of Rho (Figure 3-14). The approaches used to derive these values are indicated in the
figure. The ITC experiment of the ligand binding reaction of R and L showed that the
enthalpy of formation (ΔH°’) was – 21.6 ± 1.3 kcal mol−1. Therefore, the recombination
reaction between 11-cis-retinal and opsin is enthalpy-driven.
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Figure 3-14. Energy diagram for the recombination reaction between opsin and
retinal. All the values were obtained for Rho reconstituted into POPC/CHAPS bicelles,
at 28 °C, pH 6.0, under ambient atmospheric pressure. The changes in free energy (ΔG,
red), enthalpy (ΔH, blue) and entropy (−TΔS, green) are indicated in the diagram. The
superscript letter next to each value indicates the experimental approach used to derive
the value: (A) The kinetics of retinal entry; (B) the chromophore exchange experiment;
(C) the ITC experiment. The chromophore exchange experiment (light line) and ITC
experiment (dark line) yielded essentially consistent results on the activation enthalpy
(Δ≠Hoff) and the activation entropy (−TΔ≠Soff) for the reverse reaction.
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3.4

Discussion

3.4.1 Identifying POPC/CHAPS bicelles as a suitable model lipid bilayer system to
study Rho regeneration
The ability of G protein-coupled receptors (GPCRs) to bind with ligand has been
one of the best criteria for assessing their thermostability in various reconstitution
systems, and ligand binding generally enhances the thermostability of the receptor
(Rosenbaum et al., 2007; Degrip, 1982a). It is well known that the stability of Rho and
opsin in detergent differ strikingly. While DM-solubilized Rho denatures at
approximately 60 °C, the half-life of opsin at 30 °C is only 2 h (Degrip, 1982a).
Similarly, ligand-free β2 adrenergic receptor has a half-life of less than 1 hour at 37 °C
(Rosenbaum et al., 2007). The inefficiency of opsin to recombine with 11-cis-retinal in
DM has been a major obstacle for studying pigment regeneration (Sanchez-Martin et al.,
2013; Sakamoto and Khorana, 1995; Srinivasan et al., 2014). Successful examples to
study the recombination between opsin and 11-cis-retinal in DM system either involved a
low concentration of lipids (Schadel et al., 2003), or engineering a thermostabilized
receptor (Xie et al., 2003).
Previous biochemical studies have yielded the insight that addition of lipids into
the detergent system improves the stability of opsin and other GPCRs (Sakamoto and
Khorana, 1995; Navratilova et al., 2005). Here we employed a POPC/CHAPS bicelle
system to mimic the native membrane environment. We showed that photobleached Rho
reconstituted into POPC/CHAPS bicelles retained its ability to recombine with 11-cisretinal over a significantly longer period of time micelles (>98% regenerated after 18 h at
28 °C, cf. Figure 3-2E, F) as compared with receptors in DM micelles (half-life 2.1 hours
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at 28 °C, cf. Figure 3-2D, F). In the experiment testing opsin stability in DM, samples
were transferred into POPC/CHAPS bicelles to “quench” the denaturation process, as
well as to facilitate the regeneration of the remaining functional opsin. In this way, we
were able to capture the exact fraction of functional component at a particular time point.
Our results support the idea that the interaction between opsin and lipids play an
important role in stabilizing the ligand-free receptor (Oates and Watts, 2011).
Next we showed that using two FRET-based assays, we were able to monitor the
regeneration of ROS Rho and S144-Alexa488 Rho in POPC/CHAPS bicelles at 28 °C,
and the time-course of the regeneration was characterized by an apparent monoexponential process (cf. Figure 3-4A and 3-4C). By contrast, the experiment with ROS
Rho and S144-Alexa488 Rho in DM micelles showed a monotonic decrease with distinct
kinetics from the experiment involving POPC/CHAPS bicelles, both before and after the
addition of 11-cis-retinal (cf. Figure 3-4B and 3-4D). It is possible that this decrease is
caused by denaturation and subsequent precipitation of opsin in DM rather than real
regeneration.
Several studies on Rho regeneration in DM have reported a large decrease in Trp
fluorescence upon the addition of 11-cis-retinal (Sanchez-Martin et al., 2013; Srinivasan
et al., 2014). An alternate theory proposed that this may indicate a two-step regeneration
mechanism: the initial drop represents the fast entry of retinal into the ligand binding
channel, possibly as a non-covalent retinal-opsin complex, and the following decay
corresponds to the formation of the pigment with the PSB bond (Srinivasan et al., 2014).
However, this theory cannot explain the much smaller initial drop observed for bicellereconstituted receptor, unless we assume that in POPC/CHAPS bicelle, retinal entry
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operates in a distinct one-step mechanism. Furthermore, it is counterintuitive to assume
the initial entry of retinal into the binding pocket is faster in DM than in the
POPC/CHAPS, but the formation of the SB turned out to be rate limiting. The fast retinal
entry should position the aldehyde group of 11-cis-retinal to react with the ε-amino group
of K296, and accelerate the overall reaction. Our experiments using high (2%) and low
(0.1%) concentration of DM suggested that this initial quenching was due to retinal
partitioning into DM micelles, and did not involve any regeneration. The absence of the
initial drop of Trp fluorescence in POPC/CHAPS bicelles can be explained by the higher
concentration of bicelles (1%) than micelles (0.1%).
Rho regeneration in DM micelles could barely proceed at 28 °C, but reached
completion at 4 °C (cf. Figure3-6). Based on the denaturation kinetics at 28 °C (cf. Figure
3-2F), within two hours after photobleaching, there was substantial fraction of functional
opsin that would manifest its potential for regeneration once transferred into suitable lipid
bilayer environment. Therefore, it seems that the problem with the detergent system was
not simply opsin denaturation as McCaslin et al. proposed. We hypothesize that DM may
inhibit the ability of opsin to bind with retinal by modulating its conformation and
energetics.
Take together, these results demonstrated the utility of POPC/CHAPS bicelle as a
valuable tool for studying the regeneration of Rho, and possibly to study GPCRs in
general. The role of bicelle is two-fold: 1) it thermostabilizes the conformation of opsin,
and 2) it modulates the activity of opsin with respect to regeneration. By comparison,
DM-solubilized photobleached Rho can be divided into two fractions based on its ability
to recombine with retinal. The first fraction has undergone an irreversible denaturing
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pathway that follows first-order kinetics. The second fraction, although it retains its
potential of regeneration, cannot be as efficiently regenerated in DM as it is in
POPC/CHAPS bicelle. These findings should prompt a rethink on the activity of GPCRs
in detergent systems.
Typically, the FRET experiment for measuring regeneration kinetics lasted less
than 6 hours. The longest ITC measurement took approximately 35 hours. Yet ligand
binding was complete within 14 hours. While the chromophore exchange spanned weeks,
except at 44 °C, the dominating species during this process were retinal-bound Rho or
isoRho rather than ligand-free opsin. Therefore we believe that in the experiments of this
study we were able to maintain Rho and opsin at the functional state.
3.4.2 The kinetics of Rho regeneration
In the fluorescence-quenching assay, the concentration of 11-cis-retinal is
typically 1.5-2.0 µM. The concentration of ROS Rho in the Trp-based assay is
approximately 0.25 µM and Alexa488-Rho in the Alexa488-based assay is 5–50 nM. The
estimated concentration of bicelles is 17 µM (for the detailed calculation see Appendix
II). Considering that the partition coefficient of retinal between lipid and water is very
high, retinal is predominately found in bicelles. Thus, the ratio of empty bicelles, retinalcontaining bicelles and Rho-containing bicelles is 10: 1: (0.003~ 0.16). At any particular
time point, a Rho molecule does not necessarily have a retinal molecule in the same
bicelle, and before any recombination can occur, a retinal molecule needs to diffuse into a
Rho-containing bicelle. We asked whether in our bicelle bilayer system the diffusion of
11-cis-retinal among the bicelles could be rate limiting. If so, varying the concentrations
of 11-cis-retinal and Rho should greatly affect the observed kinetics. We showed that the
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concentration of 11-cis-retinal exhibited a simple linear correlation with the pseudo-first
order rate constants (Figure 3-7A). Moreover, the concentrations of ROS Rho (~0.25 µM)
in the Trp-based assay and Alexa488-Rho (5-50 nM) in the Alexa488-based assay differ
by at least 5-fold, but the reactions rates are not statistically different (Figure 3-7B).
We were looking for an independent test that could show rapid exchange of
retinal among bicelles. It was known that pyrene fluorescence could be quenched by
retinal (Farrens and Khorana, 1995). Therefore it is possible to monitor retinal diffusion
into pyrene-labeled bicelle based on the decrease of pyrene fluorescence. Using the same
experimental setup for monitoring Rho regeneration, we observed rapid quenching of
pyrene fluorescence upon the addition of 11-cis-retinal. However, we could not resolve
the kinetics of retinal diffusion, as mixing in the magnetically stirred cuvette was not fast
enough. To address this question, we carried out a stop-flow experiment (Figure 3-8).
Based on the results from the stop-flow experiment, we estimated that the average
lifetime of a retinal free bicelles is ~3 orders of magnitude faster than the recombination
reaction. Therefore, we ruled out the diffusion of retinal among bicelles as a rate-limiting
step in the entire regeneration process.
We tested three different Rho samples, Rho purified, recombinant expressed Rho,
and S144-Alexa488 Rho, based on either the intrinsic Trp fluorescence or the extrinsic
Alexa488 fluorescence. All of the samples showed consistent kinetics and temperaturedependence (Table 3-2). The absolute value of Rho regeneration kinetics is dependent on
the type and concentration of micelles (Matsumoto et al., 1978) and bicelles, probably
due to the partitioning of retinal into micelles and bicelles (Mccaslin and Tanford, 1981).
Therefore it is not informative to compare the absolute values unless the reconstitution
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conditions were identical. Nonetheless, we found the Arrhenius activation energy (Ea,on:
19.4 ± 1.0 ~ 21.9 ± 1.3 kcal mol−1, Table 3-2) is in good agreement with value previously
reported for Rho regeneration in ROS membrane (18.7 kcal·mol−1) (Kawaguchi et al.,
1986) and in 1% digitonin (22 kcal mol−1) (Matsumoto et al., 1978). This suggests that
regeneration in the POPC/CHAPS bicelle environment is close to the native ROS
membrane environment in photoreceptor cells.
Electrophysiological studies suggested that the pigment regeneration process
likely involves a transient non-covalent complex between retinal and opsin that precedes
the formation of the mature pigment with the PSB bond (Kefalov et al., 2001). The
tryptophan fluorescence assay reflects whether retinal resides in the binding pocket,
whereas the Alexa488 fluorescence assay indicates the formation of PSB bond. As the
retinal binding curves and thermodynamic parameters (Table 3-2) in both assays are very
similar in POPC/CHAPS bicelles, the formation of any non-covalent intermediate and the
formation of PSB bond is likely to be tightly coupled, and the retinal entry into its
binding pocket is likely to be the rate-limiting step.
We also demonstrated that the incorporation of an unnatural amino acid at
position S144, and the subsequent conjugation of a fluorophore to it, does not alter the
receptor’s behavior with respect to retinal entry. Alexa488 fluorescence is compatible
with a high concentration of retinal and thus valuable for studying mutants with slow
retinal entry kinetics. Based on these results, we anticipate S144-Alexa488 Rho to be
used as the background construct for kinetic and mechanistic studies of mutations
regulating retinal entry.
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3.4.3 The chromophore exchange experiment indicates that the PSB of Rho is less
stable than previously thought
Rho is stabilized in its inactive conformation by the inverse agonist 11-cis-retinal.
A unique feature of 11-cis-retinal as the native ligand is that it utilizes a covalent PSB
bond, in addition to a series of non-covalent weak interactions, to remain tethered to the
protein. A sufficiently long lifetime of this covalent bond is critical, as both the noncovalent retinal-opsin complex (Kefalov et al., 2001), and the apoprotein opsin (Cornwall
and Fain, 1994; Cornwall et al., 1995; Surya et al., 1995) activates the signal transduction
cascade to some extent. Spontaneous dissociation of 11-cis-retinal from cone receptor
binding pocket has been well described by biochemical and electrophysiological methods
(Matsumoto et al., 1975; Crescitelli, 1984; Kefalov et al., 2005).
An in vivo radioactive labeling study on dark-adapted mouse reported that
chromophore turnover occurs in rod receptor at a rate of 1.8 ×10−7 s−1 (Defoe and Bok,
1983). However, this study could not distinguish between de novo pigment synthesis and
chromophore exchange within the existing pigment. Here we utilized the difference in the
absorption maxima of 11-cis-retinal-bound Rho and 9-cis-retinal-bound isoRho to assess
the rate of retinal dissociation from opsin. A recent study reported that purified opsin in
DM micelles (0.05% w/v) showed a marked preference for 9-cis-retinal over 11-cisretinal in regeneration experiments, suggesting that the binding pocket of opsin is more
accessible to 9-cis-retinal than to 11-cis-retinal (Srinivasan et al., 2014). By contrast, our
results showed that Rho in POPC/CHAPS bicelles can be readily regenerated with either,
and the recombination reaction for 11-cis-retinal is even 50% faster than that for 9-cisretinal. This is in line with the idea that the retinal-binding pocket was evolved to utilize
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11-cis-retinal. It provides further evidence that the presence of lipid bilayer environment
may modulate the conformation of receptor in a distinct mode from detergent systems. In
our experiments, we found at 36 °C a koff of (1.29 ± 0.02) ×10−7 s−1. To our knowledge,
this study is the first in vitro demonstration of chromophore exchange for a rod receptor.
In a classic electrophysiological study on the physiological noises of a single rod
cell from toad retina, it was estimated that at 37 °C, in rod cells a Rho molecule “turns
on” once every 400 years (Baylor et al., 1980). The chemical nature of this spontaneous
activation of Rho remains obscure. Plausible mechanisms include 1) 11-cis-retinal may
thermo isomerize to all-trans-retinal without any photoactivation, triggering the Meta-II
pathway (Liu et al., 2009; Liu et al., 2011); 2) the breaking of the SB bond results in a
active retinal-opsin non-covalent complex (Kefalov et al., 2001); and 3) regardless of
retinal isomerization, the dissociation of retinal from the binding pocket produces opsin
with basal activity (Cornwall and Fain, 1994; Cornwall et al., 1995; Surya et al., 1995).
Previously, the rate of the thermal isomerization of 11-cis-retinal to all-trans-retinal in
1% digitonin was measured at temperatures above 70 °C, with an Ea of 24.5 kcal mol−1
(Hubbard, 1966). If we assume the Arrhenius plot for this reaction at high temperatures
extended its linearity to physiological temperature, the corresponding thermal
isomerization rate of 11-cis-retinal would be 1.9 ×10−7 s−1 at 36 °C. Nonetheless, the
thermal isomerization of bound 11-cis-retinal is likely to be different from that of free
retinal in solution. We could not determine whether thermal isomerization of 11-cisretinal to all-trans-retinal was involved in our experiment, as the large excess of 9-cisretinal to Rho imposed substantial technical challenge for quantifying the presence of alltrans-retinal. However, we obtained an Ea, off of 38.9 ± 4.4 kcal mol−1, which is clearly
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higher than the Ea of 22 kcal mol−1 for thermal activation (Baylor et al., 1980). This
indicates that the chromophore exchange observed here is at least not entirely due to
thermal isomerization of retinal; it primarily involved direct breaking of the PSB and
perhaps as well as thermal isomerization.
The apparent rate for the spontaneous dissociation of retinal from opsin (half-life
220 days at 28 °C, and 62 days at 36 °C) is in general three orders of magnitude higher
than the spontaneous activation of Rho (Baylor et al., 1980). The spontaneous
dissociation of 11-cis-retinal from cone opsin contributes to elevated noise and reduced
sensitivity of cone photoreceptor cells compared to rod photoreceptor cells (Kefalov et
al., 2005). This question is how much the spontaneous dissociation of retinal from opsin
contributes to the two components of electrical dark noise in photoreceptor cells (Baylor
et al., 1980).
3.4.4 ITC provided direct information on the reaction enthalpy of Rho
regeneration
ITC is a powerful tool for studying binding events between molecules, as it yields
information on the dissociation constant and binding enthalpy. However, examples of
using ITC to investigate ligand-binding enthalpy of GPCRs remain rare, largely because
of the difficulty of obtaining high-purity receptor samples in large quantity. To date, only
a few GPCR domains have been studied by ITC (Fernando et al., 2007; Nisius et al.,
2008; Rajarathnam and Rosgen, 2014). Here we presented the first ITC measurement of
the binding enthalpy between a full-length GPCR and its native ligand. In contrast to
photocalorimetry, our experiments are a direct measurement of the binding enthalpy and
do not rely on complicated thermodynamic cycles involving error-prone calculations of
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hydroxylamine dependent reaction steps (Cooper and Converse, 1976; Cooper, 1979).
Interestingly, the value of ΔH°’ of Rho is close to the difference between the Ea of Rho
denaturation (100 kcal mol−1) and opsin denaturation (73 kcal mol−1), suggesting that
ΔH°’ contributes substantially to the thermostabilizing effect of retinal binding to opsin
(Hubbard, 1958).
3.4.5 The energy landscape of Rho regeneration
We present a complete energy diagram based on the results of the two kinetic
studies and the calorimetry experiment. The energy diagram assumes that the dissociation
reaction of retinal from Rho is the reverse reaction of the recombination reaction of
retinal and opsin, and that the reactions proceed through a common transition state but in
opposite directions. The kinetics of the forward (kon) and reverse reaction (koff) enabled us
to calculate the change of free energy from the ground state to the transition state (Δ≠Gon
and Δ≠Goff ).
We also determined the Kd of the reaction of 11-cis-retinal and opsin to be 40 ± 2
pM at 28 °C (32 ± 2 pM at 25 °C). This value is similar to that of three high-affinity
ligands for β2 adrenergic receptor, carazolol (antagonist), iodopindolol (antagonist), BI167107 (agonist), which have a Kd of less than 100 pM (Rasmussen et al., 2011a; Manalan
et al., 1981; Contreras et al., 1986). We compared the kinetics and thermodynamic
properties of β2 adrenergic receptor and Rho binding with their ligands (Table 3-5).
Despite similar Kd and ΔG°’, the energy barriers for the association reaction between
opsin and 11-cis-retinal (Δ≠Gon), as well as for dissociation reaction (Δ≠Goff), are
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Table 3-5. The kinetic and thermodynamic parameters for β2AR and Rho with their
ligands at 25 °C

Receptor

β2AR

Rho

Ligand

BI-167107
(Rasmussen et
al., 2011a)

Carazolol
(Rosenbaum
et al., 2007)

Iodopindolol
(Contreras et
al., 1986)

11-cisretinal**

kon (M−1 s−1)

7.6×104 *

> 6.3×104 *

8.0×106

6.6×102

koff (s−1)

6.4×10-6

6.3×10-6

4.2×10-4

2.1×10-8

Kd (pM)

84

<100

53

32

ΔG°’
(kcal mol−1)

-13.7

< -13.6

-14.0

-14.3

ΔGon≠
(kcal mol−1)

10.8

> 10.9

8.0

13.6

ΔGoff≠
(kcal mol−1)

24.5

24.5

22.0

27.9

* Calculated based on the transition state theory, using Kd and koff reported in the
reference.
* * Calculated from the Arrhenius plot based on the kinetic data in this study
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particularly high. For comparison, if the ligand-receptor binding process would be
diffusion-limited (kon: 108 ~1010 M−1 s−1) (Alberty and Hammes, 1958), the Δ≠Gon is about
3.8 ~ 6.6 kcal mol−1. Thus the relatively slow retinal binding rate is advantageous for the
design of a photoreceptor, as it confers slow dissociation rate of retinal from opsin, and
hence longer lifetime for the dark-state photoreceptor.
We further utilized the temperature dependence of the binding and unbinding
kinetics to separate the enthalpic and entropic contribution to the free energy of
activation. Ideally the difference between the activation enthalpy of the forward and
reverse reactions should have the same value as the enthalpy of formation (Δ≠Hon - Δ≠Hoff
= ΔHo’). The results from the chromophore exchange experiment (light blue) and the ITC
experiment (dark blue) are within the error estimation, supporting our assumption that the
recombination reaction and the dissociation reaction measured here represent the reverse
process of each other.
The activation energy (Ea, on) for the recombination reaction in bicelles is 20.8 ±
0.9 kcal mol−1. Recently it was reported that the (Ea, on) in DM micelles is ∼13 kcal mol−1,
lower by ∼7 kcal mol−1. One possible explanation is that a receptor conformation is more
flexible in micelles than in bilayer(Kusnetzow et al., 2006), which reduces the energy
barrier for opsin to reach the conformation competent for retinal binding. Another
possible source of the difference is the viscosity of lipid bilayer, which has been reported
to contribute to the energy barrier of ligand binding in GPCRs (Lee, 2004). Retinal
binding with opsin proceeds through an intramembranous pathway (Wang and Duan,
2007), while for β2 adrenergic receptor ligand binding is more likely to occur through the
exposed extracellular surface (Wang and Duan, 2009). Therefore, the difference in Δ≠Gon
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for opsin and β2 adrenergic receptor may be partially explained the different modes of
ligand binding utilized by the two receptors.
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3.5

Materials and Methods

3.5.1

Materials
E. coli TOP10 cells (Invitrogen) were used for plasmid propagation and isolation.

1D4-Sepharose 2B was prepared as described in Chapter II (Oprian et al., 1987; Knepp et
al., 2011). Alexa488-DIBO was obtained from Molecular Probes/Thermo Fisher
Scientific as a dry powder, dissolved in DMSO (5 mM), and stored at −20 °C. n-dodecylβ-D-maltoside (DM) was obtained from Anatrace. 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC) was obtained from Avanti. 1-hexadecanoyl-2-(1pyrenedecanoyl)-sn-glycero-3-phosphocholine (β-pyrene-C10-HPC) was obtained from
Molecular Probes, Invitrogen.
3.5.2

Preparation of the POPC/CHAPS bicelles buffer
The POPC lipids were stored at −20 °C prior to use. The POPC lipids were

dissolved in 20% (w/v) CHAPS solution at a 1: 1 ratio (w:w) to make a 10% (w/v) stock
bicelle solution. The solution was frozen in liquid nitrogen and then thawed repeatedly to
facilitate the dissolution of POPC. The POPC/CHAPS stock solution was diluted with
Buffer A (25 mM MES, 25 mM HEPES, pH 6.0, 125 mM KCl) to make 1% (w/v) bicelle.
To prepare pyrene-labeled bicelle, appropriate amount of β-pyrene-C10-HPC (1mg/mL
DMSO solution) was directly added into 1% POPC/CHAPS bicelle solution.
3.5.3

Isolation of ROS membranes
Native rod outer segment (ROS) membranes were isolated under dim red light

from frozen bovine retinas (W. L. Lawson Co., Lincoln, NE) by gentle homogenization,
differential centrifugation and density gradient centrifugation as described (Papermaster
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and Dreyer, 1974; Botelho et al., 2002). Aliquots of the membranes with a Rho
concentration in the range 140–180 µM in 67 µM potassium phosphate buffer, pH 7.0,
were stored under argon at −80 °C.
3.5.4

Immunopurification of ROS Rho or mutant Rho using 1D4-sepharose resin

for the pigment regeneration studies
Bovine ROS or heterologously expressed mutant Rho were lysed with the
solubilization buffer (1% (w/v) DM, 50 mM HEPES or Tris-HCl, pH 6.8, 100 mM NaCl,
1 mM CaCl2 with complete EDTA-free Protease Inhibitor Cocktail, Roche) for at least 1
h at 4°C. To lyse cells, 1 mL of solubilization buffer was used for 107 cells. For ROS
membranes, the volume of solubilization buffer was not critical, as long as the final
solubilization buffer contains 1% DM. The lysate was cleared by centrifugation at
100,000 × g for 30 min. The supernatant fraction was mixed with 1D4-Sepharose-2B
resin (binding capacity for Rho determined by UV-Vis spectroscopy: 600 µg/mL) and
incubated overnight at 4°C. The resin was transferred in a centrifugal filter unit with a
0.45-µm microporous hydrophilic surface modified PVDF membrane (Ultrafree-CL;
Millipore), which enables efficient removal of washing buffer. The resin was first washed
with 1× DPBS containing 0.1% (w/v) DM for three times (30 min incubation each time),
and then with a low-salt buffer (0.1% (w/v) DM in 2 mM phosphate buffer, pH 6.0).
Eventually, the receptor was eluted with the elution buffer (100 µL, no less than the
volume of the resin; 0.1% (w/v) DM and 0.33 mg/mL 1D5 nonapeptide TETSQVAPA
peptide in 2 mM phosphate buffer, pH 6.0). The resin was incubated with the elution
buffer on ice for at least 1 h. The purified receptor was collected in a clean 1.5 mL
Eppendorf tube.
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3.5.5

Immunoaffinity purification of opsin using1D4-sepharose resin for the ITC

experiment
In a typical experiment, 0.25 mL aliquot of ROS membranes (~1.4 mg Rho) was
solubilized using the wash buffer (2.5 mL; 7.5 mg/mL CHAPS, 1 mg/mL POPC, 137.5
mM NaCl, 25 mM MES, 25 mM hemisodium HEPES, 0.25 mM disodium EDTA, pH 6.0,
supplemented with 0.14 mL 10% (w/v) CHAPS in water). The mixture was gently
agitated for 30 min at 4°C. The insoluble material was removed by centrifugation for 10
min at 2,200 × g in a clinical desktop centrifuge. The supernatant fraction was incubated
at 4°C for 3 h under gentle agitation with 1.6 mL packed 1D4-Sepharose 2B resin preequilibrated with wash buffer. The matrix was washed 4 times for 20 min each time with
6 mL wash buffer. The resin was then transferred into a 0.45-µm microporous
centrifugal filtering unit (Ultrafree-CL; Millipore), washed once (1.0 mL; 10 mg/mL
CHAPS, 10 mg/mL POPC, 137.5 mM NaCl, 25 mM MES, 25 mM hemisodium HEPES,
0.25 mM disodium EDTA, pH 6.0) and re-hydrated with POPC/CHAPS bicelle buffer
supplemented with 50 mM hydroxylamine (1.0 mL). The sample in the filtration unit was
illuminated with a 500 nm long-pass filter equipped fiber optics coupled microscope
illuminator (Dolan) for one hour with gentle head-over-head mixing. The resin was
washed 15 times with 1.0 mL POPC/CHAPS bicelle buffer. The large number of
washing cycles is sufficient to ensure that the concentration of hydroxylamine is reduced
below a level that might interfere with the ITC experiments. The washing buffer was
removed by centrifugation and opsin was eluted twice with 1 mL of POPC/CHAPS
bicelle buffer supplemented with 0.33 mg/mL nonapeptide TETSQVAPA. Typically, the
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protein concentration was in the range 4.7 ± 0.2 µM (corresponding to 0.18 ± 0.02 mg/mL
protein)
3.5.6

Lectin affinity purification of Rho for chromophore exchange experiment
As an alternate method to immunoaffinity purification, concanavalin A (ConA)

bound to a gel matrix was employed to purify Rho from ROS membranes. The
advantage is that the α-methylmannoside used for elution does not interfere with a
potential second purification step using the 1D4 sepharose 2B resin. Briefly, an aliquot
of ROS membranes (0.75 mL; ~4 mg Rho) was solubilized using a solubilization buffer
containing phospholipids (7.5 mL; 12.2 mg/mL CHAPS, 1 mg/mL POPC, 137.5 mM
NaCl, 25 mM MES, 25 mM hemisodium HEPES, 0.25 mM disodium EDTA, 1 mM
MnCl2 and 1 mM CaCl2, pH 6.0). The mixture was gently agitated for 1 hour at 4°C. The
insoluble material was removed by centrifugation for 10 min at 2,200 × g in a clinical
desktop centrifuge. The supernatant was incubated at 4°C for 3 hours under gentle
agitation with concanavalin A Sepharose conjugate affinity matrix (1.7 mL packed
volume; Sigma). The concanavalin molecules of the affinity matrix were cross-linked by
glutaraldehyde treatment to reduce leakage (Degrip, 1982b). The matrix was washed for
4 times, 20 min each time, with buffer OG (12.5 mL; 15 mg/mL β-octylglucoside, 137.5
mM NaCl, 25 mM MES, 25 mM hemisodium HEPES, 0.25 mM disodium EDTA, pH 6.0).
The resin was transferred in a centrifugal filter unit with a 0.45-µm microporous
hydrophilic surface modified PVDF membrane (Ultrafree-CL; Millipore). The washing
buffer was removed by centrifugation and Rho was eluted with buffer OG supplemented
with 100 mM α-methyl-D-mannoside (1 mL) for 3 times. The combined elution was
concentrated to a volume of approximately 200 µL using an Amicon Ultra-4 centrifugal
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ultrafiltration device with a regenerated cellulose membrane (Millipore). The
concentrated sample was applied to a small Sephadex G-50 column (5 cm × 0.7 cm)
equilibrated with buffer A (10 mL; 150 mM NaCl and 50 mM sodium acetate adjusted
with hydrochloric acid to pH 5.5), followed by buffer A containing 1% CHAPS (10 mL),
and 4 times 0.5 mL POPC/CHAPS bicelle buffer. The sample was eluted with the
POPC/CHAPS bicelle buffer for 5 times (200 µL each). The main Rho-containing
fractions were identified by UV-Vis spectroscopy, pooled and diluted with the
POPC/CHAPS bicelle buffer to 10 mL.
3.5.7

Determination of molar extinction coefficient of 11-cis-retinal in the

POPC/CHAPS bicelle buffer
The analysis of the results from titration calorimetry experiments in terms of
molar binding enthalpies is critically dependent on a precise knowledge of the
concentrations of ligand and protein solutions. Therefore it is necessary to determine the
molar extinction coefficients under the experimental buffer conditions. The strategy is to
utilize the know literature value for the molar extinction of 11-cis-retinal in ethanol, ε376.5
nm

= 24,935 M−1 cm−1 (Hubbard and Wald, 1952; Dieterle and Robeson, 1954; Brown and

Wald, 1956). The buffer effects on the 11-cis-retinal spectrum were determined by a
dilution assay. Briefly, an aliquot of ethanolic 11-cis-retinal solution (10 µL) was added
to ethanol or POPC/CHAPS bicelle buffer (1 mL) using a micro syringe (10 µL gas-tight
model RN, Hamilton Co., Reno, NV). The exact volume was gravimetrically determined
and used in the calculation of the dilution factor. UV-Vis spectra were recorded over the
range from 750 to 250 nm with 1-nm step size, 0.2-s integration time, and 1-nm slit width.
The experiment was performed in triplicate, resulting in 2.6% increased absorption of the
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spectral maximum in POPC/CHAPS bicelle buffer as compared with ethanol. The
observed absorption maximum of 11-cis-retinal in ethanol was at 378.5 nm, identical to
the maximum observed in POPC/CHAPS bicelle buffer. This corresponds to a molar
extinction coefficient for 11-cis-retinal in POPC/CHAPS bicelle buffer of ε378 nm = 25,574
M

−1

cm−1. The A254/A378.5 ratio is 0.73, slightly higher than the literature value of 0.70

(Brown and Wald, 1956). This indicates a high isomeric purity if the sample, as
contamination other isomers, such as all-trans-retinal or and 9-cis-retinal will result in
lower values of this ratio. The isomeric purity is confirmed by reverse phase high
performance liquid chromatography (HPLC) using an analytical C18 column and
acetonitrile mixtures with ammonium acetate buffer (pH 4.5) shows 2.4% impurities at
longer retention time for a different sample from the same master stock solution (Dr.
Shixin Ye, personal communication). In comparison, dilution in the same buffer
containing 2% digitonin instead of 1% POPC and 1% CHAPS, the absorption maximum
is red-shifted to 383.5 nm with a reduction of the absorbance of just 0.5% compared to
ethanol. In light of these findings, it is unlikely that the extinction coefficient in
POPC/CHAPS bicelle buffer is significantly different compared with ethanol solutions,
in contrast to the earlier observations that in digitonin the extinction coefficient of 11-cisretinal is about 13% reduced as compared to ethanol(Brown and Wald, 1956).
3.5.8

Determination of molar extinction coefficients of opsin and Rho
Knowledge of the molar extinction coefficient for 11-cis-retinal allows titration of

the binding site for determination of the extinction coefficients for opsin and Rho in
POPC/CHAPS bicelle buffer. From a linear dilution series of 11-cis-retinal with 16
concentrations in the range from 0 to 31.5 µM, 120 µL aliquots were mixed with 200 µL
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aliquots of purified opsin (10.2 µM). The samples were incubated at room temperature for
4 h in the dark. The correlation of the absorption of 11-cis-retinal in buffer at 378 nm,
corrected for a dilution factor df = 0.375, and of Rho in the opsin samples at 499 nm
yields a perfectly linear correlation at sub-stoichiometric ratios, corresponding to a molar
extinction coefficient of Rho ε499 nm = 42,742 M−1 cm−1.
3.5.9

Assessing the stability of opsin solubilized in DM micelles
The purified opsin (15 µL, 2.7 µM, solubilized in 0.1% DM) was aliquoted into

1.5-mL Eppendorf tubes and photobleached by irradiating with a 505-nm LED light
source (Thorlabs) for 30 s. After photobleaching, the samples were kept in the dark at 28
°C for varied durations. Then 135 µL of POPC/CHAPS bicelle buffer supplemented with
11-cis-retinal. The final concentration of opsin was 0.27 µM, and the molar ratio of 11cis-retinal to opsin was 1.5:1. The regeneration reaction was allowed to proceed
overnight (>15 h) to reach completion. The dark and the photobleached spectrum of the
regenerated samples were recorded as described above. In the presence of 11-cis-retinal,
longer exposure to 505-nm LED light source (1 min) were required to fully photo bleach
the photoreceptor. The extent of regeneration was evaluated based on the 500-nm
absorbance of the difference spectrum.
3.5.10 Assessing the stability of opsin solubilized in POPC/CHAPS bicelles
The purified opsin (15 µL, 2.7 µM, solubilized in 0.1% DM) was added to 120 µL
of POPC/CHAPS bicelle buffer. The samples were photobleached by irradiating with a
505-nm LED light source (Thorlabs) for 30 seconds. After photobleaching, the samples
were incubated in the dark at 28 °C for varied durations. Then 11-cis-retinal diluted in
POPC/CHAPS bicelle buffer (15 µL) was added into the opsin samples. The final
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concentration of opsin was 0.27 µM, and the molar ratio of 11-cis-retinal to opsin was
1.5:1. The regeneration reaction was allowed to proceed overnight (>15 h) to reach
completion. The dark and photobleached spectrum of the regenerated samples were
recorded as described above. In the presence of 11-cis-retinal, longer exposure to 505-nm
LED light source (1 min) were required to fully photo bleach the photoreceptor. The
extent of regeneration was evaluated based on the 500-nm absorbance of the difference
spectrum.
3.5.11 Measuring retinal entry and release kinetics based on quenching of Trp
fluorescence
Fluorescence spectroscopy was performed at 28 °C on a SPEX Fluorolog Tau-3
spectrofluorometer (Horiba) in photon-counting mode. The time-course experiments
were done by adding aliquots of the elution samples from receptors (30 µL) to the
POPC/CHAPS bicelle buffer to give a final concentration of 0.25-0.30 µM under constant
stirring. The excitation wavelength was 295 nm with a 0.6-nm band-pass, and the
emission was measured at a wavelength of 330 nm with a 15-nm band-pass. The 11-cisretinal or 9-cis-retinal stock solution in ethanol was diluted in the POPC/CHAPS bicelle
buffer, and 20 µL of this working dilution was added to the cuvette to give a desired final
concentration. For each measurement, the concentration of freshly diluted retinal was
determined from its 378-nm absorbance (extinction coefficient 24,400 M−1 s−1). The
reaction rate constant for retinal release was obtained by fitting the fluorescence signal
corresponding to Meta-II decay with monoexponential decay model. The pseudo-first
order rate constant (k1) was obtained by fitting the fluorescence signal corresponding to
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pigment regeneration with monoexponential decay model. The second-order
recombination reaction rate constant (k2) was calculated as k1/cretinal.
The procedure for preparing Alexa488-labeled Rho has been described in
Section 2.4.7. Measurement of retinal entry kinetics based on quenching of Alexa488
fluorescence has been described in Section 2.4.13.
3.5.12 The chromophore exchange of ROS Rho
Retinoid solution in benzene (approximately 0.3 mL 30 mM) was transferred to
nitric acid washed 4-mL glass vial. The solvent was evaporated under a stream of argon
under red light. The sample was kept at high vacuum for 15 min. Then the retinoids was
dissolved in pure ethanol (0.5 mL). The stock solution was diluted by 20-fold (0.1 mL of
stock solution in 1.9 mL ethanol), and a UV-Vis spectrum of a 1:100 dilution in ethanol
was measured. Concentrations were normalized to about 2mM for the diluted stock.
Lectin-affinity purified ROS Rho was obtained in the POPC/CHAPS bicelle buffer and
diluted with the bicelle buffer to give a total volume of 6.74 mL (0.21 mg mL−1, 5.2 µM).
The sample was divided into five volumes and supplemented with the following: A)
ethanol; B) 11-cis-retinal; C) 9-cis retinal (concentration); D) all-trans-retinal E) 50 mM
NH2OH. Each combination of Rho with retinal were incubated under five different
conditions: 1) 28 °C for 11.6 days (106 s); 2) 36 °C for 11.6 days (106 s); 3) 44 °C for
11.6 days (106 s); 4) 28 °C for 2×11.6 days (2×106 s); 5) 36 °C for 2×11.6 days (2×106 s);
6) 44 °C for 2×11.6 days (2×106 s); 7) 28 °C for 3×11.6 days (3×106 s). The samples
were denoted as A1, A2, … A6, A7….E6, E7. Each sample contained a total volume of
150 µL (32 µg of Rho), and supplemented with retinals (3.75 µL of 2 mM ethanolic
solution, final concentration 49 µM). The samples were kept in 200-µL PCR tubes inside
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1.5-mL brown micro centrifuge tubes. Each set of 5 tubes was kept in large UZ tubes and
wrapped in aluminum foil and incubated in a large brown screw cap glass in a water bath.
To overcome buoyancy, large steel rods were added into the UZ tubes as weights. At the
end of incubation, the samples were checked for their volume, and no loss was observed.
The samples were then purified using 1D4-sepharose resin. The slurry of 1D4-Sepharose2B (100 µL) was loaded in Microcon-MC 0.2-µm PVDF filter and spun to remove the
storage buffer. Then the samples were added to resin and mixed at 4 °C for 4 h on the
wheel. The unbound fraction was checked with UV-Vis to confirm complete
immunoprecipitation. The resin was washed 5 times with 400-µL wash buffer (Buffer A
+ 0.75% CHAPS + 0.1% POPC). The mixture of Rho and isorhodopsin) was eluted with
the elution buffer (wash buffer + 0.33 mg mL−1 1D5 peptide, 3×30 µL, 20 min each
time). The purified receptor was characterized using UV-Vis spectroscopy.
We found that at 44 °C, there is significant opsin denaturation, which needs to be
corrected for. Let the total recovery of isoRho and rhodopsin be a, and the fraction of
isoRho exchanged from rhodopsin be b:

a=

[isoRho]recovered +[Rho]recovered
[Rho]initial

b=

[isoRho]recovered
[isoRho]recovered +[Rho]recovered

The fraction of retinal spontaneous dissociation is (1−a+ab).
3.5.13 Determination of the binding enthalpy of 11-cis-retinal and opsin using ITC
For each measurement, opsin and 11-cis-retinal bicelle solution were prepared
fresh. Purified opsin was obtained in the POPC/CHAPS bicelle buffer. The concentration
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of the opsin sample was determined to by UV-Vis spectroscopy (4.7 ± 0.2 µM). To avoid
the dilution heat of ethanol in water, the ethanolic solution of 11-cis-retinal was
evaporated with argon under red light, and re-dissolved in POPC/CHAPS bicelle buffer.
The solution was centrifuged (14, 000 × g, 10 min) to remove any the insoluble fraction.
The concentration of 11-cis-retinal solution was determined by UV-Vis spectroscopy.
3.5.14 Determination of retinal diffusion kinetics among bicelles
In the stop-flow apparatus, the donor POPC/CHAPS bicelle contains 100 µM 11cis-retinal, and the acceptor POPC/CHAPS bicelle are doped with 0.1% β-pyrene-C10HPC (w/w). The experiment was carried out under dim red light. The temperature of
solutions was maintained at 28 °C by pumping water from water bath with temperature
controller into the sample chamber. The two solutions were simultaneously injected into
the mixing chamber. After rapid mixing, the transfer of retinal was monitored by the
decrease of pyrene fluorescence. The fluorescence signal was acquired from 360 nm to
585 nm, at a rate of 60 scans s−1. The spectrum of pyrene was extracted by principle
component analysis. The component corresponding pyrene fluorescence was fitted using
monoexponential model with background.
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Chapter Four: Mutagenesis study to identify the retinal entry pathway
in opsin

4.1

Summary
The visual photoreceptor rhodopsin (Rho) consists of a chromophore 11-cis-

retinal bound inside a heptahelical polypeptide backbone. However, the molecular
mechanism for retinal to enter the ligand binding channel is not well understood. Here we
approached this question by assessing how mutations affect retinal entry and release
kinetics. We measured the entry kinetics by two FRET-based assays utilizing intrinsic
tryptophan fluorescence and extrinsic Alexa488 fluorescence of a bioorthogonallylabeled Rho mutant. We identified a set of residues at the fifth and sixth transmembrane
(TM) helices where mutations exert a much greater influence on the retinal entry kinetics
than on the retinal release kinetics. We employed three criteria to evaluate the relative
influence of these mutations: 1) the correlation between side-chain size and entry
kinetics; 2) the change in the activation energy for retinal entry; 3) the effect of
increasing polarity at these sites. We found that three sites, F208, F212 and A269, are
particularly important in regulating retinal entry. Based on these findings, we propose a
model for retinal entry.
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4.2.

Introduction
The visual photoreceptor Rho consists of an apoprotein opsin and its native ligand

11-cis-retinal that is covalently linked to K296 of opsin via a protonated Schiff base
(PSB) bond (Wald, 1968). 11-cis-retinal is a strong inverse agonist that stabilizes Rho at
its inactive state with minimal basal activity. Upon photobleaching, 11-cis-retinal absorbs
a photo to isomerize to all-trans-retinal, triggering a series of conformational changes to
reach the active Meta-II Rho, the state capable of activating transducin. Meta-II Rho
signaling is shut off by phosphorylation of the receptor and subsequent binding with
arrestin (Wilden et al., 1986; Kühn and Wilden, 1987), a process called desensitization
that occurs within tens of milliseconds to one second in photoreceptor cells (Richard and
Lisman, 1992; Ranganathan and Stevens, 1995). The hallmark of GPCR activation is the
relative rotation of TM3, TM5, and particular the outward tilt of TM6, which opens the
cytoplasmic cavity for G protein binding. Biochemical and structural studies have firmly
established the correlation between this particular conformation and the receptor’s
capacity to activate G protein (Farrens et al., 1996; Sheikh et al., 1996; Park et al., 2008;
Deupi et al., 2012a; Rasmussen et al., 2011b).
The docking mode of 11-cis-retinal in the ligand binding channel of dark-state
Rho has been defined first through biochemical studies (Nakayama and Khorana, 1990b)
and structural studies (Palczewski et al., 2000; Okada et al., 2004). Nonetheless, the
mechanism for 11-cis-retinal to enter and exit the binding pocket remains obscure. A
bewildering feature about the crystal structure of the dark-state Rho is that it reveals no
obvious ligand entry or exit site on the protein surface, while other GPCRs invariably
exhibit a ligand binding channel accessible to the extracellular environment (Katritch et
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al., 2012). By comparison, in the structures of opsin (Park et al., 2008) and Meta-II Rho
(Choe et al., 2011), two openings are found in proximity of the two ends of retinal (Choe
et al., 2011; Hildebrand et al., 2009), one between TM1 and TM7 close to the PSB
linkage (Opening A) as a result of the rotamer change of F293, the other between TM5
and TM6 close to the β-ionone ring (Opening B) due to the outward movement of F208,
F212 and F273. Based on the structural studies, it was inferred that retinal entry and
release proceed through an intramembraneous pathway, utilizing these two openings to
enter and exit the ligand binding pocket (Piechnick et al., 2012; Hildebrand et al., 2009).
The second inference was that retinal entry requires the active conformation, as the two
openings are not found in the inactive state. This “active conformation” theory seems
appealing because it is in line with the high partition coefficient of retinal between lipid
bilayer and water (Frederiksen et al., 2012), and consistent with the sequence of events in
Rho activation and signaling.
For the two openings, there are in principle five possible scenarios for retinal
entry and release: 1) Opening A for both entry and release; 2) Opening B for both entry
and release; 3) Opening A for entry and B for release; 4) A for release and B for entry;
and 5) retinal entry and release promiscuously use Opening A and B. The molecular
dynamics simulation alone could not distinguish the specific roles of these two openings
(Hildebrand et al., 2009).
To answer this question with experimental evidence, Piechnick et al. generated a
series of mutations at the putative entry and exit site and the middle of the ligand-binding
channel, and measured the effect of these mutations on retinal entry and release kinetics.
Their rationale was straightforward: if a particular opening is used for retinal entry, then a
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mutation at this site is expected to alter the entry kinetics but have little effect on the exit
rate, and vice versa. However, the results did not fall into the predicted pattern: a number
of mutations simultaneously changed the entry and exit kinetics (Piechnick et al., 2012).

Figure 4-1. Comparison of the crystal structure of dark-state Rho (PDB accession
code 1U19) and Meta-II Rho (3XPO). The polypeptide backbones (view from the EC
side) of Rho are shown in cyan, and that of Meta-II Rho in pink. The residues are
highlighted as sticks (dark state: blue; Meta-II: magenta). 11-cis-retinal is shown in
yellow and all-trans-retinal in orange. The N-terminus and EC loops are removed to
reveal the retinal. The transition from inactive conformation to active conformation
exposed two openings (Opening A and B) at the two ends of the bound retinal. Four
residues (Opening A: F208, F212, F273; Opening B: F293) at the two openings have
undergone major structural changes, rotating outward from the inactive state.

158	
  

It was reported that the constitutively active mutant M257Y (Han et al., 1998)
exhibits slower rather than faster retinal entry kinetics, and fusing a transducin-mimic
peptide known to stabilize the active conformation to the C-terminus of Rho also reduces
the binding rate {Schafer, 2015 #1428}. These observations constitute a greater attack on
the active conformation theory, because both M257Y mutation and transducin peptide
fusion are expected to shifts the equilibrium to the active conformation (Deupi et al.,
2012a; Tsukamoto and Farrens, 2013). Therefore, the Meta-II Rho and opsin structure
characterized by the outwardly tilted TM6 may not represent the conformation competent
for retinal uptake. Retinal entry obviously cannot occur at Meta-II state while the binding
pocket is still being occupied. Yet it remains unclear whether after all-trans-retinal
dissociation, opsin would spontaneously “collapse” to the inactive conformation, or retain
the active-state-like conformation until retinal entry “reset” it. The specific location of the
aforementioned Opening A and B were assigned based on the active conformation, which
may underlie the ambiguous results in the earlier retinal entry kinetics study (Piechnick et
al., 2012).
Here we present results on retinal entry and release in Rho mutants. We adopted a
similar approach based on site-directed mutagenesis combined with retinal entry and exit
kinetics. We improved the experimental design in several important ways. First, we
reconstituted the receptor into POPC/CHAPS bicelles, which thermostabilizes the ligandfree opsin more effectively than DM micelle. Second, we used two complementary
FRET-based assays to measure the retinal entry kinetics. The Trp-based assay detects
retinal uptake by the ligand-binding channel, and the Alexa488-based assay reflects the
formation of PSB.
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4.3 Results
4.3.1 The mutations at TM5 and TM6 primarily alter the retinal entry kinetics but
not the exit kinetics
We generated a series of mutations at five sites close to Opening B (between TM5
and TM6): F208, F212, A269, G270, F273. The side chains of F208, F212 and F273
exhibited major translocations in the structure of Meta-II Rho. A269 is situated on the
opposite side of F212, and we reasoned that increasing the size of the side chain might
contribute to the sterical hindrance. In both dark-state Rho and Meta-II Rho, these
residues point outward from, rather than protrude into the ligand binding channel. G270
was added as reference. We utilized the Trp fluorescence quenching assay (the details of
the assay has been described in Chapter 2 and Chapter 3) to measure the retinal entry and
exit kinetics. We found that these mutations have a much more pronounced effect on the
retinal entry rates than the retinal exit rate. The mutant with the fastest retinal entry
kinetics was G270 L (4.2 ± 0.4 as compared with wt), the slowest F212 W (0.043 ±
0.022), spanning two orders of magnitude. By comparison, the release kinetics ranged
from 2.4 ± 1.0 (F212A) to 0.78 (A269F). Therefore, the mutations at Opening B (Figure
4-2) exert a much greater effect on the kinetics retinal entry than release.
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Figure 4-2. The tested TM5/6 mutations. The side view of polypeptide backbones of
Rho (1U19) and Meta-II Rho (3XPO) are shown in cyan, and that of Meta-II Rho in
pink. The five residues tested in the present study (F208, A269, G270, F273, F273) are
shown as sticks (dark state: blue; Meta-II: magenta), 11-cis-retinal in yellow and alltrans-retinal in orange.

4.3.2

The effect of side-chain size is dependent on the site

We assessed how varying the side-chain size will alter the retinal entry kinetics. We
chose a series of hydrophobic residues A, L, F, W, with increasing sterical hindrance. In
this way we avoided dramatic alteration in their electrostatic, hydrogen bonding and
hydrophilicity properties. For A269 and G270, we did not have the W mutation, or the L
mutation for F273. For the F208, F212, A269, F273 mutants, we utilized both the Trpbased assay and Alexa488-based assay to ascertain the proper formation of a mature
pigment as indicated by the PSB. The entry kinetics measured by the two different assays
is generally consistent, as we have observed for the wt Rho. Therefore, we concluded that
these mutations do not affect PSB formation; their primary role is to modulate the
property of ligand entry site.
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Figure 4-3. The retinal entry and release kinetics. All the values are normalized
against that of wt Rho (dash line). The entry kinetics are shown as red bar, and the release
kinetics as grey empty circle. The mutants are arranged based on their entry kinetics. For
the tested mutants, the variation in retinal entry kinetics is much greater than that of the
release kinetics.
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Figure 4-4. The effect of changing the side-chain size. All the values are normalized
against that of wt Rho. The entry kinetics are shown as blue (measured by the change in
Trp fluorescence) and turquoise (measured by Alexa488 fluorescence) bars, and the
release kinetics as grey empty circle.

To our surprise, we found that increasing the side-chain size did not necessarily
slow down the entry kinetics, and reducing the side-chain size may not always accelerate
it: the behaviors of these mutations are site-dependent. For F208, increasing the sidechain size (F208W) or decreasing it (F208A) both resulted in slower retinal entry
kinetics. For F212 and A269, the consequences of the mutations are more
straightforward: retinal entry kinetics is negatively correlated with the side-chain size.
We also tested the double mutant F212A/A269F, whose effect is the energetic
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combination of the two individual mutations. The mutations at G270 are relatively minor
compared with other sites, although G270L caused significantly faster entry kinetics. The
effect of F273 mutations is the opposite of that of F212 and A269: decreasing the sidechain size led to slower retinal uptake.
4.3.3 The mutations affect both the activation enthalpy and entropy of retinal entry
reaction
We measured the temperature-dependent retinal entry kinetics for five mutants,
F208W, F212A, F212W, F273A, and F273W by Alexa488-based retinal entry assay. The
fluorescence of Alexa488 falls into a clean window of retinal absorbance. As a result, this
assay is compatible with a wide range of retinal concentrations and enabled us to measure
retinal entry kinetics over three-orders of magnitude (k2 10 ∼104 M−1 s−1). This dynamic
range is superior that that of the Trp-based assay, as the Trp fluorescence signal is
significantly quenched by a high concentration of retinal, which would impose a great
technical difficulty for measurements in “slow” mutants. We have previously
benchmarked the Alexa488-based assay against the Trp-based assay, and demonstrated
that the engineered S144-Alexa488 Rho exhibited similar thermodynamic parameters
compared with wt Rho (Chapter Three).
We calculated the change in the activation free energy, enthalpy and entropic term
for these mutants. We found that two mutations, F208W and F212A, caused significant
change in the activation enthalpy. F208W increased the activation enthalpy (ΔH) by 4.8 ±
3.1 kcal mol−1 while F212A reduced it by −3.7 ± 1.6 kcal mol−1. We also found that
F208W, F212A and F212W changed the entropic term (−TΔS, calculated for 28 °C) by
3.9 ± 3.1 kcal mol−1, −3.5 ± 1.6 kcal mol−1, and −3.0 ± 1.8 kcal mol−1, respectively. The
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thermodynamic effects of F273A/W are less significant compared to the mutations at
F208 and F212.

Figure 4-5. The activation energy of F208, F212 and F273 mutants. A-C) The
thermodynamic effect of increasing the side-chain size (W) and decreasing it (A) at
position 208, 212 and 273 are assessed by Eyring plot. The entry kinetics are measured
by Alexa488 fluorescence quenching on S144-Alexa488 Rho background. D) The
changes in activation free energy (Δ≠G, green), enthalpy (Δ≠H, blue), and entropy
(−TΔ≠S, violet) are shown as bar graphs.
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4.3.4

Polar residues at TM5 and TM6 slows down retinal entry
We also tested the effect of adding polar residues at position 208, 212, 269, and

270. Compared with alanine and phenylalanine, serine and tyrosine only differ from them
in having an additional hydroxyl group, the comparison of S/A and Y/F pairs are
particularly meaningful as it minimizes the influence on the sterical factor. We found that
substitution of A for S at position 212 and 269 caused a sharp decrease in retinal entry
kinetics. Similar effect was observed for F212Y. We could not measure the retinal entry
kinetics for A269Y because this mutant simply could not be regenerated after prolonged
incubation with a high concentration of retinal (15 µM, over 48 h). Thus compared with
A269F, A269Y further slowed down retinal entry kinetics. F212T and A269T also
impeded retinal entry. The behavior of site 208 was different from 212 and 269. Two
mutants, F208S and F208T, exhibited slower retinal entry kinetics, while F208Y
accelerated retinal uptake. Different from 208, 212 and 269, G270S does not cause a
significant change compared to wt or G270A.
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Figure 4-6. The effect of polar mutations at position 208, 212, 269 and 270. All the
values are normalized against that of wt Rho. The entry kinetics are shown as blue
(measured by the change in Trp fluorescence) and turquoise (measured by Alexa488
fluorescence) bars, and the release kinetics as grey empty circles. With the exception of
F208Y, increasing the polarity at position 208, 212 and 269 reduced the retinal entry
kinetics.
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4.4

Discussion

4.4.1

A model for retinal uptake by the ligand binding pocket

Based on the retinal entry and release kinetics for the tested mutants, we propose the
following model for retinal entry and release in Rho, whose key points are summarized as
follows: 1) the crystal structure of Meta-II Rho represents the Rho conformation when
all-trans-retinal dissociates from the ligand binding channel (i.e. Meta-II decay); 2) after
retinal release, active-state-like opsin (Ops∗) collapses to a conformation resembling the
inactive state (Ops); 3) the population of ligand-free opsin exists in an equilibrium of
different conformations, one of which is competent for retinal uptake (Ops∗∗); 4) retinal
entry occurs at the Opening A of Ops∗∗ between TM5 and TM6, with F208, F212, and
A269 as the gating residues; 5) the rate-determining step for the recombination reaction
between opsin and 11-cis-retinal is the initial binding between opsin and retinal to form a
non-covalent complex, rather than Schiff base formation, while the rate-determining step
for the retinal release is Schiff base hydrolysis rather than its dissociation from the
ligand-binding channel.
4.4.2

The active conformation is for retinal release, not for retinal entry
In our attempt to derive the model for retinal entry and release, we first rejected

the theory that retinal entry requires the active conformation (Piechnick et al., 2012). In
the introduction we have discussed the implication of the slower retinal entry kinetics
observed for opsin carrying the activating mutation M257Y and the transducin-peptide
fusion(Schafer and Farrens, 2015). More importantly, the active conformation theory
contradicts the fact that opsin has a marked preference for 11-cis-retinal over all-trans-
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Figure 4-7. The model for retinal entry and release. A) The scheme of retinal entry
and release. All-trans-retinal in the photoactivated Meta-II Rho was released through
either Opening A between TM1 and TM7, or Opening B between TM5 and TM6. The
ligand-free, inactive opsin exists in an equilibrium between different conformations.
Opsin∗ resembles the active conformation and is capable of activating transducin.
Opsin∗∗ is the conformation for retinal entry. We postulate that the overall backbone of
Opsin∗∗ is closer to the inactive conformation than to the active conformation. B) The
location of retinal entry site Opening C (red circle) are shown on the polypeptide
backbone of dark-state Rho. The key residues F208, F212 and A269 are shown as sticks
in blue. Opening B (red dash circle) found in the active conformation are one turn of
helix above Opening C.
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retinal, into the ligand binding channel. Various lines of evidence have demonstrated that
the active conformation makes the ligand binding channel more accessible to all-transretinal. It was also known that a lower pH promotes the active conformation (Vogel and
Siebert, 2001) and that all-trans-retinal stimulates opsin’s ability to activate transducin
only at weakly acidic pH (Sachs et al., 2000), indicating a correlation between active
conformation and all-trans-retinal binding. Two activating mutations, E113Q (Sakmar et
al., 1989) and M257Y (Schafer and Farrens, 2015) have been shown to enable opsin to
bind with all-trans retinal. Mutant opsin stabilized towards active conformation was
shown to have higher affinity for all-trans-retinal binding than for 11-cis-retinal (Schafer
and Farrens, 2015). Thus if the active conformation theory is true, opsin’s affinity with
all-trans-retinal should have been much higher than what has been observed. In fact, the
ligand-free opsin with the active conformation was obtained at pH 6.0 (Park et al., 2008).
Thus we contend that this structure is not the suitable basis for understanding retinal
entry.
However, we agree that the Meta-II Rho structure (Choe et al., 2011) reflects the
conformation when retinal release occurs. The susceptibility of the Schiff base to
hydroxylamine (Wald and Brown, 1953) and sodium borohydride (Bownds and Wald,
1965) indicates the receptor maintains until the hydrolysis of Schiff base. Also, it has
been shown that TM3 resetting and retinal release as measured by the increase in Trp
fluorescence are tightly coupled (Farrens and Khorana, 1995). The two openings provides
ready egresses for retinal to dissociate from the binding channel.
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4.4.3 The retinal entry site is located between TM5 and TM6
We next came to the conclusion that the entry site is located between TM5 and
TM6. First, we have identified a cluster of mutations on TM5 and TM6 that exert a
significant impact on the entry kinetics, but not the release kinetics. The TM5/6
mutations are distal from the PSB and are unlikely to perturb the formation or hydrolysis
of imine. Moreover, in Chapter 3 we have shown that the energy barrier for retinal
binding measured by the Trp-based fluorescence quenching assay and the Alexa488based assay are essentially the same, which suggests that in the process of pigment
regeneration, it is the first step (i.e. retinal entering into the ligand binding channel, rather
than the formation of Schiff base bond) that determines the overall reaction rate.
Therefore, these mutations can have such a pronounced effect only by modulating the
accessibility of the retinal-binding channel. Second, we found that two mutations, F208W
and F212A, changed the activation enthalpy of retinal entry, suggesting these two sites
may directly interact with the incoming retinal. If an opening between TM5 and TM6 do
mediate retinal entry, then the aldehyde group should precede the polyene chain and the
β-ionone ring to gain access to the binding channel. This scenario would explain our
observation that polar residues would reduce the entry kinetics, as the hydroxyl group
may interact with the carbonyl group of retinal through dipole-dipole interaction or
hydrogen bonding. Furthermore, the entry kinetics is insensitive to mutations at F293
(Piechnick et al., 2012), which is a key gating residue at Opening A.
4.4.4 F208, F212 and A269 are likely to be part of the entry site
Then which residues in TM5 and TM6 constitute the entry site? The emergence of
Opening B requires the rotation of TM5 and TM6. However, we have excluded this
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conformation to be responsible for retinal entry. We postulate that the actual opening is
comprised of three residues, F208, F212 and A269 (Opening C), which are situated one
turn of helix lower than Opening B exposed in the Meta-II structure. The electron density
at Opening C in dark-state Rho is lower than what is generally found between other
helices (Okada, 2004). The ligand-free opsin is flexible and dynamic than dark-state Rho,
and a sufficiently large opening may be created by the motion of TM5 and TM6 and the
rotation of the side chains. Our mutagenesis data support the presence of Opening C.
F212 is a conserved residue in Rho and short-wavelength sensitive cone receptor. A
series of F212 mutations (F212A/C/S/T/W) have a significant impact on the retinal entry
kinetics, supporting its essential role in retinal entry. The behavior of site 269 resembles
that of site 212: increasing side-chain size or polarity at site 212 and 269 invariably
impeded retinal entry. By comparison, increasing side-chain size (G270F) and polarity
(G270S) at site 270 barely affected the entry kinetics, suggesting these effects are specific
to the sites located on the trajectory of incoming retinal.
The behaviors of F208 and F273 mutants are different from F212 and A269
mutants. The effect of F208W is to decrease entry kinetics and increase the activation
enthalpy. However, the slower entry kinetics for F208A is counterintuitive, as this
mutation is expected to make Opening C larger. The finding that F273A reduced entry
kinetics and F273W accelerated it is also puzzling. Similar observations have been
reported for F208A and F273A (Schafer et al., 2015). It should be kept in mind that the
effect of these hydrophobic mutations can be multi-fold: 1) it may change the sterical
hindrance at Opening C; 2) it may alter the residue’s interaction with its neighboring
residues; 3) it may affect the dynamics of helix motion; 4) it may disrupt the overall
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folding. The first effect regarding sterical hindrance is relevant only to those sites that are
part of Opening C. The second and the third effect are not so critically dependent on the
mutation’s closeness to Opening C, but are likely to diminish at the distance increases.
We tried to avoid the fourth effect by judicious choice of mutation. One plausible cause
for the unexpected entry kinetics of F208A, F273A and F273W is the π-π stacking
interaction between F212-F208 and F208-F273. In both inactive conformation and active
conformation, the T-shaped or parallel-displaced orientation of these three phenylalanines
are for adequate for π-π stacking to occur (McGaughey et al., 1998). Therefore, F212,
F208 and F273 are possibly coupled to fine-tune the dynamics of Opening C. Consistent
with this idea, the F273A/W mutations exert a less significant effect than F208 and F212
mutation the activation enthalpy and entropy of retinal entry kinetics. Furthermore, the
phenyl group of F208 may serve as the spacer for the upper rim of Opening C, and
removing the side chain of F208 caused the opening to partially collapse. It has been
reported that F208 and A269 are functionally complementary; they together act as a pivot
between TM5 and TM6 (Tsukamoto et al., 2010). We do not rule out the possibility that
F208A has produced some unpredictable consequence.
4.4.5 The retinal exit site
In the end we asked in which direction retinal moves out of the ligand-binding
channel. Addition of hydroxylamine accelerates retinal release by more than 102 fold,
thus the rate-limiting step in retinal release is likely to be Schiff base hydrolysis rather
than retinal egress from the binding pocket. The implication of this rate-limiting step is
that we cannot exclude Opening B as the exit site simply because most TM5/TM6
mutations do not significantly alter the release kinetics. It is possible that retinal
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promiscuously uses Opening A and B for exit. Molecular dynamic simulation using the
ligand-free opsin structure suggested that TM5-TM6 opening is more frequently utilized
than the TM1-TM7 opening for exit (Wang and Duan, 2011). However, we noticed that
increasing the side-chain size at A272 (A272V/I/F) greatly accelerated retinal releases
(Piechnick et al., 2012). In the Meta-II state, the side chain of A272 directly interacts
with the β-ionone ring of all-trans-retinal. Thus, a straightforward explanation is that
A272V/I/F may “push” the retinal out of the binding channel once Opening A becomes
available. These data suggest that exit through Opening A is a possible scenario.
4.4.6 Comparison with the previously published mutagenesis data on retinal entry
and release
In an earlier study, Piechnick et al. characterized the retinal entry and release
kinetics for mutations in the middle of ligand binding channel, close to Opening A, and
close to Opening B (Figure 4-8) (Piechnick et al., 2012). For retinal entry, Piechnick et
a.l used UV-Vis spectroscopy to monitor retinal entry, in reality the formation of PSB
(although these kinetics of the two processes are often numerically close). Retinal release
was measured by change in Trp fluorescence.
Not surprisingly, drastic changes in retinal entry and release kinetics were
observed for mutations in the middle of ligand binding pocket (E181, S186, Y268,
A292). E181 has been suggested to act together with S186 as a counterion to stabilize the
PSB in Meta-I state (Ludeke et al., 2005; Sekharan and Buss, 2008). The observation that
E181Q on Meta-II decay has been described (Lewis et al., 2004). E181, S186 and Y268
have been identified as part of the hydrogen bonding network for maintaining PSB
stability in the dark-state and regulating its hydrolysis in the photoactivated state (Choe et
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al., 2011; Janz and Farrens, 2004). A292 has been found to make contact the C14 of 11cis-retinal with E181 (Okada et al., 2004). Increasing its side-chain size (A292V/L/F) is
retinal with E181 (Okada et al., 2004). Increasing its side-chain size (A292V/L/F) is
expected to add a constriction site for retinal to move through the binding channel, hence
explaining the simultaneously reduced entry and release kinetics.
Among the mutations close to Opening A (M39, L40, Y43, M44, F91, T94, T289,
F293), M39, as the structure and kinetic data suggested, may be too distal from Opening
A to have a significant effect. L40, M44 and F91 are situated on the trajectory of retinal if
it would move through Opening A, and mutating these residues is expected to be
consequential. However, any mutation inside the helix bundle has a theoretical possibility
of disrupting the native folding of ligand binding channel and consequently alter the
retinal entry or release kinetics. Replacing a non-polar residue to a polar or charged one
(e.g. L40D) may cause a rearrangement of the internal hydrogen-bonding network.
Moreover, switching between aliphatic and aromatic residue can make a significant
difference by creating or abolishing cation-π or π-π interaction (note that the protonated
Schiff base is positively charged). Y43 has been found make hydrogen bonding with the
carbonyl oxygen of F293 in dark-state Rho, whose breaking is required for transition to
Meta-II state (Adamian and Liang, 2002; Tikhonova et al., 2008). T94 and T289
participate in a conserved internal hydrogen bonding network that also involves E181,
S186 (Choe et al., 2011; Janz and Farrens, 2004). Therefore, the observed slower retinal
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Figure 4-8. The sites studied in the previous report (Piechnick et al., 2012). A) The
sites whose side chains point into the helix bundle (top view). B) The sites are participate
in the internal hydrogen bonding network (top view). C) The sites at Opening A (top
view). D) The sites at Opening A (side view). The N-terminus and EC loops are removed
in the top view to reveal the retinal and highlighted residues.
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entry for T289A/D/R/F and T94I mutants might arise from alteration in Schiff base
chemistry. The slower Meta-II decay rate for T94I has been described previously (Gross
et al., 2003a). Among all residues close to Opening A, F293 exhibits the greatest
structural change in photoactivation. The essentially unchanged retinal entry kinetics for
F293 mutations fits into our model, i.e., the conformation for retinal uptake resembles
that of the inactive state, and Opening C between TM5 and TM6 is used for retinal entry.
For retinal release, since the phenyl group of F293 has been completely displaced from
the exit site, F293A/L mutations would not make a great difference with respect to
sterical hindrance.
In agreement with our observation that mutations at TM5/6 generally do not
perturb the retinal release, in the set of mutations chosen by Piechnick et al. (V204, I205,
M207, F208, F273, F276), I205Q, F208L/Q, F273L/Q and F276L/Q exhibited retinal
release kinetics similar to that of wt Rho. However, a confounding finding was that
mutations M207A, A272V/I, and V204F significantly increased retinal release kinetics.
A scrutiny of the structure reveals that the side chains of A272 and V204 protrude into
the helix bundle, particularly A272, which makes direct contacts with the β-ionone ring
of all trans-retinal in Meta-II state (Choe et al., 2011). Thus apart from the possibility to
disrupt the overall folding of ligand binding channel, substituting A272 for larger
residues may result in clashes between the β-ionone ring and site 272, thus explaining the
highly accelerated retinal release rate for A272I. M207 has been predicted a key residue
for the formation of retinal binding pocket (Moitra et al., 2012) and the mutation M207A
possibly makes the binding pocket less adequate for retinal to dock, resulting in the
reduced entry kinetics and increased release kinetics. F208L was also tested in our study,
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for which we obtained a retinal entry rate close to that of wt, while Piechnick et al. found
it slowed down entry kinetics. Interestingly, Piechnick et al. also observed that adding
polar groups to TM5/6 residues (L→Q) slowed down retinal entry.
Overall, the observed effects for most of the mutations reported in this earlier
study could be explained by existing structural, biochemical and spectroscopical data on
Rho. However, many of these mutations are incapable of providing clear evidence on the
question addressed in the present study, as they are likely to cause rearrangement of
hydrogen bonding network or abnormal folding of ligand binding channel. Based on the
above analysis, we reasoned that it is crucial to test the residues that primarily act as the
“gate” of the retinal entry or exit site.
4.4.6 Perspective and future direction
Several additional mutants or experiments may be considered to help clarify the
mechanism for retinal entry in opsin. First, the Eyring plot of F208A and an A269 mutant
(A269L or A269F) may provide insights into the role of F208 and A269 in regulating
Opening C. Second, the double mutant F208A/A269F may answer whether F208 and
A269 are functionally complementary with respect to retinal entry. Third, F293W mutant
can be used to assess the role of Opening A in retinal release.
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4.5

Materials and Methods
The methods for heterologous expression of wt and mutant Rho, site-specific

fluorescent labeling of azF-Rho, and measurement of the retinal entry and release kinetics
have been described in Chapter 2 and Chapter 3.
4.5.1

Site-directed mutagenesis
Rho mutants are created on the wt background or S144amb background. The

primers used to generate these mutations are listed in Table 4-1.
Table 4-1 The primers for site-directed mutagenesis

Mutation

Forward (5’→3’)

Reverse (5’→3’)

F208A
F028S
F208L
F208M
F208Y
F208W
F212A
F212C
F212T
F212S
F212L
F212W
A269T
A269S
A269F
A269Y
G270A
G270L
G270F
F273A
F273W

catctacatggccgtggtccacttcatc
catctacatgtccgtggtccacttcatc
catctacatgctggtggtccacttcatc
catctacatgatggtggtccacttcatc
catctacatgtacgtggtccacttcatc
catctacatgtgggtggtccacttcatc
gttcgtggtccacgccatcatcccgctg
gttcgtggtccactgcatcatcccgctg
gttcgtggtccacaccatcatcccgctg
gttcgtggtccactccatcatcccgctg
gttcgtggtccacctgatcatcccgctg
cgtggtccactggatcatcccgctgattg
gctgccatataccggtgtggcgttctac
ctgccatatagcggtgtggcgttctacatc
ctgccatatttcggtgtggcgttctacatc
gctgccatattacggtgtggcgttctac
ctgccatatgctgccgtggcgttctacatc
ctgccatatgctctggtggcgttctacatc
ctgccatatgctttcgtggcgttctacatc
ctggtgtggcggcctacatcttcacccatc
ctggtgtggcgtggtacatcttcacccatc

gatgaagtggaccacggccatgtagatg
gatgaagtggaccacggacatgtagatg
gatgaagtggaccaccagcatgtagatg
gatgaagtggaccaccatcatgtagatg
gatgaagtggaccacgtacatgtagatg
gatgaagtggaccacccacatgtagatg
cagcgggatgatggcgtggaccacgaac
cagcgggatgatgcagtggaccacgaac
cagcgggatgatggtgtggaccacgaac
cagcgggatgatggagtggaccacgaac
cagcgggatgatcaggtggaccacgaac
caatcagcgggatgatccagtggaccacg
gtagaacgccacaccgtaatatggcagc
gatgtagaacgccacaccgctatatggcag
gatgtagaacgccacaccgaaatatggcag
gtagaacgccacaccgtaatatggcagc
gatgtagaacgccacggcagcatatggcag
gatgtagaacgccaccagagcatatggcag
gatgtagaacgccacgaaagcatatggcag
gatgggtgaagatgtaggccgccacaccag
gatgggtgaagatgtaccacgccacaccag
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Chapter Five: Conclusion and Perspective

5.1 Developing novel chemical biology tools for studying GPCRs
This thesis presents a general approach for the labeling of GPCRs with useful
chemical probes or chemically reactive handles at defined sites by combining unnatural
amino acid (uaa) mutagenesis and bioorthogonal chemistry. A comparative study was
conducted to assess several different strategies for labeling uaa residues genetically
encoded into GPCRs expressed in mammalian cells in culture. Using the visual pigment
Rho as a model GPCR, the strain-promoted [3+2] azide-alkyne reaction (SpAAC)
between dibenzocyclooctyne (DIBO) and p-azido-L-phenylalanine (azF) was shown to be
a suitable strategy for attaching labels to GPCRs. Then the specificity, kinetics, and
topology-dependent reactivity of the labeling chemistry were characterized for Rho. The
reaction rate of SpAAC with azF situated in the transmembrane region of the receptor
was found to exhibit up to 1000-fold enhancement, which was attributed to DIBO
partitioning into the hydrophobic core of micelles. The capability of labeling residues
embedded in hydrophobic environment makes the combination of SpAAC with azF a
promising approach for studying membrane proteins. In conclusion, the methods
described in this thesis add to the chemical biology tool kit for probing the structurefunction relationship in GPCRs.
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5.2

The applications of the bioorthogonal labeling strategy

5.2.1

A FRET-based assay for measuring ligand binding kinetics of GPCRs
The possibility of attaching extrinsic fluorescent reporters to GPCRs enabled a

general scheme for measuring ligand-binding kinetics based on the FRET between the
ligand and the fluorescent reporter. The ligand can be chemically modified to make a
FRET pair with the fluorescent label. In the case of Alexa488-labeled Rho, the ligand 11cis-retinal is natural chromophore, which is capable of quenching the fluorescence of
Alexa488. Thus the kinetics of the recombination reaction between the ligand-free opsin
and 11-cis-retinal can be monitored by the decrease of Alexa488 signal. Compared with
the assays based on the intrinsic tryptophan fluorescence, the extrinsic fluorescent
reporters can be tailored to have optimal photophysical properties so as to enhance the
sensitivity and dynamic range of the ligand-binding assay.
This assay was first utilized to address the energetics of the recombination
reaction between opsin and 11-cis-retinal. The activation energy for retinal binding was
obtained from the temperature-dependent retinal entry kinetics. The activation energy for
the reverse reaction was measured by chromophore exchange of the bound 11-cis-retinal
with exogenous 9-cis-retinal. The reaction enthalpy was measured by ITC. Based on
these results, the complete energy diagram was derived for the binding between 11-cisretinal and opsin.
Next this ligand-binding assay was applied to study the mutations of highly
conserved amino acid residues putatively involved in the pathway for retinal entry and/or
release. A set of mutations located at the fifth and sixth transmembrane (TM) helices was
found to exert a much greater influence on the retinal entry kinetics than on the retinal
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release kinetics. Three criteria were used to evaluate the influence of these mutations: 1)
the correlation between side-chain size and entry kinetics; 2) the change in the activation
energy for retinal entry; 3) the effect of increasing polarity at these sites. Based on these
findings, a model was proposed to describe the retinal entry pathway leading from the
membrane-embedded receptor surface to the ligand-biding site in the transmembrane
core.
5.2.2

Single-molecule fluorescence study of fluorescently labeled GPCRs
The temporal resolution and the capability of multi-color tracking make single-

molecule fluorescence ideally suited for probing the signaling complex of GPCRs. We
developed a single-molecule total internal reflection fluorescence (smTIRF) platform to
image fluorescently labeled receptors and the dynamic assembly of the signaling complex
(Huber and Sakmar, 2011). TIRF methods enable selective excitation of fluorophores by
the evanescent wave immediately adjacent to the glass-water interface. The fluorescent
labeled receptors are captured to the TIRF surface via antigen-antibody interaction to
facilitate long-term visualization of the ligand-receptor binding dynamics. The brightness
and photostability of organic dyes make them better choices than fluorescent proteins for
tracking the binding events at time scales of hours.
We tested Rho labeled with three different Alexa fluorophores at position 144 on
the single-molecule TIRF set-up (Figure 5-1) (Tian et al., 2013a). We were able to
distinguish the signals from different fluorophores in the QuadView detection scheme,
and register the position of labeled receptors in the TIRF image. In principle, receptor
demonization and receptor-ligand binding can be determined from the co-localization of
different fluorescent labels. However, co-localization is limited by the axial and lateral
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resolution of the TIRF microscope, which are one or two orders of magnitude larger than
the dimension of receptors (< 5 nm). Thus co-localization of fluorophores is a necessary,
but not sufficient criterion for identifying intermolecular interaction.

Figure 5-1. Images of single-fluorophore spots. One side of the quadratic image
corresponds to 40 µm in the sample plane. A) The QuadView image of Alexa488 Rho,
Alexa555-Rho and Alexa647-Rho. B) A false color image of the same data after
subtraction of static background from “hot” pixels of the CCD sensor and after
application of a 2D convolution with a spot-enhancing filter that was shown to be the
optimal detector of a Gaussian-like spot in 1/ω2 noise (Sage et al., 2005). C) The merged
pseudo-color image of the three detection channels. Figure taken from (Tian et al.,
2013b).
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Figure 5-2. The smTIRF images for Alexa555-labeled and Alexa647-labeled Rho.
Three channels were recorded at the same time: 1) excitation: 532 nm; emission: 555 nm595 nm (cyan, donor channel); 2) excitation: 642 nm; emission: 655 nm-705 nm (red,
acceptor channel); 3) excitation: 532 nm; emission: 655 nm-705 nm (green, FRET
channel). Each image contains the following samples: A) S144-Alexa555 Rho (cyan). B)
S144-Alexa647 Rho (red). C) The mixture of S144-Alexa555 Rho and S144-Alexa647
Rho (cyan + red). D) S144azF Rho co-labeled with Alexa555-DIBO and Alexa647DIBO, i.e., one sample was treated simultaneously with two labeling reagents and then
purified together. In this particular sample, a number of FRET signal could be detected.
Because the FRET signal (green) overlaps with the acceptor signal (red), the merged
signals are represented as yellow dots (circled).
Another approach for detecting intermolecular interaction is to monitor the FRET
signal between donor and acceptor fluorophores. The energy transfer is sensitive to small
changes of the distance on the nanoscale (Holden et al., 2014). We used Alexa555-Rho
and Alexa647-Rho to test the capability of the smTIRF platform for FRET detection. We
made an interesting observation for S144azF Rho simultaneously reacted with Alexa555-
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DIBO and Alexa647-DIBO. When S144-Alexa555 Rho and S144-Alexa647 Rho were
mixed together, few FRET signals were observed. By comparison, FRET spots were
readily detected for Rho co-labeled with two fluorophores (Figure 5-2, white circle).
Because each azF-tagged receptor only possesses one reactive handle, the FRET signals
suggest the presence of constitutive dimers in heterologously expressed Rho.
5.2.3

Site-specific bioorthogonal labeling of the chemokine CCR5 receptor
The C-C chemokine receptor 5 (CCR5) is a Class A GPCR. It is expressed on the

cell surface of leukocytes and activated by the chemotactic cytokines (chemokines), such
as macrophage inflammatory protein-1α (MIP-1α, also known as CCL3), MIP-1β
(CCL4), and regulated-and-normal-T cell-expressed and secreted (RANTES, or CCL5).
CCR5 receptor is implicated in inflammatory response. More importantly, CCR5 is
hijacked by the human immunodeficiency virus (HIV) to facilitate viral entry. The viral
envelope protein gp120 forms a tertiary complex with CCR5 and another cell-surface
glycoprotein CD4, which attaches the virus to the outer surface of host cell and
subsequently induces membrane fusion. The finding that a deletion mutation CCR5Δ32
confers resistance to macrophage-tropic HIV-1 strain has substantiated the essential role
of CCR5 in HIV infection. Therefore, molecules that block the CCR5 receptor are
potentially useful for inhibiting HIV entry. In 2007, Maraviroc, a small molecule that
binds to a cavity of CCR5, became the first FDA-approved CCR5-specific HIV entry
blocker.
We are interested in utilizing our smTIRF capability to understand the dynamic
assembly of CCR5 signaling complex. However, the CCR5 receptor bears multiple
cysteines and cannot be site-specifically labeled using maleimide or sulfonate chemistry.
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Figure 5-3. The multiplex detection scheme for FLAG-tagged CCR5 receptor using
a sandwich fluorophore-linked immunosorbent assay. A) The uaa azF genetically
encoded at a target site. SpAAC reaction is used to site-specifically attach the FLAG
peptide-epitope (green) conjugated to a DBCO (red) via a maleimide crosslinker
(DBCO-FLAG). B) Upper panel: the schematic diagram of the immunosorbent assay
(ISA) to detect the expression levels of wt and F96azF-CCR5. The receptor is captured to
the plate surface using the C-terminal-specific 1D4 mAb. The N-terminal epitope of
CCR5 is probed using anti-CCR5 T21/8-biotin mAb followed by streptavidin coupled to
IRDye 680RD (SA-680RD). Lower panel: the corresponding fluorescence image of the
triplicate wells (pseudo color: red, detected in the 700-nm channel). C) Upper panel: the
schematic diagram for detecting the labeling efficiencies of wt and F96azF-CCR5 with
DBCO-FLAG. With the receptor immobilized to the plate surface with the C-terminalspecific 1D4 mAb, the FLAG tag epitope of CCR5 is probed with anti-FLAG pAb
followed by anti-rabbit Gig conjugated to IRDye 800CW (anti-R800CW). Lower panel:
the corresponding fluorescence image of the triplicate wells (pseudo color: green,
detected in the 800 nm-channel). D) Upper panel: the schematic diagram of ISA
experiment for FLAG-labeled CCR5. The dual-color detection enabled simultaneous
quantification of the receptor expression level and the labeling efficiency by DBCOFLAG. Lower panel: the corresponding fluorescence image of the triplicate wells shown
for both the N-terminal epitope signal (red, 700-nm channel) and FLAG signal (green,
800-nm channel). Wells containing wt CCR5 treated with DBCO-FLAG shows a strong
N-terminal epitope signal, but much weaker FLAG signal. Wells containing F96azFCCR5 treated under the same reaction condition yielded strongly both the N-terminal
epitope signal and FLAG signal, indicating the presence of expressed full-length receptor
tagging with a FLAG epitope (merged, yellow). E) The integrated intensities of the wells
shown in B-D, plotted in arbitrary units (a.u.). The expression of wt CCR5 and F96azFCCR5 (red bars) and the level of FLAG signal indicate specific labeling of F96azFCCR5 (green bars). The data are presented from a representative experiment and error
bars represent the standard error of the mean of triplicate measurements. Figure taken
from (Naganathan et al., 2015).
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Thus, we would like to apply SpAAC to generate fluorescently labeled CCR5
receptor. However, the expression level of azF-CCR5 is one order of magnitude lower
than that of azF-Rho, making in-gel fluorescence and UV-Vis spectroscopy inadequate
for quantifying the extent of labeling. To efficiently identify sites that are amenable for
covalent modification, we designed a sandwich fluorophore-linked immunosorbent assay
to enable semi-high throughput microtiter plate-based detection of labeled CCR5 receptor
(Figure 5-3A) (Naganathan et al., 2015). We chose FLAG-DBCO, a dibenzocyclooctyne
reagent carrying a FLAG detection handle, to modify a set of 32 azF-CCR5 variant. The
labeled receptors are immobilized to the surface of microtiter plate using the C-terminal
specific 1D4 mAb. The N-terminus was probed with the N-terminal specific mAb, and
the FLAG tag with the anti-FLAG polyclonal antibody. The secondary antibodies each
carry two different IR fluorophores, which can be quantified independently in two IR
channels. This multiplex detection scheme enables simultaneous quantification of
receptor expression and label incorporation.
We found that F109, a site located in the hydrophobic cavity of CCR5, to be
particularly reactive with FLAG-DBCO (Figure 5-3B). In the crystal structure of CCR5
in complex with Maraviroc, F109 makes hydrophobic contacts with a phenyl ring of
Maraviroc (Tan et al., 2013). We propose to exploit the high reactivity between site
F109azF and DBCO to engineer tethered ligand that modulates the biological activity of
CCR5. While small molecule is a popular tool for probing protein function, the affinity
between the candidate small molecules and the target protein can be too low to be
practical. Creating a covalent linkage between ligand and target protein can circumvent
this issue. The high reactivity of F109azF is also in line with the earlier observations from
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labeling Rho that dibenzocyclooctyne reagents preferably label the hydrophobic
transmembrane region of the receptor.
In the next stage of work to interrogate the GPCR “signalosome,” we would like
to carry out smTIRF studies on the binding events between CCR5 receptor and various
ligands. The knowledge obtained from the labeling studies of the TM region of Rho will
be useful to design and prepare fluorescently labeled CCR5 receptor variants suitable for
FRET analysis. We would also like to generate dual-color labeled CCR5 receptor by
combining SpAAC with self-labeling SNAP/CLIP tags. This doubly labeled receptor
may yield further insights into the conformational dynamics of the CCR5 receptor in the
presence of ligands with various pharmacological characteristics. Progress along these
lines has already been achieved. In the longer term, we anticipate that the smTIRF
approach enabled by the chemical biology methods described here will shed light on the
allosteric regulation of the GPCR signaling complex and may lead to new approaches to
drug discovery.
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Appendix One: Analysis of the filtration of Alexa488-DIBO in DM
•

Symbols: c, concentration; n, amount of substance; V, volume; P, partition
coefficient; f , weight/volume percent of DM.

•

Superscript: B, bound; F, free; mic, micelle; buf, buffer.

•

Subscripts: 0, the initial condition; t, the condition at time point t; 1, filtrate; 2,
retentate.

The concentration of DM-micelle bound and free Alexa488-DIBO
The partition coefficient of Alexa488-DIBO between DM micelles and buffer is
defined as:

P=

cB
cF

Eq. (1)

Here “bound” denotes the Alexa488-DIBO molecules in the DM micelle, and
“free” the molecules in the buffer. It can be re-written as:

n B / V mic
P = F buf
n /V

Eq.(2)

The total volume of the solution equals the addition of the volume of DM micelle
and the volume of buffer.
V = V mic + V buf

Eq.(3)

Assuming the density of DM micelles is very close to that of water, the ratio of
the volume of DM and the volume of buffer numerically equals the weight/volume
percent (f) of DM:

V mic / V = f

Eq.(4)

Because f is generally below 0.01, Vmic is neglegible compared to Vbuf.
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V buf ≈ V

Eq.(5)

The total moles of DM (n) is:
n = nB + nF

Eq.(6)

The amount of Alexa488-DIBO in the micelles is:

nB =

Pf
n
1 + Pf

Eq.(7)

1
n
1 + Pf

Eq.(8)

and

nF =

The molar concentrations of Alexa488-DIBO bound in DM micelles and free in
the buffer are:
cB =

n
nB
Pf
=
mic
1 + Pf V buf
V

Eq.(9)

cF =

n
nF
1
=
buf
1 + Pf V buf
V

Eq.(10)

and

Substitute Eq. (4) into Eq.(9), and Eq.(5) into Eq.(10) we have

cB =

P n
P
1 n
=
c Eq.(11) and c F =
1 + Pf V 1 + Pf
1 + Pf V

Eq.(12)

Because the apparent concentration (c) was used to calculate the reaction rate (k2),
the rate enhancement factor is P/(1+Pf). It can be seen that for a given P, using lower
concentration of DM (smaller f) gives higher effective concentration. Practically the
concentration of DM must be above its critical micelle concentration (CMC), which is
0.17 mM, corresponding to 0.009% (w/v) to prevent precipitation of Rho. In our labeling
and kinetics study we used 0.1% (w/v).
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Derivation of the partition coefficient (P) from the filtration experiment
As the volume of the retentate decreases during centrifugation, the weight/volume
percent of DM is:
f=

V2, 0
f0
V2, t

Eq.(13)

The amount of free Alexa488-DIBO in the retentate is:

n2F =

1
n2
1 + Pf

Eq.(14)

Substitute Eq.(13) into Eq.(14)

n2F =

1
n2
1 + Pf0V2, 0 / V2, t

Eq.(15)

The concentration of free Alexa488-DIBO is:
c2F =

n2F
n2
=
V2, t V2, t + Pf0V2, 0

Eq.(16)

Assuming fast equlibrium of Alexa488-DIBO between DM micelles and buffer,
and only the Alexa488-DIBO in the buffer can flow through the membrane, thus the
concentration of Alexa488-DIBO in the filtrate is equal to that of the free Alexa488DIBO in the retentate:
c1, t = c2F

Eq.(17)

Substitute Eq.(17) into Eq. (18), we have:
c1, t =

c2, tV2, t
V2, t + Pf0V2, 0

Eq.(18)

Notice that V2, 0 = V0 = V1, t + V2, t
Eq.(19) Substitute Eq. (19) into Eq.(18) and rearrange, we have:
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P=

(c

2, t

− c1, t )V2, t

Eq.(20)

c1, t (V1, t + V2, t ) f0
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Appendix Two: the diffusion of retinal among bicelles

Estimation of the numbers of POPC and CHAPS molecules in one bicelle
Bicelles of different compositions are characterized by the molar ratio of longchain to short-chain component, denoted as q value. Here q = [POPC]/[CHAPS]. We
assume the simplest scenario where the bicelle appears to be a disc with Rho at the center
(Figure A-1, Panel B).

Figure A-1. The schematic representation of Rho reconstituted into bicelles. A) Side
view. B) Schematic view from the top.

In our bicelle buffer, the concentrations of POPC and CHAPS are both 1 mg
mL−1, and their molar concentrations are 1.3 mM and 1.6 mM, respectively, and the q
value is 0.81. The headgroup area of phosphatidylcholine is 0.71 nm2. CHAPS have a
high critical micelle concentration (CMC) of 8 to 10 mM. Thus we can assume that there
is no CHAPS micelle in the solution. We further assume that the CHAPS layer around
the rim of POPC has only one molecule, and the percentage of CHAPS dispersed in
solution is negligible. CHAPS is a bean-like detergent and it is difficult to estimate their
geometrical dimension. Here we assume that each CHAPS molecule stretches a length of
0.5 nm along the circumference of the bicelle.
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The dimension of Rho has been determined by X-ray crystallography. If described
by an ellipsoid, Rho is approximately 75 Å in height (perpendicular to the membrane), 48
Å wide in the standard view, and 35Å thick (Palczewski et al., 2000). To simplify the
issue, we assume Rho is cylindrical with a height of 75 Å and a radius of 23 Å, so that the
area of cross section remains the same.
The relationship between the numbers of POPC and CHAPS molecules are given
by the following equation:

q=

π ( r22 − r12 ) / APOPC
2π r2 / dCHAPS

= 0.81 APOPC = 0.71 nm 2

r1 = 2.3 nm dCHAPS = 0.5 nm

r2 = 3.72 nm
In each bicelle, the number of POPC is given by:

π ( r22 − r12 ) / APOPC
The calculation shows that there are 38 molecules of POPC in each lipid layer of
the bicelle. A bicelle has two layers of lipids. So there are approximately 76 POPC
molecules and 94 CHAPS molecules. The molar concentration of POPC/CHAPS bicelles
is 17 µM.

The kinetics of retinal diffusion among bicelles
In the experiment for measuring Rho regeneration kinetics, we added 20 µL of
POPC/CHAPS bicelle buffer containing 25~50 µM retinal into 480 µL of sample. The
resulting total concentration of 11-cis-retinal normally ranged from 1 µM to 2 µM. The
molar concentration of POPC/CHAPS bicelles is 17 µM, which means each bicelle has on
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average of 0.06 ∼ 0.12 retinal molecule. The concentration of Rho is 0. 25-0.30 µM.
Therefore, not every bicelle necessarily contains one molecule of Rho and at least one
molecule of retinal at the same time, and the diffusion of retinal among bicelles is
potentially a rate-limiting step. Therefore, we would like to find out what is the reaction
rate for the association reaction between Rho+ bicelles and retinal.
Let A represent bicelle, B represent retinal. The diffusion of retinal from one
retinal to another consists of two steps. First, a retinal dissociates from a bicelle. Assume
that process follows the first-order kinetics, with a time constant k1. k1 is related to the
size, shape and composition of bicelle. The rate of dissociation is:

r1 = k1 [ AB]
Second, retinal collides with a bicelle and partitions into it. This process follows
bimolecular kinetics, with a time constant k2. The rate of association is

r2 = k2 [ A ][ B]
Note that here [A] and [B] are the concentration of bicelles and retinal in the
aqueous phase. At equilibrium, the rate of association equals the rate of dissociation:

k1 [ AB] = k2 [ A ][ B]
The equilibrium constant is:

K eq =

[ AB] = k2
[ A ][ B] k1

Although the partition coefficient of retinal among bicelles (Keq) has not been
measured, it is known to be very high. A previous study on the partition of retinal
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between salamander rod cell membranes reported a partition coefficient of (1.6 ± 0.5) ×
108 (Frederiksen et al., 2012). Therefore, k2 >> k1, and the rate-limiting step for retinal
diffusion among bicelles is the time required for a free retinal in water to collide with a
bicelle.
The concentration of free retinals in the aqueous phase is proportional to the
apparent concentration of retinal in the entire system (cB).

[B] =

1
cB = α cB
1 + Pf

1
=α
1 + Pf

Here P is the partition coefficient of retinal between bicelle and water, and f is the
weight/volume percent. Let the apparent concentration of bicelle be cA.

r2 = α k2 cA cB = k2' cA cB
Therefore, the rate of diffusion is proportional to the apparent concentration of
retinal and bicelles. If the concentration of retinal is in large excess, then the observed
psuedo first order rate constant for bicelle is

kobs = k2' cB
In the stop-flow experiment, we could not reliably measure the quenching of
pyrene fluorescence at a low concentration of retinal (e.g. 1.5 µM) on our stop-flow
apparatus. Therefore, we used bicelles containing 100 µM 11-cis-retinal and retinal-free
bicelles doped with 0.1% β-pyrene-C10-HPC (w/w) at a 1:1 (v/v) ratio. After rapid
mixing, the apparent concentration of 11-cis-retinal was 50 µM, and the concentration of
pyrene+ bicelles was 8.5 µM. For the decay of pyrene fluorescence we obtained a firstorder rate constant of 36 ± 3 s−1.
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k2' = 36 ± 3 s-1 / ( 50 µM ) = ( 7.2 ± 0.6 ) × 10 5 M -1 s-1

In a typical retinal regeneration experiment, the concentration of retinal was
typically 1∼2 µM, the rate constant of retinal diffusion into bicelles is
r2 = ( 7.2 ± 0.6 ) × 10 5 M -1 s-1 × 1.5 µM ≈ 1.0 ± 0.1 s-1

By comparison, the observed first-order rate constant for Rho regeneration
normally falls into the range of 1~2 × 10−3 s−1, three order of magnitude lower than the
retinal diffusion rate. Therefore, we ruled out retinal diffusion among bicelles as the ratelimiting step in the POPC/CHAPS bicelle system, and what we measured reflects the
kinetics of the recombination between retinal and opsin.
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